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SUMMARY
The neurological condition of patients with brain tumours
often improves within 24-36 hours after corticosteroid
steroid effects on the peritumoural oedema. Clinical
studies utilising ICP monitoring, CT and NMR neuroimaging
suggest however that the effects of steroid therapy are
independent of major changes in brain oedema. If the
oedema has no significant pathophysiological effect how do
steroids improve peritumoural brain function? The
hypothesis that clinical dysfunction is not dependent on
the peritumoural oedema alone but on neuro- or
vasomodu1 a11ng substances released by the tumour is
proposed. This proposition is supported by studies which
have shown that tumour products and "activated"
extravasated plasma proteins possess variable neuro-,
vaso- and blood-brain barrier (BBB) modulating properties.
The infusion model of brain oedema was used in 40 cats and
80 rats to evaluate the relationships between brain
oedema, constituents of the oedema fluid and cortical
somatosensory and motor evoked potentials (SEPs and MEPs),
cerebral blood flow (CBF), BBB function and both
intracranial and cerebral biomechanics. Using this model
the effects of focal brain oedema produced by an infusate
of saline could be compared to the effects produced by
infusion of putative vaso- , neuro-, and BBB modulating
compounds (20% protein, bradykinln, arachidonic acid and
human glioma cyst fluid) known to be released by human
gliomas .
All infusates had minimal adverse effects, at normocapnia,
on intracranial and cerebral biomechanics, CBF, SEPs and
MEPs despite a focal increase of brain water content by
10% and the classic histological changes of brain oedema.
therapy. This effect was attributed to the
I
Except for saline all Infusates caused focal BBB opening
and are therefore secondary mediators of vasogenic brain
oedema. The bradykinin, protein and malignant glioma cyst
infusates all caused focal loss of CBF CO-, reactivity.
These results agree with clinical studies that showed no
ischemia in peritumoural oedema, loss of CBF CC>2
reactivity around gliomas, and normal SEPs in peritumoural
brain. These findings suggest that peritumoural brain
dysfunction, in the absence of brain herniation, is
independent of brain oedema but may be related to a
tumour specific, biochemically mediated loss of flow
reserve (CBF CC>2 reactivity). Under conditions of
metabolic stress this could lead to focal peritumoural
brain ischemia via an inverse steal phenomenon. Steroids
could limit impairment of CBF C02 reactivity by inhibiting
glioma protein release, extravasation of plasma protein
through the "leaky" tumour capillaries, and bradykinin
activation. Further studies into the etiology of this
peritumoural vasoparalysis could lead to adjunctive,
alternative and less toxic therapeutic options in the
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PREFACE
Neuroclinicians are familiar with the improvement in the
neurological condition of patients with brain tumours that
often occurs following coricosteroid therapy. Deficits in
motor, sensory, language or visual function may all
resolve within 24-36 hours. This amelioration was
initially attributed to the steroid effects on the
peritumoural oedema (Galicich et a 1 , 1961), a mode of
action that continues to be widely accepted. Clinical
studies utilising ICP monitoring, CT and NMR neuroimaging
suggest however that the effects of steroid therapy are
independent of major changes in brain oedema (Miller et
a 1 , 1977 ; Melnig et a 1, 1976 ; Bell et a 1 , 1987). The
guestion therefore arises as to the relationship between
peritumoural brain oedema and brain dysfunction. If the
oedema has no significant pathophysiological role how do
steroids Improve peritumoural brain function? The
hypothesis that clinical neural dysfunction attributed to
peritu moral brain oedema is , in the absence of
significant brain herniation, not dependent on the
increase in brain water content alone but on vaso- or
neuromodu 1 at i ng substances within the oedema fluid is
proposed. Support for this proposition comes from clinical
and radiological observations in patients with cerebral
neoplasms in whom neurological dysfunction is poorly
correlated to the peritumoural brain oedema (Penn, 1980)
and experimental studies that have shown that
oedematogenic tumour products and "activated" extravasated
plasma proteins possess variable neuro- and vasomodu1 a ting
properties (Baethmann et al, 1980; Wahl et al, 1988).
This thesis describes experimental work that evaluates the
relationships between brain oedema, constituents of the
VU
oedema fluid and aspects of cerebral e1ectrophysio1ogy ,
blood flow, blood brain barrier function and both
craniospinal and cerebral biomechanics. The experimental
models employed in this thesis are elaborations of methods
described in cats and rats (Osterholm et a 1 , 1 969;
Marmarou et a 1, 1980; flritake et a 1 , 1983 ; Chan et a 1,
1983; Black & Hoff, 1985), of cerebral edema produced by
direct intraparenchyma1 infusion or microinjection. These
models, which produce a pseudo-vasogenic brain oedema, are
unlike cryogenic, Ischemic, toxic and tumor implant brain
oedema models, in that they are independent of both a
primary cortical or subcortical brain insult and major
disturbances in ICP dynamics. Using this model the effects
of focal brain oedema produced by an infusate of saline
could be compared to the effects produced by infusion of
20% plasma protein, bradykinin, arachidonlc acid and human
glioma cyst fluid. The effects of oedema alone could
therefore be objectively studied and compared to the
effects of similar volumes of putative neuromodu1 ating and
oedematogen1c infusates. It was hoped that the studies
would provide insights into the pathophysiology of brain




1.1.1 Historical aspects to modern concepts
The first descriptions of brain oedema are attributed
(Bell, 1983) to Hippocrates, who described brain
"swelling" following compound fractures of the skull. Many
cases of cerebral softening described as "ramollisement"
probably referred to brain oedema (Rostan, 1823).
Ramollisement was subdivided into "jaune" and "rouge"
variants depending upon the macroscopic appearance of the
cut surface of the brain (Bennett, 1843; Solly, 1847). Law
(1855) contributed a third variant of cerebral softening
"due to serum in the (cerebral) parenchyma" that
compressed the lateral ventricles. He termed this
"ramollissement blanc" and added that it occurs
"in scrofulous subjects, most commonly females,... ever
obscure in its symptoms, and often baffling the best
directed efforts of medical skill."
By the mid 19th century there were frequent allusions in
Canstatt's Jahrbericht (1856) to brain oedema and
swelling, which were then regarded as synonymous
(Fishman, 1976). These phenomena were recognized in
conditions as diverse as cerebral tuberculoma, syphilitic
gumma, cerebral arterial occlusion, catatonia, epilepsy,
intracranial infection and intoxications, burns and brain
tumours (Law, 1855; Reynolds, 1855; Gowers, 1893;
Reichardt, 1905; Bell, 1983). Brain swelling was
postulated by Andral (1838) to be due to a disturbance of
cerebral blood vessels that led to ".. an exaggeration of
serous fluids to the brain". Bucknill & Tuke (1874) also
considered cerebral oedema as a condition "...in which the
state of the tissue (brain) is permeated by water or
seroslty". The pivotal role of excess tissue water in
brain oedema was however overlooked by most contemporary
1
anatomists and physicians (Law, 1855; Reynolds, 1855).
Pathological studies showed the oedema to be in the
hemispheric white matter, rather than the commissural
fibres, basal ganglia or cortical grey matter (Jaburek,
1936). Histological studies confirmed that the cortical
architecture was generally normal (Terplan, 1 9 3 7 ;
Greenfield, 1939) whilst in the white matter there were
abnormalities in the oligodendroglia (Bailey &
Schaltenbrandt, 1927; Penfield & Cone, 1926), and
swelling and dissolution of astrocytic processes
Alzheimers amoeboid glia (Wohlwill, 1914; Spatz, 1929).
The characteristic white matter changes were dissolution
or rarefaction of the extracellular space, irregular
swelling of the myelin sheaths and axon cylinders,
expansion of the perivascular space and degenerative
changes in the white matter vasculature (Greenfield, 1939;
Scheinker, 1941; 1947; Perret & Kernohan, 1943; Feigin &
Popoff, 1963). The latter features led several workers to
postulate abnormalities of the cerebral capillaries to be
fundamental to oedema formation (Alajouanine and Hornet,
1939; Scheinker, 1941). Paradoxically the initial electron
microscopic (EM) observations in oedematous brain caused
some confusion since they suggested the extracellular
space was only 100-200 A and that oedema was due to
swelling of the glial cells ( Gerschenfe1d et al, 1959:
Luse and Harris, 1960). These errors were later found
to be related to fixation artifacts and to a failure to
study the EM features of white matter (Klatzo, 1967;
Cervos-Navarro and Ferszt, 1980).
In the 1966 presidential address to the American
Association of Neuropathologists, Klatzo (1967) defined
brain oedema as an abnormal accumulation of fluid within
the brain parenchyma that produces volumetric enlargement.
He proposed vasogenic and cytotoxic pathogenic
mechanisms to account for the various findings concerning
2
CP
BrainOedema Type Vasogenic Cytotoxic Hydrostaic Hypo-osmotic
BBB Damaged Usually normal Normal
Variable Normal
OedemaFluid Location Extracellular whitematter Intracellular cortex" white myelinsheath Periventricular whitemat r Extracellular whitematter Intra&Extr eellular
Oedemafluid Plasma exudate Plasma ultrafiltrate CSFfiltrate Water Water
Mode1 Tumour abscess,foca1 irradiation, coldinjury Ischemia Cyanide TET Obstructive hydrocephalus (Kaolin) Hypertension Suddendecompression Water intoxicati n, Hyponatremi
Table1:Featur softhediffer nttyp sbr id ma(af rKl tzo,967;Mill r79)
the biochemical constituents and localisation of the
oedema fluid, cerebral capillary permeability changes and
cellular reactions in different models of brain oedema
(Table 1). Vasogenic brain oedema was caused by increased
BBB permeability, with extravasation of water and plasma
protein into the white matter extracellular space.
Cytotoxic oedema, in which the BBB is essentially intact,
was caused by selected poisons such as trlethyl tin (TET)
and cyanide. Neurons and glia are swollen because cell
membrane dysfunction has led to an influx of water.
Vasogenic and cytotoxic mechanisms of brain oedema were
later complemented by a third model termed Interstitial
oedema (Fishman, 1976), which occurred in the
periventricular white matter due to transependyma1 spread
of CSF in obstructive hydrocehalus. Miller (1979), in a
later review, added hydrostatic and hypoosmotic mechanisms
of brain oedema. Hydrostatic oedema usually occurs due to
decreased cerebrovascular resistance, with accumulation of
an ultrafiltrate of plasma in the extracellular space.
Hypoosmotic oedema occurs due to lowering of the plasma
osmolality (eg water overload) with accumulation of water
in the grey and white matter. These five mechanisms of
brain oedema formation (vasogenic, cytotoxic,
interstitial, hydrostatic and hypoosmotic) can be invoked
either alone or in combination to explain brain oedema
occuring in diverse clinical settings.
1.2. PERITUMOURAL BRAIN OEDEMA
1.2.i Neuropatho1ogica1 and radiological studies
Cerebral "softening" and swelling around intracranial
neoplasms had been noted since the early days of
neuropathology (Gowers, 1893; Wohlwill, 1914). Although
some German pathologists (see Scheinker, 1941) considered
that this was an unusual phenomenon many others confirmed
that peritumoural brain swelling was a common occurrence
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(Spatz, 1929; Caspar, 1933; Jaburek, 1936; Scheinker,
1941). Peritumoura1 softening and swelling varied with
tumour type (Gowers, 1893), being greater with malignant
gliomas, metastatic carcinomas and meningiomas than well
differentiated astrocytomas or oligodendrogliomas
(Jaburek, 1936; Greenfield, 1939; Bonkalo, 1939; Perret &
Kernohan, 1943). Peritumoural oedema was also noted to be
independant of tumour size, extending irregularly around
the tumour, and not significantly involving the subarcuate
fibres or cortical tissues but often extending to the
periventricular regions (Greenfield, 1939; Scheinker,
1947; Burger et al, 1983; Russell & Rubinstein, 1989). The
oedema also accounted for the angiographic and
ventricu1ographic findings of a large avascular mass
effect in relation to some tumours (Scheinker, 1947).
The recognition that hypodense areas around brain tumours
imaged using the CT scan correlated well with areas of
peritumoural edema (Lanksch et al, 1976; Torack et al,
1976) provided the first method of imaging brain edema in
vivo (Fig 1). The spatial distribution of CT imaged
peritumoral edema in the white matter and its prominence
around cerebral metastases, malignant gliomas and
meningiomas (Ikeda et al, 1984; Bradac et al, 1986; Ito et
al, 1986; Shinonaga et al, 1988) was very similar to that
described by neuropathologists. Although with low grade
astrocytomas CT definition of peritumoural edema is
limited by poor imaging of the brain-tumour interface, the
oedematous brain-tumour interface with anaplastic
astrocytoma and glioblastoma has been shown by serial CT
guided stereotactic biopsies to be the region demarcated
by contrast enhancement and contiguous hypodensity (Burger
et al, 1983; Daumas-Duport et al, 1987). The recent
clinical introduction of nuclear magnetic resonance (NMR)
imaging has shown that areas of altered T1 and T2 signal
intensity around brain neoplasms (Fig 1b) correspond
spatially and quantitatively with areas of CT imaged
5
Figure 1 : Neuroimaging of peritumoural oedema using CT
scanning (A,C,D) and NHR (B). The spatial distribution of CT
imaged oedema around a small postrolandic hemangiob1 astoma
(arrows) (A) is very similar to that seen on a T2 weightedNMR scan (B). Peritumoural oedema is generally maximal
around glioblastomas (C) and metastases (D).
b
peritumoural bratn oedema (MacDonald et al, 1986; Bell et
al, 1987). These studies confirm experimental results that
demonstrated a linear correlation between brain water
content and the longitudinal relaxation time T^ (Go and
Edzes, 1975 ; Naruse et al, 1982). T 2 Is also elevated
with brain oedema but there is not a straightforward
relationship with total tissue water (Kamman et al, 1988).
1.2.11 Quantitation of water content
Using a technique of drying wet tissue specimens to
constant weight, Stewart-Wa 1 1 a c e ( 1 939) showed that
oedematous deep white matter contained an average 11 g/100
g tissue more water than contralateral control samples,
whilst there was only a minimal increase in peritumoural
cortical water content. Subsequent studies in humans and
animals have confirmed that the increase in peritumoural
white matter water content are consistently in the 10-12 %
range (Table 2). Although some of these studies were
performed on autopsy or formalin fixed brains, there is
excellent correlation between results obtained from fresh
and fixed cerebral tissue (Adachl & Feigin, 1966; Torack
e t a 1 , 1 9 76 ).
The CT number, in Hounsfield Units, is linearly related to
tissue water content, but also influenced, non-1inear1 y,
by the tissue content of lipid, protein and electrolytes,
particularly those elements with high atomic weight such
as calcium and iron (Torack et al, 1976 ; Lanksch et al,
1976). Therefore changes in tissue components caused by
both the neoplasm and the reactive brain oedema will
compound interpretation of the CT numbers. Despite these
shortcomings estimates of brain water content from CT
number in ischemic and peritumoural brain oedema suggest
an increased water content ranging from 9-13 % higher in
white matter directly adjacent to tumour, to a 2-4 %
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The cortical and subcortical nuclear tissues were at most
increased by 1-2% (Lanksch et a 1 , 1976 ; Torack et a 1 ,
1 976 ; Takagi et al, 1981; Ito et al, 1986). Similar values
for peritumoural white matter water content were recorded
in studies that correlated NMR T1 values with brain water
content (MacDonald et al, 1986; Bell et al, 1987).
Particular T^ values correlated with white matter water
content within an error of + 2 %, but correlation between
Ti and cortical water content was less precise.
1.3 THE ETIOLOGY AND DYNAMICS OF PERITUMOURAL BRAIN
OEDEMA
1,3.i Principles of vasogenic brain oedema formation
An eguation that summarizes the principal factors
governing movement of fluid and solute across capillary
beds has been derived from Starlings Law , and used to
examine factors in vasogenic brain oedema ( Fenstermacher &
Patlak, 1976; Klatzo et al, 1980).
J = L [(P Plasma _ ptissuej _ 0 (p plasma _ tissuej jv p s s s
where Jv = Net fluid movement into tissue bed
L = Hydraulic conductivity of capillary bed
hr
og = Oncotic reflection coefficient of solute s
pplasma _ capillary hydrostatic pressure
ptissue _ interstitial tissue pressure
PsPlasma = plasma oncotic pressure of solute s
4- < Q Q 11 p
pg = tissue oncotic pressure of solute s
This eguation states that the net flow across a capillary
bed is related to the permeability of that endothelial bed
to both water <Lp) and solute (og) and the net
hydrostatic and oncotic pressures (for each solute s)
acting across that capillary bed. When considering the
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formation of perltumoural brain oedema factors that
increase L and pPlasma ancj decrease pt-*-ssue or 0 which
P ®
for simplicity can be considered as the inverse of
capillary permeability for that particular solute, will
potentiate oedema production.
1.3.ii The predominant role of neoplastic capillaries in
the genesis of peritumoural oedema
Cerebral capillaries normally prevent any bulk movement of
water or solute into the brain due to their low Lp and
high o values. Comparative analysis of the L ofb p
different capillary beds has shown that mesenteric
capillaries are 3000 x, heart capillaries 1000 x and
muscle capillaries 100 x more permeable to water than
cerebral capillaries ( Fenstermacher & Patlak, 1 976). For
cerebral capillaries the og for Na+ and Cl+ is almost 1 ie
they are almost totally impermeable. Simp 1istica 1 ly these
biophysical factors together with tight junctions between
endothelial cells, the continuous basement membrane and
relative lack of pinocytotic vesicles, under normal
conditions, provide the basis of the BBB (Houthof, 1987).
Few of these properties are possessed by the neoplastic
endothelium of intracranial tumours. Vascular endothelial
proliferation is a recognised feature of anaplastic
gliomas (Russell & Rubenstein, 1989). Although some blood
vessels may be reactive rather than neoplastic they have
abnormalities of the tight junctions, increased
interendothe1ia 1 fenestrations, variable increases in
pinocytotic vesicles, endothelial hyperplasia, and
irregularities of both the basement membrane and its glial
investiture (Long, 1970; Weller et a 1 , 1977 ; Coomber et
al, 1987; Stewart et al, 1987).
Experimental, clinical, CT and PET studies utilising
radioactive tracers, iodinated agents and vital dyes of
varying molecular weight and hydrodynamic radius have
ID
revealed that within a particular tumour capillary
permeability is highly variable and a blood tumour barrier
similar to the BBB does not exist (Hossmann et a 1 , 1980,
1983; Groothuis et al, 1982; Hawkins et al, 1984; see
Brooks et al, 1986). Recognition of the "leakiaess" of
brain tumour capillaries was Initially exploited by the
use of protein bound radioactive tracers such as I12^Human
serum albumin in the diagnosis and localization of these
lesions. Different tumours demonstrate variable capillary
"leaklness" that is a reflection of their level of
dedifferen11ation and embryo1og1ca 1 origin. Even within
one tumour type there may be regional variability in
capillary permeability (Groothuis et al, 1982). The
"opening" of neoplastic endothelium to low but not high MW
compounds is confirmed by a dissociation between
electrolyte (Na+, C1-) and protein extravasation (Bodsch
et al, 1987). The importance of protein MW and
hydrodynamic radius, is confirmed by immunohistochemica 1
studies which reveal that the absolute quantity of protein
extravasation and content of higher MW proteins (Ig M,
transferritin, ceruloplasmin) are maximal in glioblastoma,
intermediate in meningioma and metastatic neoplasia and
lowest in astrocytoma and other well differentiated
gliomas (Szymas & Hossmann, 1984; Seitz & Wechsler, 1987).
Mean levels of serum protein, in perltumoural oedema
fluid, vary from 6 to 25% of serum level (Bodsch et al,
1987). Such levels are not considered to have a major
impact on the colloid osmotic equilibrium since the
oncotic effect of extracellular Na+ is much more
Important (Bothe et al, 1984; Bodsch et al, 1987).
Peritumoural Na+ content (range 365-624 mEq/kg dry weight)
is at least double (147-169 mEq/kg dry weight) that found
in normal white matter (Aleu et al, 1966; Hossman et al,
1980; Bodsch et al, 1987). Tissue oncotic pressure will
also be increased by solutes and macromo1 ecu 1es released
by tumour necrosis, tumour secretion and the activity of
U
tumour related proteolytic enzymes (eg tissue plasminogen
activator (TPA), meta11oprotease, hydrolase, acety1 beta-d-
g1ucose-aminidase and beta-glucuronidase) on extracellular
protein (McCormick and Wallace 1981; Quindlen and Bucher,
1987; Sawaya & Highsmith, 1988). These compounds may
modulate the level of tumour and peritumoural brain tissue
water but not principally by an oncotic effect (Bodsch et
al, 1987). Clearance of extracellular proteins, some of
which are phagocytosed by glia (Klatzo, 1967; Hossmann et
al, 1983; Seitz & Wechsler, 1987) is thought to be
contribute to clearance of the oedema fluid (Klatzo et
al, 1980; Harmarou et al, 1980)
1.3.111 The contribution of BBB dysfunction in the
peritumoural region, tumour blood flow and venous
in humans and animals have revealed a spectrum of findings
ranging from the normal to the grossly abnormal. These
differences seem related to whether the tumour studied has
a distinctive border (eg meningioma, rat C6) or like
glioblastoma, infiltrates the brain (Long, 1970; Hossmann
et al, 1980; Stewart et al, 1987). Experimental studies
of peritumoural capillary permeability in rats, rabbits
and cats have generally shown preservation of the BBB
(Herzog et al, 1965; Hossmann et al, 1980, 1983; Farrell
et al, 1987). Although the implanted tumours used in these
studies Invariably do not infiltrate the brain they
compliment human studies using contrast enhanced CT scans,
supported by stereotactic biopsy and post mortem studies,
that have demonstrated that extravastlon of the contrast
agent in malignant gliomas, and metastases, is confined to
the neoplastic capillary bed (Burger et al, 1983; Dumas-
Duport et al, 1987). Similarly PET studies report
Op -1 "1
extravastion of tracers ( Rb, C-methyl-albumin and
f) ft
Ga-EDTA) that is limited to the tumour interstitium
outflow obstruction to oedema formation
studies of peritumoural brain capillaries
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(Brooks et a 1 , 1984 ; Hawkins et a 1, 1984; Brooks et a 1,
1986).
Tumour hypervascu1 arity and vascular shunts visualized on
angiography correlate poorly with quantification of tumour
blood flow using positron emission tomography (PET) and
operative surgical findings (Lammertsma et al, 1985:
Bradac et al, 1986). PET studies show considerable
variations in blood flow (range from 3 to 102, median 24
ml/100 g/min) within gliomas and cerebral metastases
(Lammertsma et al, 1 985). The mean blood flow in gliomas
(35 ml/100 g/ min) is double that of metastases (18 ml/100
g/min), so tumour blood flow would not seem to be directly
related to oedema formation (Brooks et al, 1986). Venous
outflow obstruction caused by either tumoural invasion or
thrombosis of neoplastic veins could raise intracaplllary
pressure and enhance oedema formation (Casanova, 1984).
However analyses of the tumour blood volume in 81 patients
demonstrated mean values of 2.5 to 4.0 ml/100 g wet tissue
regardless of tumour type and extent of peritumoural
oedema (Lammertsma et al, 1985; Bodsch et al, 1987). It
would therefore seem that peritumoural oedema, which is
produced at between 0.5 and 3.2 ml/hr (Ito et al, 1988),
principally arises from the neoplastic endothelium with
minimal contribution from peritumoural capillaries.
Factors such as tumour blood flow, interstitial venous
thrombosis and obstruction of major venous sinuses seem in
general to be unimportant (Bonkalo, 1939; Greenfield,
1939; Perret & Kernohan, 1943; Russell & Rubinstein, 1989;
Bradac et al, 1986; Quindlen & Bucher, 1987).
1 . 3.iv Tumour related sustances favouring oedema
production and retention
The proposal that intracranial neoplasms secrete
eicosanoids, peptides or enzymes that promote peritumoural
oedema formation is not new (Greenfield, 1939; Scheinker,
1941) but it has recently been supported by
ultrastructural, biochemical and pharmacological findings
(Arenander & Vellis, 1980; 1981; Shitara et a 1 , 1983;
Phil 1 ipon et a 1 , 1984 ; Black et a 1 , 1986 ; Cooper et a 1 ,
1984 ; Stewart et a 1 , 1987 ; Quindlen and Bucher, 1987 ;
Sawaya & Highsmith, 1988). Whether tumour secreted
compounds can modulate capillary permeability was
speculative until a vascular permeability factor with MW
30-56,000 was isolated from cultured human astroglial
cells (Bruce et a 1 , 1987; Criscuolo et a 1 , 1988).
Production of this factor could be specifically blocked by
addition of d e x a m e t h a s o n e to the culture medium.
Pretreatment of the test animal with dexamethasone also
blocked the protein's permeability enhancing effects on
dermal capillaries (Bruce et a 1 , 1987). The level of TPA
produced by brain tumours also correlates with the
volume of peritumoural brain oedema as quantitated by CT
scan (Quindlen and Bucher, 1987; Sawaya & Highsmith,
1988). Corticosteroids are potent inhibitors of TPA
production. Tumour secreted polyamines and lipids may also
contribute to oedematogenesis since levels of putrescine,
spermidine, esterified triglycerides and steryl esters are
increased in the more malignant gliomas (Smith et a 1,
1968; Dempsey et a 1 , 1985; Scalabrino et a 1 , 1 9 8 5 ;
Yamakazi et al, 1986).
The possible role of such biochemical factors released by
tissue destruction, thrombosis, ischemia, immunological
and Inflammatory reactions, tumour secretion or
"activation" of extravasated plasma protein in the
pathogenesis of vasogenic brain oedema has been the
subject of considerable research (see Baethmann et al,
1980; 1989; Shinonaga et al, 1988; Wahl et al, 1988).
These pathological phenomena are characteristic of many
gliomas and cerebral metastases (Russell & Rubenstein,
1989), and it has been proposed that a wide range of
compounds (see Table 3) may increase capillary or venular
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COMPOUND SOURCE









Glut am at e Damaged brain
Serotonin Platelets ,
D am aged brain
Hist amine Mast cells,
D amaged brain





Proteolyic enzymes Damaged brain,
Leucocyt es
C5a, C5adesAarg Inflammed brain
Table 3: Some postulated secondary mediators of vasogenic
brain oedema together with mechanisms and factors in
their local production (After Baethmann et a 1 , 1980;
Allison, 1987).
permeability or alter capillary hydrostatic pressure
through either arteriolar dilatation or venular
constriction (Baethmann et al, 1980; Unterberg et al,
1986; Allison, 1987; Wahl et al, 1988). These factors,
termed secondary mediators, may be direct acting
oedematogens, have synergistic actions with each other or
be leucocyte or mast cell dependent (Table 3). At present
there is conflicting evidence concerning the role of
these, and other, putative secondary mediator compounds in
peritumoural oederaatogenesis (Black et al, 1986; Ikeda et
al, 1987; Unterberg et al, 1987a; 1987b). However if these
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factors are important they must modulate neoplastic
endothelium locally since peritumoural BBB function is
preserved (see Section 1.3.ii).
1.4 PATHOPHYSIOLOGICAL ASPECTS OF PERITUMOURAL BRAIN
OEDEMA
1.4.i Biomechanical effects on the brain
Peritumoural oedema aggravates the mass effect caused by
an intracranial tumour (Scheinker, 1947; Klatzo, 1967).
The oedematous brain may indeed be responsible for most of
this mass effect since its volume effect is related to
the increased brain water content and the third power of
the radius of the oedematous brain (Elliot & Jaspar,
1949). The combined mass effect elevates local tissue
pressure and both ICP and craniospinal elastance in an
exponential fashion (Miller, 1979). These effects can lead
to local impairment of cerebral perfusion pressure (CPP)
and brain shifts. Cerebral herniations can cause focal
brain tissue destruction and aggravate brain Ischemia
(Miller, 1979). The timing of these pathophysiological
events will depend upon the rate of growth and the
location of the tumour and secondary problems such as
hydrocephalus and the balance between oedema formation and
resolution (Ito et a 1, 1986, 1988).
As oedema worsens local brain tissue compliance rises and
hydraulic resistance falls ie the ease with which water
passes through the brain rises (Marmarou et a 1 , 1980 ;
Walstra et a 1, 1980 ; Ito et a 1, 1988 ; Hatashita and Hoff,
1988). This phenomenon, together with a favourable
pressure gradient between peritumoural interstitial and
intraventricular pressures, facilitates bulk diffusion of
the oedema fluid away from the region of formation, at an
estimated speed of 1.9 mm/hr (Ito et a 1, 1988), and
transependymal clearance into the ventricular system
1G
(Klatzo et a 1 , 1980 ; Reulen et a 1 , 1977 ; 1980).
Peritumoural brain oedema, unlike most clinical and
experimental models, is unique since production of oedema
fluid will progressively increase and overwhelm normal
clearance mechanisms.
1.4.ii Structural and cellular changes in oedematous
brain
Peritumoural oedema has a predilection for the white
matter of the centrum ovale with relative sparing of the
commissural, capsular and subarcuate fibres (Greenfield,
1939; Scheinker, 1941; Perret and Kernohan, 1943; Hossmann
et a 1, 1980 ; Szymas & Hossman, 1984; Seitz & Wechsler,
1987). The white matter extracellular space becomes sieve
like or trabecu1 ated , and often contains lakes of luxol
blue-PAS or Masson trichrome positive material that is
histologically and immunohistochemically identical to
material contained within the congested vascular
compartment (Feigin & Popoff, 1963; Szymas & Hossmann,
1984; Seitz & Wechsler, 1987). Histopatho1ogica1 studies,
using myelin stains, showed pallor in the peritumoural
brain (Perret & Kernohan, 1943; Scheinker, 1947; Burger et
a 1 , 1983). This pallor could represent either the
dilutional effects of increased tissue water (Greenfield,
1939; Feigin & Popoff, 1963) or peritumoural
demyelination. Quantitative studies of lipid content in
the peritumoural region have shown either a normal (Hwang
et al, 1986) or a 30 % reduction in lipid content (Lanksch
et al, 1976), whilst qualitative studies have shown
alterations in cerebrosides, cholesterol and esterified
cholesterol (Yanagahara & Cummings, 1968). If peritumoural
demyelination is found the toxic effects of cerebral
irradiation and chemotherapy on peritumoural white matter
must also be considered as etiological factors (Burger et
al, 1983; Russell & Rubensteln, 1989).
\i
Light microscopic findings in oedematous peritumoural
brain reveal changes in glial cytoplasm and nuclei,
congestion of blood vessels, widening of the perivascular
and extracellular spaces, separation and swelling of
myelin sheaths, irregular swelling of axis cylinders,
loosening of the ground substance and preservation of
cortical architecture (Caspar, 1933; Jaburek, 1 9 3 6 ;
Greenfield, 1939; Scheinker, 1941). The glial changes were
proportional to the severity and duration of the oedema
and astrocytic changes were greater than those seen in
oligodendrocytes (Perret & Kernohan, 1943; Feigin &
Popoff, 1962 ; Aleu et a 1 , 1966; Szymas & Hossmann, 1984).
Immunohistochemica1 and immunof1uorescent studies revealed
that many swollen astrocytes contain extravasated plasma
protein (Klatzo, 1967; Brett & Weller, 1978; Hossmann et
al, 1980; Szymas & Hossmann, 1984). Cortical neurones in
lamina III were only damaged if ICP had been severely
raised or local ischemia had occurred (Caspar, 1933;
Greenfield, 1 939).
1.4.iii The biochemical composition of oedema fluid
Peritumoural oedema fluid has Na and CI ratios and levels
(120-150 uEg/ml) similar to plasma (Stewart-Wallace, 1939;
Hossman et al, 1980; Bodsch et al, 1987) and contains
"lakes" of proteinaceous material histochemically similar
to plasma protein (Feigin & Popoff, 1963; Aleu et al,
1966). The concentration of plasma protein in the
peritumoural oedema fluid ranges from 4 to 16 mg/ml (Bothe
et al, 1984; Bodsch et al, 1987). Qualitative analysis of
the extravasated protein using immunofluorescent,
biochemical and immunoperoxidase techniques showed that
most was albumin (MW 65,000), pre-albumin (MW 61,000) and
low MW immunoglobulins (Cummings, 1961 ; Brett & Weller,
1978; Hossman et al, 1980; Szymas & Hossman, 1984; Seitz &
Wechsler, 1987). In addition a plethora of tumour related
compounds (see Section 1.3.lv) will be carried by bulk
flow of the oedema fluid into the peritumoural brain.
1 .4.iv A dichotomy between structural and biochemical
changes and electrophysiological dysfunction
With derangement of the white matter extracellular space,
glial morphology and biochemical microenvironment
peritumoural axonal, neuronal and glial function would be
expected to be abnormal. However although brain impedance
is decreased (Go, 1980), cortical somatosensory evoked
profound oedema induced by cortical freezing (Sutton et
al, 1980), and brain tumours (Penn, 1980). When cortical
SEPs ipsilateral to brain tumours have been abnormal the
asymmetry is freguently in the components subsequent to
the primary cortical response ie the N1g (median nerve) or
P40 (tibial nerve) and it is often difficult to ascertain
whether these anomalies arise because of brain
destruction, cortical distortion or peritumoural oedema
(Shibasaki et al, 1977; Stohr et al, 1981; Ebner et al,
1982; Whittle et al, 1987). Changes in the cortical SEP
and direct cortical response have been reported in some
models of brain oedema but these invariably have had
superadded cortical damage or cerebral ischemia (Sutton et
al, 1980; Dempsey et al, 1985; Kataoka et al, 1987; Murota
e t a 1, 1 9 88).
Focal Increases in the proportion of the slow (delta and
theta waveform) components of the EEG are frequently
recorded in the montages overlying brain tumours.
Peritumoural oedema per se is rarely considered
responsible for this polymorphic delta EEG activity
(Gastaut et al, 1979; Passerinl et al, 1983; Nagata et al,
1985), although others have reported a correlation between
slow wave activity and the extent of peritumoural oedema
(Steudel et al, 1976; Nagata et al, 1985 cases 4 and 15).
Experimental work suggests the EEG changes are the result
(SEP) waveforms are often preserved despite
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of cerebral damage or cortical deafferentatlon due to
tumour destruction, ischemia or secondary brain
herniations rather than effects due to the peritumoural
oedema (Schaul et a 1 , 1976 ; Sutton et a 1 , 1980).
Experimental studies of implanted tumours in cats have
utilised fast Fourier EEG analysis as a more sensitive
method of detecting electrophysiological changes but only
minor abnormalities were detected in 40% of animals
(Hossmann et al, 1 980). Although the EEG can be analysed
using sophisticated mathematical techniques and
microcomputer software the resultant data, whether
computerized mapping or power ratio index (Nagata et al,
1985), are only as good as the initial data (Ojemann,
1985). The paucity of electrophysiological changes in the
peritumoural region of many tumours correlates well with
PET studies that have shown either normal, or only
slightly decreased, CKRQ2 i*1 human peritumoural brain
(Lammertsma et al, 1985; Brooks et al, 1986).
1 .4.v Peritumoural brain oedema and brain dysfunction
The relationship between brain dysfunction and
peritumoural oedema is complex and cannot be simply
explained in terms of increased brain water content,
cerebral ischemia, demyelination, expansion of the
extracellular space, electrophysiological changes, or
biomechanical changes in the brain. On many occasions
there is no correlation between the extent of cerebral
oedema as imaged by CT scan and clinical indications of
focal neurological dysfunction (Penn, 1980; see Fig 1).
Since the introduction of steroids for the treatment of
brain tumours (Galicich et al, 1961) it has been observed
that many clinical deficits resolve within 24-48 hours of
treatment. The dramatic ameliorative effect of
corticosteroid therapy suggests that in some patients a
biochemically mediated phenomenon is causing the neural
deficit. CT, NMR, ICP and quantitative experimental
ao
studies support the contention that dysfunction is
biochemically mediated rather than related to the
increased tissue water content. Steroid induced resolution
of CT imaged peritumoural oedema is not significant until
five days after onset of methy1predniso1one therapy
although clinical improvement occurred earlier (Lerch and
von Wild, 1983 ; Hatam et a 1, 1983). Reduction in brain
water content, indirectly quantified by T1 from NMR
images, was also negligible within the first four days of
therapy (Bell et al, 1987). Reductions in ICP following
steroid therapy also lagged behind clinical improvement
although steroids did cause some early changes in cerebral
elastance (Miller et al, 1977; Miller, 1979). Experimental
studios of steroid induced reduction of peritumoural brain
water content have also shown that at least 3 days of
therapy is necessary to significantly reduce water content
(Yamada et al, 1979; Hossmann et al, 1983)
The hypothesis that a tumour secretes or releases factors
that are carried by bulk flow into the peritumoural region
where they impair axonal, glial or neuronal function is
not new (Greenfield, 1939; Hossmann et al, 1980). Studies
of tumour lines in vitro have revealed that as well as
eicosanoids, polyamines, and TPRs glial and meningeal
cells secrete a spectrum of proteins (Arenander and
Vellis, 1980 ; 1981; Shitara et al, 1982). Th ese proteins
are not considered to be the products of cell lysis since
they can be obtained from cultures with 99% cell viability
(Shitara et al, 1982), and subfractlonation reveals highly
reproducible SDS-gel peaks that do not include membrane
labelled proteins (Arenander & Vellis, 1980; 1981). Two
dimensional gel electrophoresis studies have provided
semi-quantitative data on the MW and isoelectric points of
brain proteins and have shown that brain tumours contain
proteins not detected in normal brain and that high and
low grade gliomas also have characteristic protein
profiles (Narayan et al, 1986; Sawaya & Highsmith, 1988).
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If tumour specific factors do contribute to peritumoural
brain dysfunction then their release or activation should
be inhibited by steroids since the time course of clinical
amelioration after commencement of therapy is similar to
that required for steroid receptors to influence genetic
expression and protein production by receptive cells
(Arenander & Vellis, 1981). Steroids are known to inhibit
a wide spectrum of protein synthesis by tumour cells
including TPA and tumour permeability factor (Shitara et
al, 1982; Arenander and Vellis, 1980, Bruce et al, 1987;
Quindlen and Bucher, 1987; Criscuolo et al, 1988).
Steroids also block activation of phospholipase A2 and
thereby limit arachldonic acid release from membrane
phospholipids. Since arachidonic acid can modulate
membrane potentials and neuronal function by altering GABA
binding (Schwarz et al, 1988), inhibiting brain
mitochondrial function (Hillered and Chan, 1988),
modulating aspartate, GABA and glutamate uptake mechanisms
in nerve terminals, neurones and astrocytes (Yu et al,
1986; Dorman et al, 1986), and by inhibiting choline
uptake and acetylcholine synthesis and reaccumulation in
synaptosomes (Boksa et al, 1988), the potential functional
benefits of steroids due to this action alone are
extremely wlderanging. Steroids may also exert their
beneficial effects by rectifying or restoring normal
capillary transport mechanisms thereby decreasing oedema
production and potential spread of neuromodu1 ating
compounds (Hossmann et al, 1983; Ito et al, 1988; Nakagawa
et al, 1988). PET studies have shown that they do not
have a major effect on either blood flow or metabolism in
either the tumour or adjacent brain (Leenders et al,
1985).
1.4.vi Aims of thesis work
The aim of the experiments undertaken in this project was
to investigate the relationships between focal brain
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oedema and brain dysfunction using a model of brain oedema
that avoided a primary (ie oedema producing) brain insult.
The experimental design allowed an evaluation of
the contribution of postulated "secondary mediators of
brain oedema" to both the etiology and pathophysiology of
brain oedema. It also enabled the interrelationships bet¬
ween brain oedema, brain biomechanics, CBF and parameters
of electrophysiological function to be studied without the
compounding problems of either major rises in ICP or
cerebral tissue herniation.
The hypotheses to be tested were that brain oedema per se
did not cause brain dysfunction and that the reversible
brain dysfunction, seen in patients with malignant gliomas
shortly after commencement of steroid therapy, is
attributable to tumour related vaso- or neuromodulative
compounds released into the oedema fluid. The compounds
chosen for study (saline, 20% protein solution,
bradykinin, glioma cyst fluid and arachidonic acid)
enabled the effects of particular compounds in the oedema
fluid to be evaluated. The contributions of these
compounds to the etiology and pathophysiology of vasogenic
brain oedema and brain dysfunction was therefore
evaluated. The experimental findings were be related to
clinical observations of peritumoural brain oedema and the
known effects and actions of steroids.
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METHODOLOGY
2.1 Plan of investigation
An 1ntraparenchyma 1 infusion model of brain oedema was
designed utilising modifications of feline experimental
protocols previously described (Osterholm et a 1, 1 9 6 9 ;
Long et al, 1980) and elaborated by Marmarou et al
(1980). A similar protocol utilising modifications of
previous techniques (Chan et al, 1983; Black & Hoff, 1985)
was developed for the rat. This experimental design was
essentially an in vivo system that enabled the effects of
intraparenchyma1 infusion of putative mediators of brain
oedema and brain dysfunction to be quantified. The
infusates studied have all been implicated in the
pathogenesis of brain oedema (Baethmann et al, 1980;
Fishman & Chan, 1980 ; Wah 1 et al, 1988 ; see section
1 . 3.iv) but their contribution to oedematous brain
dysfunction has not previously been evaluated.
(3) Bradykinin 5-150 ug/ml (6) Human glioma cyst fluid
Selection of Neurophysiological parameters studied
The parameters that were studied before, during and after
the intracerebral infusions included:
Infusates studied
( 1 ) Sham (4) Arachidonic acid 2-15 mg/ml
(5) 20% protein solution(2) Normal saline
(1 ) CBFg and C B Fw both ipsilateral and
the side of infusion
t o
(2) Cortical SEPs to median nerve stimulation
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(3) IC P as measured by monitoring intraventricular CSF
pressure
(4) Cerebral pressure-volume index (PVI), and lumped
craniospinal compliance (Ci).
(5) Dynamic CSF outflow resistance (R0K
(6) Brain tissue hydraulic resistance (R ^) and cerebral
tissue compliance (C^).
Following the completion of the intraparenchyma1 infusion
the following neurophysio1oglea 1 parameters were measured;
(1) Reactivity of the cerebral vasculature to alterations
in P CO,
(2) Spinal motor evoked potentials (MEP) following
transcranial or focal stimulation of each hemisphere
Following sacrifice of the animal the following parameters
were studied;
(1) The specific gravity, and water content, of both
cerebral cortical and subcortical (white matter)
tis sue.
(2) The extent of blood brain barrier disruption caused
by the infusion
(3) Histological analysis of the brain adjacent to and
distant from the region of infusion
The measurement of these parameters during sham and saline
infusions enabled acquisition of baseline data and an
assessment of the validity and utility of the rodent and
feline models of cerebral infusion oedema. The changes
from these baseline values caused by similar volumes of
different infusates could then be established. The
contribution to both neurophysiological dysfunction (ie
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alterations in CBF, SEPs, MEPs, ICP, PVI) and the genesis
of cerebral oedema (tissue water contents, disruption of
the BBB) of particular compounds could then be evaluated.
These experiments were performed by the author under
licence using anaesthetic and surgical techniques approved
by the Home Office under the Prevention of Cruelty to
Animals Act 1876.
2.2 RODENT INFUSION MODEL
2.2.1 General preparation
Male Wistar rats (Wgh 300-450 gm) were anesthetised by
intraperitoneal urethane (1.2 g/kg, given as a 20%
solution in distilled water). The femoral artery was
cannulated with polyethelene tubing and a tracheostomy
tube positioned. The animal was then placed in a
stereotactic frame (Narashige Instruments, Japan) and the
temperature maintained at 3 7 °C by a thermoregulated
warming blanket.
The animal was then paralysed (Gallamine 4 mg/kg) and
ventilated, with an air/oxygen mixture, on a Harvard 680
Rodent respirator (Harvard Apparatus Co., Inc., South
Natick, Massachusetts). Tidal volume was 3.0 +■ 0.5 ml and
the respiratory rate adjusted to maintain P CO- in the
3 Z
range 35+5 mm Hg. Oxygen inflow to the ventilator was
adjusted to maintain the P 0o in the range 150 + 50 mm3 ^ —
Hg. Continuous arterial BP monitoring was done through the
femoral arterial line using a Bentley transducer connected
to a Rikadenki chart recorder. Blood gas analysis (P_0o,3 Z
P
a C 0 2 and PH) was done using an ILS 1302 system
(Instrumentation Laboratory SpA, Milan, Italy).
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2.2.11 infusion and brain biomechanics
A midline scalp incision was made, the periosteum
diathermied and removed to expose the bregma and coronal
suture. A 2 mm burrhole was then drilled 1.2 mm anterior
and 3.0 mm lateral to the bregma point. Using a
stereotactic manipulator a 25 G round ended needle was
then placed at a depth of 3.0 mm. Using these coordinates
the tip of the infusion needle would be placed deep to the
junction of the caudatoputamen nucleus and the subcortical
white matter (Paxinos & Watson, 1982; Fig 2). The
frontopolar and precentral cortical areas overlie this
infusion locus (Krieg, 1946) and which functionally
includes the anterior limit of the primary somatosensory
cortex for the forelimb (Hall & Lindholm, 1974). The dura
was then covered with fragments of chopped surgicel
(Johnson & Johnson, Slough, England) and the burrhole
sealed with methy 1 methacry1 ate. In all the experiments the
burrholes were drilled, and extradural and intracerebral
electrodes or needles placed using either surgical loupes
(x4 magnification) or the operating microscope.
The infusate, contained in a 1 ml syringe, was connected
to the 25 G needle by polyethylene tubing. The rate of
infusion was regulated by a Vickers Treonic IP4 infusion
pump (Vickers Medical, Priestley Rd, Basingstoke, Hants,
England) the barrel of which had been modified to seat a 1
ml syringe. Using this modification a metered infusion
rate of 3.4 ml/hr delivered 0.1 ml fluid/hr. The flow rate
of the Infusion pump had previously been checked, and was
found to be accurate, against resistant pressures ranging
from 10-100 mmHg. A Bell and Howell 4/422 transducer was
connected in parallel with the infusion line so that
infusion pressure could be monitored continuously
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Figure 2:A Coronal section of the rodent brain (+1.2 mm
from bregma) outlining the infusion locus and dissipation
of the fluid. Abbreviations gCC genu of corpus callosum;
FrPSS frontoparietal somatosensory cortex; CPu
caudatoputamen nucleus (After Paxinos & Watson, 1982).
Figure 2B shows a surface view of the rodent brain
outlining the forelimb primary somatosensory cortex in
relation to topographic stereotaxic coordinates (After
Hall & Lindholm, 1974).
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on a Rikadenki chart recorder.
The brain tissue hydraulic resistance (R^) was calculated
using the following equation
Pinf
Rt = (Marmarou et al, 1 9 80)
Q
where Q = infusion rate (ml/min)
and P^nf = infusion line pressure (mmHg)
The brain tissue compliance (Cfc) was calculated using the
following equation:-
V
Ct = (Marmarou et al, 1980)
Pinf
where V = volume of fluid infused
and Ptnf = -^nfus^on pressure
2.2.iii Intraventricular CSF pressure monitoring
A 2 mm burrhole was centred 1.0 mm posterior and 1.5 mm
lateral to the bregma point on the calvarium contraleral
to the site of placement of the infusion needle. The
ventricle was then cannulated with a round ended 25 G
needle fixed in a stereotactic manipulator at a depth of
2.6 mm. Placement in the ventricle was confirmed by the
recording of respiratory regulated pressure changes and an
increase in ICP following manual compression of the
abdomen. The burrhole was then lined with chopped surgicel
y
and sealed with me thy 1 me th ac r^l a t e.
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The ICP was recorded in mm Hg via a Bentley transducer
onto a Rikadenki chart recorder, with the zero reference
point being at the level of the ear bars of the
sterotactic frame.
2.2.iv Regional cerebral blood flow (rCBF)
Regional CBF was measured by the hydrogen (H2 ) clearance
technique (Pasztor et a 1 , 1 973). Two 2mm burrholes were
drilled bilaterally 4 mm from the midline at the anterior
and posterior ends of the parietal bone. The dura was
opened under magnified vision using a 23 G needle with a
bent tip. Teflon coated 90% platinum/ 10% iridium
electrodes (250 micron diameter) with the distal 1 mm
bared were then placed 1.5 mm into the cortex using a
stereotactic manipulator. The burrholes were then filled
with surgicel and sealed with meth1ymethacry1 ate . A
reference electrode, polarised at -400 mV was positioned
in a subcutaneous thoracic pouch.
H
2 was administered at a concentration of 6-10 % by a
sidearm to the ventilatory tubing. H2 clearance curves
were obtained by pen recording the current output from the
polarised electrode system onto a Rikadenki chart recorder
with chart speed set at 2 cm/min. The initial 30 seconds
of the clearance curve was discarded, with the CBF being
obtained by analysis of the curve over the ensuing two
minutes. Five points (30 s apart) from each curve were fed
into a computer programme that calculated the CBF in
ml/100 gm brain/ min.
After completion of the intracerebral infusion the rodent
ventilator tidal volume and rate of respiration were
altered so that the arterial CO
2 level was sequentially
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Increased from 25 mm Hg to 60 mm Hg. Hj clearance curves
were obtained at various values within this range. At
least twenty minutes elapsed between recording of CBF, and
usually CBF was recorded at four different CC>2 levels for
each rat. Reactivity was analysed by plotting CBF against
CO 2 > Linear regression analysis of CBF and CC>2 data and
correlation coeeficients were calculated using the
commercial statistics computer programme MINITAB (Ryan et
a 1, 1 985).
2.2.V Cortical somatosensory evoked potential (SEP)
Burrholes of 2mm diameter were drilled bilaterally in the
midparietal region 3mm behind the bregma and 4 mm lateral
to the midline. This location overlies the cortical area
extent of the primaru somatosensory cortex for the
forelimb (Krieg, 1946; Hall and Lindholm, 1974; Fig 2.1).
The dura was exposed but not opened. The burrhole was then
filled with conduction paste (Dracard Electrode Gel,
Maidstone, Kent). Platinum alloy ball electrodes were then
placed epidurally using a stereotactic manipulator. A
reference needle electrode was placed subcutaneously over
the nasal ridge, and an earth plate electrode
subcutaneously over the thorax. These electrodes were
connected to a PA 89 peamplifier, which was in turn
connected to a Medelec MS92a signal averaging unit.
Stimulating electrodes (Stainless steel 26 G needle
electrodes were positioned on the dorsal and volar aspects
of both forepaws.
Stimuli of 6 - 10 mA (square wave shocks of 0.1 ms
duration) were delivered from a Medelec S10II at 5 Hz
across the stimulating electrodes. Epochs of 20 -50 ms
s caudalis which represents the posterior
were studied and 128-512 stimuli averaged. The frequency
bandpass was set at 20-2000 Hz, with amplifier sensitivity
at 20 or 50 uV. All records were duplicated and copied
onto an inbuilt chart recorder that documented voltage and
timescale. Peak latencies were displayed by cursor readout
and documented with each set of recordings.
2.2.vl Brain water and Specific gravimetric (SG)
One hour after the conclusion of the infusion the rat was
decapitated, the calvarium removed with bone rongeurs and
the dura removed from the underlying brain. The cerebrum
was removed by sections at the level of the rhinal sulcus
and the mesencephalon (at the plane between the cerebellum
and occipital region). Each hemisphere was then weighed,
and placed in a drying oven at 80°C until a constant
weight was attained (usually 48 hrs). The % tissue water
content was calculated from estimation of the wet/dry
weighting of the cerebrum;
%water = Wet weight - dry weight
Wet weight x 100
In other rats local brain tissue SG was measured to obtain
data on water content in small cortical and subcortical
tissue samples. The technique of gravimetry employed
(Marmarou et al, 1978,1982) required rapid removal of the
cerebrum after termination of the experiment. Cortical and
subcortical brain tissue samples measuring 2-4 mm were
then obtained and dropped into a layered
kerosene/bromobenzene column. The isogravimetr1c point was
the depth in mm to which the tissue particles had
sedimented at 2 minutes. The SG was obtained by reference
to a linear regression equation derived from the depths to
which standard droplets from five samples of potassium
sulphate (5 u L ) of varying SG (1.021, 1.025, 1.035, 1.040,
1 .045) had sedimented.
2.3 FELINE INFUSION MODEL
2.3.1 General preparation
Mongrel cats weighing between 2.9 and 4.5 kg were
anaesthetised by Intraperitoneal injection of
Pentobarbital 45 mg/kg. A tracheostomy was performed and
the animal intubated with a noncuffed Size 9 Portex
endotracheal tube. The femoral artery and vein were
cannulated with polyethelene tubing. The animal was placed
in a stereotactic frame (Narashlge Instruments, Japan) in
the sphinx position. Following paralysis with pancuronium
(0.05 mg/Kg) ventilation was commenced with a 66% N20; 33%
O
2 mixture administered through a Harvard Cat ventilator.
Tidal volume was 30 + 5 ml and respiratory rate was
adjusted to maintain arterial C02 in the range 33 +_ 3 mm
Hg and p a O 2 greater than 100 mm Hg. A continuous infusion
of lactated Ringers solution was delivered intravenously
at a rate of 1 ml/kg/hr. The animal was placed on a
thermoregu1ated (via rectal thermometer) warming blanket
so that body temperature was maintained at 3 7.5 °C. Blood
pressure and arterial blood gases were measured as
described in the Rodent model (See Section 2.2.1).
2.3.11 Intracerebral infusion and brain tissue hydraulic
resistance
A 2 mm burrhole was drilled 9.5 mm lateral and 19 mm
anterior to the zero reference point. The tip of a 23 G
needle was then placed at a depth of 9 mm using a
stereotactic manipulator (Fig 3). These coordinates
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Figure 3A: Lateral view of the feline brain showing coronal
level of infusion, and outlining the infusion locus deep in
the forebrain white matter.
Figures 3B: Lateral view of feline brain (after Guldin &
Markowitsch, 1984) outling the major sulci and Brodmann
areas corresponding to the primary somatosensory (Area 2,3)
and motor cortex (Area 4,6,8). Figure 3C Superior aspect of
the feline cranium outlining placement of electrodes and
monitoring lines and their relationship to the motor (M) and
somatosensory (Ss) cortex (after Dong et al, 1982). Key o =
Ag/AgCl electrode (SEP); ^ = p1 atinum/iridium electrode
(CBF); H = Intraventricular needle (ICP).
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would place the tip of the infusion needle in the white
matter of the anterior centrum ovale in direct proximity
to the primary somatosensory thalamocortical and
corticospinal fibres (Snider & Niemer, 1962; Guldin et al,
1984). The burrhole was then lined with surgicel and
sealed with methylmethacrylate. The infusion rate (0.2
ml/hr) was controlled and infusion pressure, from which
the Rt was calculated, measured as described in section
2.2.ii. The period of infusion was three hours.
2.3.iii ICP, Pressure-volume index (PVI), intracranial
A 2 mm burrhole was drilled at a position 3.5 lateral and
14 mm anterior to the zero reference plane on the
23 G spinal needle connected via saline filled tubing to a
Bentley transducer was positioned in the lateral ventricle
which was usually encountered at a depth of 13+1 mm.
Correct position was confirmed by obtaining a pulsatile
ICP waveform on a Rikadenki chart recorder, and by
observation of an increase in ICP with manual compression
of the abdomen. The range of ICP monitoring was 0-90 mm
Hg. The zero reference point for the Bentley transducer
was at the level of the ear bars.
PVI, Ci and Ro were calculated following intraventricular
bolus injections of 0.1ml saline by use of the following
eguations (Marmarou et al, 1975).
compliance (C^) and CSF outflow resistance (Rc)
ca1varium to the side of infusion (Fig 3). A
V









whe re V = Volume of bolus injection
PQ = Baseline ICP prior to bolus injection
Pp = Peak ICP after bolus injection
P2= ICP at time T2 after bolus intraventricular
inj ection
T
2 = Time after intraventricular injection
These parameters were calculated as baseline values and
then every hour during the period of infusion and three
hours after completion of the infusion.
2.3.iv rCBF
CBF was measured in four brain areas every 30 minutes
during the period of infusion using the hydrogen clearance
technique as described in section 2.2.iv. Two electrodes
were positioned bilaterally into the sigmoid and coronalis
gyri following craniectomy through the frontal sinus and
dural opening with an 11 Blade and hooked 21 G needle (Fig
3). A parietal electrode was similarly positioned in both
posterior suprasylvian gyri. Once positioned the exposed
dura was covered with surgicel and the electrodes cemented
in position and cranium sealed using methylmethacrylate.
The anterior electrodes were positioned approximately 5 mm
3G
anterior, and the parietal electrodes approximately 10 mm
posterior to the infusion site. A Ag/AgCl reference
electrode was placed in a subcutaneous neck pouch and
polarised to -400 mV. Hydrogen (6-10%) was administered to
the animal through a side arm on the inspiratory limb of
the ventilatory circuit. CBF was calculated from the
clearance curves in a similar method as described in
section 2.2.iv.
After completion of the intracerebral infusion the
ventilator tidal volume and rate of respiration were
altered so that the arterial CO2 levels was increased from
25 mm Hg to 60 mm Hg. CBF measurements were obtained at
various values within this range. At least 25 minutes
elapsed between recording of CBF, and usually CBF was
recorded at five different CO2 levels for each cat.
Reactivity data was analysed as described in section
2.2. 1 v.
2.3.V Cortical SEP recording
Cortical SEPs were recorded from the skull surface
overlying the anterior ectosylvian gyrus using Ag/AgCl
disc electrodes referenced to an electrode placed
subcutaneously in the region of the nasion (Fig 3). An
earth electrode plate was positioned subcutaneos1y over
the lumbosacral region. The earth, recording and reference
electrodes were connected via a PA89 Medelec preamplifier
to a MS92a signal averaging unit. Stimulating electrodes
(26 G stainless steel) were placed subcutaneously in the
dorsal and volar aspects of the radial side of each
forepaw. Accurate placement of the latter electrodes in
relation to the median nerve was confirmed by rythmical
forepaw twitching following electrical stimulation (5-8
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mA, 0.1 ms duration, 5 Hz). Epochs of 20-100 ids were
studied with parameters of signal averaging which were as
described in section 2.2.v.
2.3.vi Motor Evoked potentials (MEP)
Spinal motor evoked potentials (Levy et a 1 , 1984) were
recorded subdurally from the low thoracic region two and
one half to three hours after termination of the
intraparenchyma1 infusion. The spinal MEP was generated by
either transcranial or direct cortical stimulation with
the anode being either the Ag/AgCl electrode overlying the
respective anterior ectosylvlan gyrus or the platinum-
irldium electrodes in the sigmoid or coronalis gyrl. In
both cases the cathode was a Ag/AgCl electrode attached to
the hard palate. Parameters were 5-20 mA stimulus of 0.3
ms duration delivered at 20Hz. The spinal MEP was recorded
subdurally using a platinum alloy ball electrode
referenced to a paraspinal needle electrode. These
electrodes were connected to a Medelec PA 89 preamplifier
and an MS 92A signal averaging unit. Between 28 and 256
stimuli were averaged. Epochs of 10 ms were analysed with
bandpass set at 20-2000 Hz. All recordings were obtained
at normocapnia and normotension.
2.3.vii Brain water and specific gravity
Following the completion of the experiment all monitoring
lines were removed from the skull and the calvarium
removed with bone rongeurs. A lethal intravenous dose of
pentobarbital (60 mg/kg) was administered. The animal was
then decapitated and a total craniectomy performed. The
calvarlal dura which was initially left intact was then
opened coronally in a plane 1 mm anterior to the infusion
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needle entry point. Small blocks of cortex (2-4 mm ) were
removed from locations 3 mm lateral and medial to the
infusion needle and from similar locations from the
contralateral hemisphere. Specific gravity measurements
were made in a layered kerosene-bromobenzene column as
described in section 2.2.vli. The hemisphere was then
incised by coronal section through the plane 1 mm anterior
to the intracerebral infusion. Specimens (2-4 mm ) of
white matter were then removed from the locus of, and 5 mm
from, the infusion needle and dropped into the kerosene-
bromobenzene column. Specimens from similar positions in
the contralateral hemisphere were also analysed. Tissue
water content of the samples was calculated from the SG
values using the standard eguation after sham, saline,
arachidonlc acid and bradykinin Infusions (Marmarou et al,
1978) and the corrected formula after 20% protein and
glioma cyst infusates (Marmarou et al, 1982).
2 .3.vill Blood brain barrier disruption and light
microscopic tissue changes
One hour prior to sacrifice of the animal Evans Blue 2%
was administered intravenously at 1 ml/kg body weight.
After sacrifice of the animal brain tissue specimens were
taken for gravimetric analysis and then the brain was
placed in 10% forma 1in/sa 1 i ne. After fixation for five
days the brain was coronally sectioned and examined
macroscopica 11y for extravasation of the blue dye. The
brains were photographed and the area of Evans blue
extravasation in the coronal plane of infusion
guantitated. Selected brains were examined using light
microscopy after staining with hematoxylin and eosin (H &
E), luxol blue-PAS and so 1ochrome-cyanin.
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2.4 INFUSATES
The following infusates were used;
1 - Normal saline. (Sodium chloride 0.9%, Boots Hospital
products. The Boots Company PLC, Nottingham). This
solution contained Sodium and chloride ions 150 mmol/1
with pH of 6.89. The pH of the saline/5% ether infusate
was 7.05.
2- 20% protein solution (see appendix 1) This solution was
buffered to pH 7.50 using a 0.5 M tris amino buffer.
3- Bradykinin 5 and 150 ug/ml (5 x 10"6M and 1.5 x 1 0"4M
respectively) in normal saline. (Bradykinin, Sigma B-3259,
Sigma Chemical company St Louis, Mo, USA). The pH of these
solutions were 6.98 (5 ug/ml) and 7.25 (1 50 ug/ml).
4-Arachidonic acid 2 to 15 mg/ml (6.6 x 10"^M to 5 x 10~^M
respectively. Arachidonic acid (Sigma A-6382, Sigma
Chemical company) was dissolved in diethyl ether and
further solubilized in normal saline so that the final
concentraton of ether in the solutions was 5%. The pH of
the arachidonic acid 10 mg/ml infusate was 6.21.
5 - Human glioma cyst fluid. Cyst fluid was obtained
following CT guided stereotaxic biopsy from four patients.
Two had glioblastoma (EB and GD), one an anaplastic
astrocytoma (JH) and one an oligodendroglioma (TF). The
electrolyte, protein, and enzyme contents of these fluid
are listed in Appendix 2. The pH of these four cyst fluids
varied from 7.51 to 7.62.
All infusates were either freshly prepared or stored at
- 40°C before usage.
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2.5 STATISTICAL METHODS
Statistical analysis was performed using the dedicated
commercial computer package MINITAB (Ryan et al, 1983).
Correlation coefficients were calculated by linear
regression analysis. Linear regression data was compared
by analysis of covariance. Paired data was analysed by
using the paired or unpaired Student's t-test. Data was
considered significantly different if p 0.05, unless
multiple comparisons were being made in which case
Bonferroni's correction was used.
2.6 JUSTIFICATION OF METHODOLOGY
2.6.1 The infusion model of brain oedema
Experimental studies of brain oedema induced by cold
lesions, ischemic Insults, tumour xenotransplantation,
irradiation, systemic or focal exposure to toxins and
infectious agents have examined many aspects of
oedematogenesis, the biomechanics of brain oedema and
mechanisms of oedema resolution (Herzog et al, 1965; see
Klatzo, 1967; Westergaard, 1975; Csanda, 1980; Baethmann
et al, 1980 ;; Hossmann et al, 1980; Klatzo et al, 1 9 8 0;
Reulen et al, 1977; 1980; Bothe et al, 1984 ; Hatashlta
and Hoff, 1988). However these models are in general
unsatisfactory for examining the relationships between
brain oedema and specific aspects of altered brain
physiology since it is difficult to differentiate between
the n e u r ophys i o1ogica 1 changes attributable to the
destructive cerebral lesion generating the oedema and
those attributable to the oedema per se. Compartmental
herniation of cerebral tissues and the effects of raised
ICP also complicate interpretation of data (Schaul et al,
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1976).
To overcome many of these problems a model of focal brain
oedema that was generated by slow intracerebral infusion
of fluid into the forebrain white matter of the cat was
developed (Marmarou et al, 1980). This model has the
advantage of avoiding any primary neural destruction and
allows the regulated infusion of specific solutions. Such
a model of cerebral oedema can be used to study the
oedematogenic, biomechan i ca 1 , electrophysiological and
cerebrovascular effects of putative vaso and
neuromodu1 ating agents in the infusate. Direct delivery of
the fluid into the white matter also provides a more
relevant evaluation of the possible roles of the infused
compounds in brain oedenatogenesis and dysfunction,
associated with intracranial neoplasms, ischemia,
encephalitis or trauma, than perfusion of the compound(s)
through the ventricular system, on isolated vessels or
over the cortical surface (Oettinger et al, 1976;
Westergaard, 1975; Unterberg & Baethmann, 1984; Unterberg
et al, 1987b). The latter experimental approaches may be
appropriate for evaluating brain oedema associated with
meningitis but a recent study evaluating the
oedematogenic potential of bradykinin, histamine,
serotonin and arachidonic acid administered to the brain
surface demonstrated that findings with regard to pial
vascular permeability cannot reliably be extrapolated to
their action on brain parenchymal vascular permeability
(Watanabe & Rosenblum, 1987). A study of the oedematogenic
potential of particular compounds in normal white matter
is more relevant to common clinical patterns of brain
oedema. Some studies which have addressed this question
have utilised an intracerebral microinjection technique
to evaluate the oedematogenic potential of arachidonic
m
acid, LTB4, LTC4 and LTE4 as well as xanthine oxidase,
cyclic adenosine monophosphate, ouabain and serotonin
(Bulle, 1 957 ; Osterholm et al, 1 969 ; Go et al, 1 980 ; Long
et al, 1980 ; Chan et al, 1983; Aritake et al, 1983 ; Black
& Hoff, 1985; Unterberg et al, 1987a). None of these
workers have however simultaneously investigated changes
in cerebral vasomotor tone or e1ectrophysio1ogy that could
be attributed to either the agent or the associated
oedema. Karmarou's initial studies with the infusion
oedema model analysed the biomechanics of brain oedema,
and in a series of other experiments his group briefly
described biomechanical, neurophysiological and
and CSF infusion and confirmed the infusion model
resembled the "classical" histological and ultrastructural
findings of brain oedema (Lax et al, 1979; Walstra et al,
1980; Marmarou et al, 1980; Tanaka et al, 1983; Tsubokawa
e t a 1 , 1 9 8 3 ).
If intracerebral saline infusion provides a good
histological, and biomechanical model of brain oedema that
causes minimal changes in electrophysiological and
cerebrovascular function what particular poblems may be
usefully addressed using this model? If a brain neoplasm,
with abnormal capillary endothelium, is simply
conceptualized as a point source generator of oedema fluid
that passes into an otherwise undamaged peritumoural
region then the infusion models fits this concept.
Utilisation of the infusion model followed by post mortem
examination of coronal sections of the brain for
extravasation of intravenous vital dyes would seem an
ideal method with which to assess the potency of
postulated secondary mediators of vasogenic brain oedema.
Simultaneous studies of cerebrovascular and
sequelae of intracerebral saline, protein
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electrophysiological parameters also enable a study of the
relationship between brain oedema, compounds in the
infusate and brain dysfunction.
2.6.ii Limitations of the infusion oedema model
Although the infusion model of brain oedema has several
advantages it has no clinical parallel. The acute nature
of oedema production, the rate of infusion, the
hydrostatic infusion pressure and composition of the
infusate may have little relevance to the dynamics of
oedema production in the clinical situation. The infusion
causes acute distention of the extracellular white matter
and separation of axonal fibres which may damage synapses
and astrocytic or oligodendroglial processes. The
phenomenon of spreading cortical depression (Leao, 1 944 ;
Leao, 1986) can occur after intracerebral injection of
compounds that alter the brain electrolyte
microenvironment and may alter vascular and
electrophysiological regulation making the effects of
infusates difficult to interpret (Lauritzen, 1984; Leao,
1986; Wahl et al, 1987). Infusion of particular compounds
in saline or buffered solutions may spuriously evaluate
their oedematogenic or neuromodu1 ating potential since in
vivo the compound may be readily inactivated by enzyme
systems, or other components of oedema fluid. For example
the adverse effects of arachidonic acid on cellular
respiration, choline uptake and acetyl choline
accumulation are blocked by the addition of albumin to
perfusates (Boksa et al, 1988; Hillered & Chan, 1988), and
kinin activation would be limited by smaller MW enzymes in
oedema fluid exudate (see next section).
A major disadvantage of the infusion model in rats is the
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relative paucity of the subcortical white matter.
Vasogenic brain oedema is essentially a white matter
phenomenon and deposition of fluid into the corpus
striatum, which is obligatory to minimise leakage of the
infusate back along the needle tract, probably involves
clearance mechanisms and vascular responses that cannot
be extrapolated to' either the clinical situation or
effects on white matter. This is a particular criticism
of previous studies utilising arachidonic acid and LT
infusions (Aritake et a 1 , 1983 ; Black & Hoff, 1985; Chan
e t a 1 , 1 9 8 3 ).
2.6.iii Choice of infusates
Sham and Saline Infusions
Sham and normal saline infusion were chosen to evaluate
the general and neurophysiological effects of
intracerebral infusion and to demonstrate any
methodological shortcomings. Since the sodium contents of
both human and cat peritumoral oedema fluid have been
shown to lie between 130-150 mEq/ml (Bothe et a 1, 1984 ;
Bodsch et al, 1987) these preliminary experiments should
provide realistic baseline data against which the effects
of other infusates could be compared.
Arachidonic acid (MW 304)
Arachidonic acid and both its cyc1ooxygenase generated
prostanoid (prostaglandin (PG) and thromboxanes) and
lipoxygenase generated leukotriene (LT) metabolites are
produced or released in several disorders that are also
associated with brain oedema formation (Bazan et al, 1980;
Fishman & Chan, 1981; Gamache et al, 1986 ; Dempsey et al,
4b
1987; Snimizu et a 1, 1987 ; Westcott et a 1, 1987 ; Katz et
a 1 , 1988). Following ischemic brain damage influx of
A2 and the release of arachidonic acid from membrane
phospolipids such as phosphatidylinositol and
phosphatdycholine (Bazan et a 1, 1980; Wolfe, 1982 ; Walker
and Pickard, 1985; Shimlzu et al, 1987; Katz et al, 1988).
Cell membranes from human glioma cell lines, normal glia
and neurones all contain high levels of these
phospholipids, but the phospholipids in glial tumours
contain more arachidonic acid and linoleic acid than
control brain (Poduslo et al 1983; Hattori et al, 1987).
Brain tumours grown in tissue culture produce PGE2, PGF2
alpha, 6 oxo PG F1 alpha and thromboxane B2 (Cooper et al,
1984; Lauro et al, 1986; Castelli et al, 1987). The
production of prostanoids by tumours was variable, but was
highest in the meningomas and poorly differentiated
gliomas. Metastatic brain tumours produced large amounts
of LTC4 (13.8 + 8.5 pg/mg tissue) when compared to levels
in nondiseased (0.4 pg/mg tissue) brain (Black et al,
1986). The level of LTC4 in gliomas was found to be 6.2 +
2.3 pg/mg and there was a positive correlation between the
amount of perltumoural oedema and the tissue LTC4 level.
Arachidonic acid, LTC4, LTD4, PGE2 and PGF2alpha modulate
cerebral arterial and pial vessel tone and also increase
capillary permeability when they are administered by
either cortical or isolated vessel superfusion (see Walker
& Pickard, 1985; Olesen & Crone, 1986: Unterberg et al,
1987b). These findings, together with the known large
amounts of phospholipid contained in neoplastic cells, the
large areas of ischemic and coagulative necrosis seen in
malignant gliomas, and the release of eicosanoids from
inflammatory cells (Gamache et al, 1986; Shlnonaga et al,
calcium causes activation of phosphollpase
4 (o
1988) all suggest that eicosanoids have a role In
peritumoura1 brain oedematogenesis .
Bradykinin (MW 1000)
Bradykinin, a nonapeptide formed from the beta-2
macrog1obu1in ( MW 1 80,000) kininogen-preka11ikrein, is a
potential secondary mediator of vasogenic brain oedema
since it is a potent peripheral vasodilator and modulator
of capillary permeability (Baethmann et a 1, 1980; Regoli &
Barabe, 1980). Elevated bradykinin levels have been found
in brain oedema fluid generated by freeze lesions and
cerebral ischemia (Kaier-Hauff et a 1 , 1 984), and beta-2
macroglobulins are likely to be extravasated into human
gliomas (see Seitz & Wechsler, 1987). Aprotinin, a
protease that inhibits bradykinin formation, can limit
oedema caused by freeze injury to and surgical excision of
the brain (Czernicki, 1979 ; Unterberg et a 1 , 1986). Other
studies evaluating the possible role of bradykinin in
brain oedematogenesis have delivered bradykinin to the
brain by ventriculo-cisternal perfusion, cortical
superfusion and Isolated cerebral vessel perfusion.
Cortical superfusion studies have shown that bradykinin
vasoconstricts cat and human pial veins in concentrations
as low as 4 x 10~^M (Unterberg et al, 1984) and 10"^M
(Hardebo et al, 1987) respectively. Pial arteriolar
dilation has been recorded with bradykinin concentrations
ranging from 1 ug/ml (10_6M) (Kontos et al, 1 984 ) to 4 x
10~5 M (Unterberg et al, 1984). Pial venule permeability
_ rz
is increased by 10 M bradykinin but leakage is limited
to Na+-f1uorescein (MW 376), since concentrations up to 4
_ O
x 10 M failed to cause leakage of larger MW tracers
(Unterberg et al, 1984; Wahl et al, 1988). Ventrlculo-
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cisternal perfusion of 10 6 M bradykinin causes mild
subependymal oedema (Unterberg & Baethmann, 1984).
Although these studies may be appropriate for evaluating
the possible role of bradykinin in brain oedema associated
with meningitis for several reasons they are a suboptimal
model for predicting its role in brain oedema related to
intracranial tumours, cerebral infarction and parenchymal
infection. Firstly brain parenchymal vessels may not have
the vasomotor and permeability characteristics of the pia 1
vasculature (Watanabe & Rosenblum, 1987) and secondly
normal brain contains kininases, oligopeptidases and
endopeptldases all of which enzymatica1ly cleave
bradykinin under a variety of physiological conditions
(Camargo et al, 1987; McDermott et al, 1987). The activity
of these enzymes, and other plasma protease and kallikrein
inhibitors such as alpha-1-antitrypsin (MW 54,000) and
antithrombin III (MW 58,000), is crucial when considering
pathophysiological effects since normally in vivo these
enzymes limit the T / 2 0 ^ bradykinin in various tissues to
between 30 seconds and 3 minutes (Regoli and Barabe,
1980). Therefore pathophysiological findings using
bradykinin perfusion of the brain surface, at particular
concentrations may have little relevance to the
pathophysiological action of similar concentrations of
bradykinin on cerebral parenchymal vessels in vivo.
Protein Solution
When designing this study it was proposed to grow gliomas
in tissue culture and infuse the culture supernatant into
the brain to evaluate the oedematogenlc and
neurophysio1ogica 1 modulating potential of tumour related
products. A 20% protein solution (Appendix 1) was the
48
chosen culture medium and would therefore have acted as
the control Infusate for the culture infusions. However
due to logistic and technical difficulties tissue culture
was not established. Nonetheless the 20% protein solution
would seem an appropriate infusate since oedema fluid due
to brain abscess and tumours, in both humans and cats, has
a protein content of 4 to 16 mg/ml which is equivalent
to between 6 to 25% plasma protein (Bothe et a 1, 1984;
Bodsch et al, 1987). Analysis of extravasated protein
using immunofluorescent, biochemical and immunoperox idase
techniques has shown that most is albumin ( M W 69,000),
pre-albumin (MW 61,000) and low MW immunoglobulins
(Cummin gs, 1961; Brett & Weller, 1978 ; Hossman et al,
1980; Szymas & Hossman, 1984; Seitz & Wechsler, 1987).
This extravasated extracellular protein may modulate glial
membrane potential since intracellular uptake of
polyanionic protein may alter the Gibbs-Donnan
equilibrium, and K+ efflux (Bodsch et al, 1987). Since
peritumoural protein extravasation is diminished by
steroid therapy in experimental and clinical situations
(Hossmann et al, 1983; Bodsch et al, 1987; Nakagawa et al,
1987; Ito et al, 1988), some extravasated plasma proteins
may alter BBB permeability (Unterberg & Baethmann, 1984;
Oettinger et al, 1976) and since extracellular plasma
protein is cleared more slowly from the cortex than the
white matter (Go et al, 1980) they may contribute to the
pathophysiology of brain oedema and dysfunction.
Glioma Cyst fluid
Since the tissue culture of gliomas was not established,
to test the hypothesis that gliomas produce factors that
mediate vasogenic brain oedema and neuronal or axonal
modulation, glioma cyst fluid was infused. Although the
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e1ectrophoretic and biochemical studies suggest that most
of the protein in these fluids was extravasated plasma
proteins, they would undoubtedly also contain tumour
secretions and tumour cell debris that would be unique to
a particular tumour. Levels of the polyamines putrescine
and N1 -acety1spermidine are higher in cyst fluid from
malignant gliomas compared to low grade astrocytoma
(Yamazaki et al, 1986), and the quantities of higher MW
proteins such as Ig M, transferritin, ceru1 op 1 asmin show
similar variations (Seitz and Wechsler, 1987; see Appendix
2 ) .
The glioma cyst fluid was obtained during CT guided
stereotactic tumour biopsy, using a Nashold cannula and
the BRW stereotaxic system (Apuzzo et al, 1983). Cyst
fluid was tested from four patients with supratentorial
gliomas. Two patients with glioblastoma (GD-GBM and EB-
GBM) had major peritumoural oedema and associated brain
dysfunction, one with an anaplastic astrocytoma (JH-AA)
had moderate oedema and clinical dysfunction and one, with
an oligodendroglioma causing intractable focal epilepsy,
(TF-Oligo) had minimal peritumoural oedema and no clinical
deficit (Appendix 2). It was postulated that experimental
BBB disruption and neuronal modulation would correspond to
the extent of CT imaged peritumoural oedema and associated
clinical dysfunction.
2.6.iv Assessment of brain oedema
Indirect calculation of water content in oedematous brains
from specific gravimetric data has been widely used since
Nelson and colleagues (1971) described their simple method
of quantitating water content from the SGtissue ^SGt^ and
SGgoiids (SGs) of small tissue samples (5-15 mg)
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utilising a layered bromobenzene-kerosene column. Tissue
water content can be calculated from the equation
gm H20/gm tissue = 1 - (SGt - 1)/(1-1/SGs) SGt
Using a water intoxication model the SGg of white matter
was shown to be a constant (Nelson et al, 1971), however
if the oedema fluid contains protein and other solutes the
SGg is raised and tissue water may be underestimated. This
problem led to correction factors being introduced when
the oedema fluid contained protein (Marmarou et al, 1982).
However the content of oedema fluid rarely parallels serum
protein levels and empirical corrections may have to be
made (Bell et al, 1 987b). Others however maintain that SG^
gives a good measure of brain tissue water content
regardless of oedema fluid constituents (Bothe et al,
1984). The major advantages of microgravimetric methods
over wet/dry weighing are its simplicity, rapidity and the
facility to analyse small tissue samples (Marmarou et al,
1978). However there are other limitations with the method
due to factors, independent of the tissue water content,
that will alter SGt« These variables include the sample
size, timing of isogravimetric point, the blood volume of
the tissue sample as well as the the SG of the oedema
fluid (Ferzst et al, 1980). These problems are
acknowledged by proponents of the technique and studies
have been made about the effect of sample size and timing
of 1sogra v i m e tric point (Ferzst et al, 1 980), and of the
influence of changes in tissue blood volume (Picozzi et
al, 1 985 ). Microgravimetry has been widely used in both
experimental and human material and has produced water
content values similar to those obtained using wet/dry
weighing techniques (Marmarou et al, 1982; Bell et al,
1987; 1987b).
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2.6.v Assessment of ICP dynamics and brain biomechanics
The classical changes in brain biomechanics that occur
with brain oedema (ICP, craniospinal compliance, PVI and
Rt) have been alluded to in section 1 .4 . i . The
mathematical models for studying these parameters have
been developed validated and applied in cats using a
variety of experimental protocols (Harmarou et a 1, 1975;
Marmarou et a 1, 1980 ; Takizawa et a 1, 1985; 1986a;1986b;
Gray and Rosner, 1987; Hatashlta & Hoff, 1988).
2.6.vi Assessment of BBB integrity
The importance of disruption of the BBB in the genesis of
the oedema was first demonstrated by Prados and colleagues
(1945) who confirmed that the vital dye trypan blue was
present in cerebral oedema caused by exposure of the brain
to air. Trypan blue and Evans blue (both M W 576) bind to
serum albumin and are markers for BBB disruption to
molecules of circa 69,000. Other indicators of variable MW
and hydrodynamic radius can also be used to assess BBB
integrity and include Horse radish peroxidase (MW 40,000),
Na-Fluorescein (MW 376), DITC-Dextran (MW 20,000 - 62,000).
These compounds are generally detected by sophisticated
techniques such as electron microscopy (HRP) and phase
contrast microscopy ( N a-F1ourescie n ) whereas Evans Blue
extravasation into the brain can be quantitated by simple
planimetry or more accurately using sphectrophotometry
(Durward et al, 1983). Since Evans Blue binds to albumin,
which is the predominant protein in peritumoural brain
oedema fluid, and it has been extensively used in studies
of BBB disruption (Csanda, 1980; Hossmann et al, 1980;
Durward et al, 1983; Chan et al, 1983; Black & Hoff, 1985)
it would seem a simple and appropriate choice.
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2 .6 . v 1 i CBF quantitation
The H2 clearance technique is a simple and inexpensive
method of measuring CBF that has been widely used since
its desription (Auckland, 1965; Pazstor et al, 1973). This
method is based on the Fick principle and the mathematical
model developed by Kety describing equilibration of freely
diffusable, metabo1ica1 1 y inert tracers between tissue and
vascular compartments (Kety, 1951). The mathmatical
derivation and reduction from the Fick equation
d Qt = F t(C a - Cv) (1) to Ct = C0(e"kt) (2)
d t
where Qt is the amount of tracer taken up by the tissues,
F. the tissue blood flow, C and C the coneentrations inT- a V
the arterial and venous blood, C t and Cg the
concentrations of tracer in the tissue at time t and 0,
and k the blood flow per unit of tissue has been
extensively reviewed (Young, 1980; Farrar (1987). This
derivation utilises the unitary partition coefficient of
hydrogen, and the zero value of Cg during desaturation.
Integration of equation (2) provides
lnCt = InCg - kt
which corresponds to a regression equation y = b - mx.
Therefore by plotting the logarithm of the H2 desaturation
curve with time, the slope of desaturation gives the
tissue blood flow. Desaturation curves are obtained by
recording the current generated by the oxidation of tissue
hydrogen on the surface of the platinum electrodes
(Auckland et al, 1965)
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This method relies on assumptions concerning the rate of
H2 equilibration between tissue and vascular compartments,
the arterial H2 level being zero during desaturation and
the electrical potentials being generated solely by H2
Interaction with the platinum electrode (Young, 1980). CBF
values obtained using hydrogen clearance techniques are
similar to those obtained using microspheres (Heiss &
Traup, 1981) and some studies using 1 4 C antipyrine
autoradiographic studies (Fieschi et al, 1969). There are
several accepted limitations to the technique which
include the problem of tissue damage caused by insertion
of electrodes, uncertainty as to the volume of tissue
represented by a flow value, the bi or p o 1 y e xp on en t i a 1
nature of some clearance curves (occurring when cortical
and white matter clearance curves are superimposed) and
spurious oxidative potentials generated by tissue 02, pH
and ascorbic acid concentrations (Young, 1980; Farrer,
1987). Despite these problems the technique has been
extensively used to record rat and cat CBF and CBF C02
reactivity (Marmarou et al, 1980; Tanaka et al, 1983; Bell
et al, 1985; Ianotti et al, 1984; Gray & Rosner, 1987).
2.6.viii Evoked potential recording
Generation of evoked potentials by stimulation of a
particular sensory system and recording an averaged
electrical response at various points along the ascending
pathway is now a standard neurophysiologlcal investigative
technique. The ascending somatosensory pathway includes
the dorsal column nuclei, the medial lemniscus, the
ventroposter 1 or thalamic nuclei, the thalamocortical
projections, the primary somatosensory cortex and cortical
association fibres. In both cats and rats these pathways
have been extensively studied and the cortical SEP
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waveform and generators of the various components
described using an array of stimulating parameters and
cortical electrode placements (Towe et a 1 , 1964 ;
Poliakowa, 1972; Hall & Lindholm, 1974; Wiederholt and
Iragui-Madoz, 1977; Iragui-Madoz and Wiederholt, 1977;
Sutton et a 1, 1980; 1982 ; Allison et a 1, 1982; Dong et a 1,
1982 ; Chapin et a 1 , 1984; Dykes and Lamour, 1988;
Fehlings et al, 1988).
The cortical HEP waveform following transcranial (skull
overlying M1 to pharynx) or direct motor cortical
stimulation in the cat consists of an initial direct (D)
wave due to either pyramidal or basal dendrite excitation
followed by indirect (I) waves due to either recurrent
stimulation of the same neuron or interneurone excitation
(Patton and Amassian, 1954; Levy et al, 1984; Amassian et
al, 1987). The neuronal generators of the HEP waveform are
currently the subject of some debate particularly with
regard to the contribution of nonpyramidal descending
pathways (see review by Amassian et al, 1987; York,
1987). The descending HEP recorded from the midthoracic
spinal cord following transcranial stimulation of the
motor cortex consists of a polyphasic waveform thought to
(Levy et al, 1984). The morphology and latency of the MEP
varies with stimulus intensity, frequency and duration,
the stimulating electrode size and location and recording
location (Levy et al, 1984; Geddes, 1987). If these
parameters are defined the descending MEP would seem a
satisfactory method of assessing the integrity of
conduction through oedematous brain.
If brain oedema or a particular lnfusate in the oedema
fluid modulates axonal function then changes should occur
axonal volleys generated by the D and I waves
S5
in specific components of either the SEP or HEP waveform
if the fluid is deposited into the relevant fibre tracts.
Both these evoked potentials are readily acquired, easy to
interpret and have known anatomical substrates which makes
them ideal parameters for functional monitoring (Dong et
a 1, 1982; Levy et a 1, 1984; Amasslan et a 1, 1987 ; Fehlings
e t a 1 , 1 9 8 8).
2.6.1x Histological studies
The histological features of brain oedema have been
reviewed in section 1.3. To validate that the infusion
model causes these histological features a standard stain
(H & E), a myelin stain (So1ochrome-cyanin) and stain
showing proteinaceous material (PAS) were selected. These
simple studies provide an analysis of tissue reaction and
patterns of spread of the infusate(s). They may also
provide some Insight into mechanisms of BBB disruption
following particular infusates.
SECTION 3: RESULTS
3.1 RODENT MODEL OF INFUSION OEDEMA
3.1 .i General comments
Preparation of the rat for the infusion oedema studies
usually took two hours. Induction of anaesthesia following
intraperitoneal urethrane usually occurred within five
minutes. Generally the rats remained metabo1ica 1 1 y and
physiologically stable throughout the duration of an
experiment. If the animal was not anaesthetised by ten
minutes it was assumed that delivery of the anesthetic had
not been completely intraperitoneal. In a number of such
animals watery diarrhoea occurred, probably due to enteric
injection. In such circumstances the experiment was
discontinued and any data discarded.
Experiments using sham infusion, 0.1 ml saline infusion
and 0.1 ml 20% protein infusion were performed in over 80
rats. Spatial limitations dictated that several series of
experiments were performed to compile all data (focal
brain tissue SG, total hemispheric water content,
intracranial pressure, brain tissue hydraulic resistance,
cerebral tissue compliance, cortical SEPs, regional CBF
and CBF c 0
2 reactivity) for one infusate. The
intraparenchymal infusion was always into the left frontal
region and the series of experiments performed included-
L frontal infusion - R Intraventricular pressure monitoring
L frontal infusion - Bilateral CBF recording
L frontal infusion - Bilateral SEP recording
Data concerning infusion pressure, brain water content,
cortical and subcortical specific gravity was compiled
from the various series of experiments.
5'7
3.1.11 BRAIN WATER CONTENT AND SPECIFIC GRAVITY
■3
The specific gravity of 2-4 mm segments of cortical and
subcortical tissues following (1) sham infusion
placement of a 25G needle stereotactically into the white
matter for one hour with no infusion, (2) infusion of 0.1
ml saline and (3) infusion of 0.1 ml 20% protein solution
over one hour, were recorded. The subcortical tissue
specific gravity (Appendix 6; Table A-1), adjacent to the
infusion site, was significantly reduced, when compared to
the noninfused "control" hemisphere, following both saline
(mean 1.0325 ; p < .001) and 20% protein (mean 1.0332 ; p <,
0.001) infusions, but was not significantly reduced by
sham infusion (mean 1.0384; p = 0.69.). There was no
significant change in the SG of cortical tissue (Table A-
2) adjacent to any of the infusion sites (mean 1.0423)
when compared to the contralateral hemisphere (1.0417).
Total brain hemispheric water content was determined in 26
rats after either saline (mean 77.5%) or 20% protein
(78.3%) infusion. Although there were minor differences in
water content between infused and contralateral
hemispheres none of these differences were statistically
significant (Table A.3).
3.1.111 INTRAVENTRICULAR PRESSURE
Intraventricular CSF pressure was recorded in 14 rats.
There was a small rise from baseline values during
intracerebral infusion in both saline and 20% protein
groups (Tables A-4, A-5). After completion of the saline
infusion this increase was just statistically significant
(p = .04) however part of this increased is related to the
higher P CO, at the completion of the infusion. When
a £
correction is made for the differences in p
a c ° 2 the ICP
change is not significant (see Appendix 3).
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Figure 4:Patterns of infusion pressure (P^ f) recorded
during intracerebral infusion. A normal experimental
record with early peak rise in ^ followed by a rapid
fall to levels just above ICP. Figures B and C illustrate
patterns of Pjnf that occur if the infusion line is
blocked (B) or leaks (C). Such patterns were occasionally
recorded in the rat but not in the cat experiments.
Using both the saline and protein infusates characteristic
infusion line pressures ( p i n f ^ were obtained (Fig 4 )^.
There was a peak infusion pressure of approximately 40
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Figure 5: Changes in mean infusion pressure (P inf) during 0.1
ml/hr infusion with saline and 20% protein into the rat
nucleus caudatoputamen.
mmHg between 1-3 minutes after commencement of the
infusion. In the susequent 1 -2 minutes there was a 15 -
20 mmHg fall in pressure until a fairly constant was
obtained (Fig 5). Measurement of P-n^ was particularly
useful for detecting occult blockage of the infusion line
or leakage of the infusate around the infusion needle,
presumably into the subarachnoid or subdural spaces (Fig
4) .
Calculation of Rt and C t revealed characteristic and
similar patterns of change in both the saline and 10%
protein infusion groups. R fell significantly from peak
O
values (mean 24.3 x 10 mmHg/ml/min) the first 20 minutes,
and then by less significant amounts throughout the course
of infusion to mean values of 11.5 x 10 mraHg/ml/min at 60
minutes (Tables A.6 and A-7). With both infusates C t
increased during the infusion from an initial mean value
of 0.21 x 10 3 ml/mmHg to 4.85 (saline) and 5.55 x 10 3
ml/mmHg (20% protein) at 60 minutes (Tables A-6, A-7).
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3.1.V CORTICAL SOMATOSENSORY EVOKED POTENTIALS
Figure 6: Right and left rat cortical SEP waveforms
following contralateral forepaw stimulation during left
frontal intracerebral infusion of 0.1 ml 20% protein/hr. A
= baseline; B = 20 min; C = 40 min; D = 60 min.
5 ms
Characteristic cortical SEPs following forepaw stimulation
were obtained (Fig 6). The major components in the initial
35 ms were ^12 ^14 ^20 anc' ^ 2 8 * The amplitude of the
maximal N-P component varied between animals from 3 to 13
uv, but in general amplitude of the SEP remained stable
for both infused and control hemispheres during the study.
For comparative purposes the latencies of the SEPs from
the infused hemisphere were compared to those of the
contralateral hemisphere. There was no significant
Gl
asymmetry in SEP short or long latency components in the
0.1 ml saline infusion group (Table A.8). In the 20%
protein infusion group the 1?28 component from both the
ms over the one hour infusion period, otherwise the SEP
waveform remained stable (Table A.9).
3.1.vi CEREBRAL BLOOD FLOW
CBF data was pooled so that at least 10 flows were
obtained for each electrode locus in both ssaline and 20%
protei infusion experiments. Twenty five minute intervals
between flows were required in order to obtain stable
electrode baselines. Two clearances were performed in each
experiment to check electrode stability before recording
baseline data. In all experiments CBF values below 20
ml/1OOg brain/min were considered to be flows from either
white matter or damaged cortex, and were discarded.
During saline infusion there was a tendency for the CBF
adjacent to the left frontal infusion needle to decrease
from a mean baseline value of 37 ml/1OOg/mln to 29
ml/1OOg/min and remain depressed during the infusion (Fig
7 and Table A-10). A similar but transient (20 minute)
reduction was also seen in the left posterior parietal
region. Because of the spread of the data and the
magnitude of the SD the reduction in CBF adjacent to the
infusion site was not statistically significant (p =
0.15). The large SD occurred because individual CBF
values ranged from 22 - 81 ml/ 100 g brain/ minute for
baseline flows, and remained at these levels, at all
locations, throughout the experiment. The right
hemispheric CBF remained stable (mean circa 37
ml/1OOg/min) throughout the course of infusion.
During 20% protein infusion the CBF decreased at all
electrode locations over the initial 20 minutes but by 70
infused and hemisphere was increased by 2-3
bZ
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Figure 7: Regional CBF changes during 0.1 ml/hr saline
infusion into the left caudatoputamen nucleus. Data points
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Figure 8: Regional CBF changes during 0.1 ml/hr 20%
protein infusion into the left caudatoputamen nucleus.
Data points are mean, and where shown, + SEM.
minutes was similar to baseline values (FigS and Table
A.11). Due to the size of the SD none of these changes
were statistically significant (p = 0.26 for the
difference between baseline and 20 minute CBF values at
the L anterior parietal electrode). The range of
individual values for baseline CBF was large (25 - 81 ml/
100 g brain/ min), although this was smaller at later time
points (21 -67 ml/100 g brain/min). Similar ranges were
recorded at all electrodes throughout the course of
expe riments.
Following the left frontal intracerebral infusion the
cerebrovascular reactivity to PgCOj was tested over the
range 25 to 59 mmHg. CBF data was pooled from a large
series of experiments (n = 16 saline infusion, n = 11
protein infusion) to enable acguisition of sufficient flow
values across the spectrum of C02 values.
A series of experiments performed to obtain normal
cerebrovascular reactivity data for rats using this
anaesthetic protocol has previously been published and
recorded an increases of 1 ml/ 100 g brain/ min for each
one torr increase in pacC>2 the PgC02 range 23 to 60
mmHg (Bell et al, 1985). The regression equation that
described this relationship was;
CBF = 1.0 (P=C0_) + 2
a Z
n = 50 r = 0.70 p<0.001
with CBF expressed as ml/1 OOg brain/min and PaCC>2 as mmHg.
Following saline infusion cerebrovascua1r reactivity to
changes in p a C 0 2 was preserved at all electrode locations
with an increase in CBF of 1 - 1.5 ml/ 100 g brain / min
per torr increase in C02 (Table A.12). Following the 20%
protein infusion focal CBF CC>2 reactivity adjacent to the
infusion site was reduced by 65% compared to the
noninfused hemisphere (Table A.12). The correlation
coefficient for the CBF and P CO- data at this location
a Z
G4
was also substantially reduced when compared to the other
locations but analysis of covariance revealed the
differences between the two anterior parietal locations to
at normal levels at the other locations following 20%
protein infusion (Table A.13).
3.1.viii BLOOD BRAIN BARRIER DISRUPTION AND HISTOLOGICAL
STUDIES
Light microscopic studies of H & E stained sections of the
rat forebrain were studied after left frontal infusion of
2% Nile blue. These studies showed that the infusate was
deposited at the junction of the hemispheric white matter
and caudate nucleus, and spread along the white matter
planes medially into the corpus callosum, and laterally
into the corona radlata. There was also mild ipsllateral
ventricular effacement (Fig 9). Light microscopic studies
following saline infusion revealed pallor, vacuolation
and expansion of the subcortical white matter from the
corpus callosum medially to the anterior amygdaloid area
laterally. The space between fibre tract bundles was
clearly enlarged but astrocytes and oligodendroglia
appeared normal. The caudate nucleus and deep cortical
laminae were normal.
Examination of coronal sections of the rat brains that
were given 1 ml/kg of 2% Evans blue one hour after
infusion and one hour prior to sacrifice revealed no
intraparenchyma 1 staining following the sham, saline or
20% protein infusions. There was also minimal staining
detected beneath both the burr hole and at the site of the
infusion needle tract.





Figure 9: Low (x40) and high (x100) power photomicrographs
of coronal sections of the rat brain at the plane of
infusion site. The infusate (2% Nile Blue in saline) is
deposited into the external part of the caudatoputamen
nucleus deep to the subcortical white matter (cf Fig 2).
There has been spread of the infusate into the callosal
fibres and deeper cortical laminae, but spread within the
caudatoputamen nucleus is limited. The white matter extra¬
cellular space appears trabeculated. Both sections H & E.
(,t>
3.2 FELINE MODEL OF INFUSION OEDEMA
3.2.1 General comments
A total of 40 experiments was performed, these included
Administration of the intraperitoneal barbiturate was
uncomplicated and general anaesthesia was usually present
within 10-15 minutes. Thereafter the animal tended to
remain metabo1ica11y and physiologically extremely stable
over a total anesthesia time of 10-11 hours. After the cat
was positioned in the stereotaxic frame, the order of
cranial preparation of the experiment was (1) drilling of
all burrholes, (2) placement of 6 platinum iridium
electrodes, (3) placement of infusion needle, (4)
placement of intraventricular needle and (6) placement of
Ag/AgCl extracranial disc electrodes. This sequence
enabled a longer period of stabilization for the platinum
/iridium electrodes, and least probability of dislodging
the ventricular needle. Preparation usually took four
hours, followed by the three hour infusion period and a
further three hours to acquire the CBF CC>2 and MEP data.
3.2.ii BRAIN WATER CONTENT AND SPECIFIC GRAVITY
In all series of experiments mean water content of
cortical tissue from the noninfused (control) left
hemisphere ranged between 78.5 % (SG 1.0465) and 81.0 %
(SG 1.0399). Following the various infusates the cortical
water content of the infused right hemisphere was either
similar to or slightly greater (1 - 2 % ) than the
noninfused hemisphere. The maximal increase in cortical
4 Saline infusion
4 Sham infusion
9 20% protein infusion
7 Arachidonic acid infusion




Figure 10: White matter water content following 0.6 ml
infusion of various solutions into the right forebrain white
matter. Control values are for the left anterior forebrain
white matter. All data mean + SP.
water content (2.2 %) occurred following arachidonic acid
infusion. Although this represented a statistically
significant increase (p = 0.008) the elevated cortical
water content (80.7 %) was lower than control values from
other experiments (Tables A.13 to A.22).
The mean white matter water content for the noninfused
(control) left anterior centrum ovale ranged from 67.2 %
(SG 1.0436) to 69.9 % (SG 1.0407). In the sham infused
cats no significant difference (p = 0.45) in white matter
water content was detected (Table A.13). Increases in
white matter water content following the various infusions
(dB
ranged from 7.9 to 12.5 g t^O/lOO g tissue and were all
highly significant (Fig 10 and Tables A.14 to A.22). The
increase in white matter water content was not related to
the administered dose of either arachidonic acid (2 - 15
mg/ml) or bradykinin (5 - 150 ug/ml). Infusion of cyst
fluids from glioblastoma, anaplastic astrocytoma or
oligodendroglioma all produced similar increases in white
matter water content (Tables A.19 to A.22).
3.2.ill INTRAVENTRICULAR PRESSURE
ICP monitoring through the ventricular needle was usually
obtained without difficulty. Ventricular placement of the
needle was confirmed by a rapid 5 - 10 mmHg increase in
ICP with manual compression of the cat abdomen. Baseline
mean ICP recorded in the various series of experiments
ranged from 4.8 to 9.8 mmHg, with a pulse pressure of 1 -2
mmHg, at PaCC>2 levels of 33 mmHg and mean arterial BP of
120 mmHg.
Various patterns of ICP change were recorded both during
and after the infusions (Fig 11). In the 3 sham infusion
cats mean ICP, at normocapnia, increased from baseline
mean of 4.8 mmHg to 7.8 mmHg at 180 minutes (Table A.23).
In two of these animals ICP remained stable at around 5
mmHg whilst in the third animal ICP increased from
baseline levels of 5 mmHg to 15 mmHg at 180 minutes.
ICP was recorded in four cats having intracerebral saline
infusion. In all animals mean blood pressure (120 mmHg)
and P C0o (34 mmHg) were similar throughout the course of
a. Z
experiment. Three cats (including one sallne/5% ether
infusion) had infusion at 0.2 ml/hr and one had an
infusion at 0.3 ml/hr. The mean baseline ICP was 5.5







Figure 11: Changes in mean ICP in the cat during and after a
180 minute period of either sham infusion or intracerebral
infusion with arachidonic acid or glioma cyst fluid. The mean
rise in ICP with saline and 20% protein infusates was very
similar to that recorded with arachidonic acid infusion. The
mean rise in ICP recorded with bradykinin infusates was
between that recorded with arachidonic acid and glioma cyst
infusate. With the exception of the sham infusion mean ICP
rises were statistically significant (see Tables A - 2 4 to A -
31 ) .
ml/hr infusion and 36 mmHg with a 0.3 ml/hr infusion
(Table A.24).
There were moderate elevations in ICP during bradykinin,
20% protein and arachidonic acid infusion at 0.2 ml/hour
(Fig 11). ICP increases, from baseline means of around
5mmHg, ranged from 8.9 to 14 mmHg at 180 minutes and all
were statistically significant (Tables A.25 to A.27).
Three hours after cessation of the infusions ICP had
decreased from 180 minute values in all series of
experiments.
After infusion with the various glioma cyst fluid
infusates ICP at 180 minutes had risen from mean baseline
values of between 3 and 9.8 mmHg by between 9.2 and 15.3
70
mmHg. Three hours after completion of the infusion mean
IC P had fallen back towards baseline values (Tables A.28
to A.31). When the glioma cyst fluid experiments were
analysed collectively the rise from baseline to 180 minute
ICP values was highly significant (p ^ .001).
When the 180 minute sham infusion mean TCP was compared to
the 180 minute mean ICP after the various infusions there
was no statistically significant difference between any
group. P values ranged from 0.19 (sham versus 20% protein)
to 0.013 (sham versus glioma cyst infusion). Significance
reguired a p value of < 0.0083.
3.2.iv INTRACRANIAL PRESSURE VOLUME INDEX
P VI was calculated following a 0.1 ml saline intra¬
ventricular bolus in all series of experiments before,
each hour during and after Intracerebral infusion.
Baseline mean PVI ranged from 0.34 3 to 0.5 38 ml for all
series of experiments. PVI did not alter significantly in
any group throughout the 6 hour period of experiment
(Tables A.32 and A.33).
I
3.2.V CSF OUTFLOW RESISTANCE (Rq)
R was calculated following 0.1 ml saline intraventricular
bolus before, each hour during and after the intracerebral
infusion. In all except one series of two experiments,
where mean baseline Rq was 170 mmHg/ml/mln, mean baseline
R ranged from 70 to 99 mmHg/ml/min.
Statistically insignificant rises from baseline to 180
minute Rq values were encountered with sham (mean increase
79 mmHg/ml/min), 20% protein (64), and saline (85)
infusates (Table A-34). Rises from baseline to 180 minute
~1 I
R values that were statistically significant at the 0.05
to 0.01 level (Table A-34) occurred after bradykinin (mean
Increase of 119 mmHg/ml/min and arachidonic acid (336)
infusions. The most significant increase in RQ occurred
after the glioma cyst infu sates (p = . 0 0 2 j when analysed
collectively), although the increases with specific cyst
fluids did range from 82 (EB-GBM) to 319 (GD-GBM)
mmHg/ml/min (Table A-35).
Three hours after completion of infusion Rq was returning
towards baseline values in the sham, arachidonic acid,
bradykinin and OLI-TF infusates, but remained elevated in
the 20% protein and all malignant glioma infusates.
3.2.vi CRANIOSPINAL COMPLIANCE (C^
Lumped C ^ was calculated using PVI data before, during and
after infusion. Baseline C ^ in different series of
experiments ranged from 0.022 to 0.047 ml/mmHg. During all
series of experiments C ^ fell during the period of
infusion (Fig 12). This decrease in C^ was lowest (.018
ml/mmHg), and not statistically significant, in the sham
infusion cats (Table A.36). Mean C^ decreased by 70%
during the period of saline infusion (p = 0.013). In the
other infusion groups the fall in C ^ was of similar
magnitude and level of statistical significance (Table A-
36 and A- 3 7 ).
At the completion of the infusions C ^ was lowest in the
glioma cyst infusion experiments. Although these animals
also had the lowest mean baseline levels of C^ the
reduction in C ^ , when all glioma cyst infusion cats were
analysed collectively, was highly significant (p = 0.003).
Three hours after completion of the infusion C ^ values
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Figure 12: Patterns of change in lumped craniospinal
compliance from baseline values during 180 minute
period of intracerebral infusion. Compliance fell
significantly during the infusion period with all solutions.
After cessation of the infusion compliance either stabilised
around 180 minute values or slowly increased. The fall in
compliance with sham infusion is not statistically
significant,
3.2.vii BRAIN TISSUE HYDRAULIC RESISTANCE
Brain tissue hydraulic resistance C R t) was recorded during
infusion in 8 cats. The pattern of infusion pressure
(Pinf) change was similar regardless of the infusate, in
that rose in the initial three minutes to around 35
mraHg, then over the subsequent 2- 5 minutes fell to around
15 mmHg. Thereafter Pjnf slightly increased until the
infusion was complete (cf Fig 4 and Table A.38). In most
"73
cases after the initial 10 minutes of infusion the P j_ n f
was several mmHg above the ICP. Calculation of the (Rt
= pinf / where Q, the flow rate was .0033 ml/min)
revealed that there was a highly significant decrease (p<
0.001) in Rt from mean peak (2-3 minute) value of 9.8 x
O O
10 mmHg/ml/mins to 4.3 x 10 mmHg/ml/min 10 minutes after
the start of infusion (Table A.38). Although R ^
suseguently increased over the remaining 170 minutes of
infusion, these changes were not significant.
3.2.viii CORTICAL SOMATOSENSORY EVOKED POTENTIALS
Cortical SEPs following contralateral forepaw stimulation
were recorded in all series of experiments. Epochs were
set at 50 and 100 ms to enable documentation of both the
short and long latency components. Waveforms recorded were
polyphasic and contained major components with latencies
at Ng P .J g N i y p28 an<3 n47* This pattern of cortical SEP is
Illustrated in Fig 13. The amplitude of the - N 1 7
component was variable between cats (range 3-35 uV) but
remained stable to within several uV for any Individual
hemisphere during an experiment. For comparative purposes
the latencies of the infused right hemisphere SEPs were
compared with those of the noninfused (control) hemisphere
The components of the cortical SEP with latencies shorter
than the P28 were generally highly reproducible throughout
all series of experiments although in some animals the Ng-
P.|Q component was a W shaped complex with latencies of N6-
P7-N8-P10 (see 4 hour right hemispheric waveform Fig 15).
Where there was a either shortening or delay in waveform
latency such changes were recorded bilaterally (Tables A-
40, 41 and A-44). The ?2g anci especially the latencies
were subject to some variation but there was no particular




Figure 13: Cortical SEP waveforms recorded from the left (L)
and right (R) hemispheres following contralateral median
nerve stimulation in the cat, during a 180 minute period of
saline infusion into the right forebrain white matter. The
waveform is composed of N^, P^g, Njy,P2g and components
that are reproducible throughout the infusion period.
range of values recorded for these two components was
similar for the two hemispheres (Tables A-39 to A-47).
Cortical SEPs from the infused hemisphere changed in three
cats. These were the GD-GBM cat number 1 (Fig 14), the
solitary cat infused with 150 ug/ml bradykinin (Fig 15)
15
10 his
Figure 14 : Cat cortical SEP waveforms recorded from the
right (R) and left (L) hemispheres following contralateral
median nerve stimulation, during and after three hour period
of infusion of GD-GBM glioma cyst fluid into the right
forebrain white matter. The baseline waveforms are
symmetrical (0). After two hours P 2 8 ~ N 4 0 P 6 5 component
becomes prominent in the right cortical SEP and persists,
although decreasing in amplitude after three hours, until
the end of the experiment. The left cortical SEP remains
stable. 0-6 refer to hours after start of the infusion.
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Figure 15 : Cat cortical SEP waveforms recorded from the
right (R) and left (L) hemispheres following contralateral
median nerve stimulation, during and after three hour period
of infusion of bradykinin 15Dug/ml into the right forebrain
white matter. The baseline waveforms are symmetrical
although a little "noisy" (0). After two hours a P28~^45~^70
component becomes prominent in the right cortical SEP and
persists, although decreasing in amplitude after four hours,
until the end of the experiment. Between three and four
hours there is also flattening of the ^i7-P28 amplitude. 0 -
5 refer to hours after start of the infusion.
and the TF-oligo cat. The major changes seen in these
11
experiments were flattening of the Ni7_p28 component, the
development of a large amplitude, broad latency negative
wave with peak latency around 40 -50 ms and a prominent
P wave with latency between 5 7 -6 7 ms (Fig 14 and 15). In
none of these cats was there impairment of cerebral
perfusion pressure although there was a significant focal
(right frontal) reduction in rCBF in the GD-GBM cat (see
3.2.x). The change in SEP with the GD-GBM infusion
occurred only in the first of the two cats studied with
this glioblastoma cyst fluid even though both cats had a
similar focal reduction in rCBF.
3.2. ix MOTOR EVOKED POTENTIALS
Motor evoked potentials (MEPs) were recorded subdurally at
between Tg and T12 following transcranial stimulation, at
the conclusion of the cerebrovascular reactivity
experiments. Polyphasic waveforms consisting of one or two
large initial negative (N^ , N j) waves and subsequent
smaller amplitude, longer latency N waves were recorded in
each cat (Fig 16). All the waveform components were short
latency with the longest component being less than 7 ms.
In no experiment was there any significant asymmetry of
response when comparing the latencies of the N^ waves
generated by right and left hemicranial stimulation or by
direct cortical stimulation throught the platinum iridium
electrodes (Tables A.48 to A-53). The amplitudes for the
N .J - P i component are also included in these tables. The
magnitude of this component wave was directly related to
stimulus Intensity when a submaximal stimulus was used to
evoke the response. This phenomenon is well illustrated in
a series of experiments performed using graded direct
cortical stimulation through a frontal platinum iridium
electrode (Appendix 4)
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Figure 16: Patterns of thoracic spinal MEPs recorded
following heraicranial stimulation in the cat. The waveform
was usually characterised by one (A) or two (B,C) large
amplitude negative components, with a variable number
oflonger latency smaller amplitude negative waves (A right
and C left). The large amplitude N components were
symmetrical in all animals despite the right sided
subcortical oedema and presence of arachidonic acid,
bradykinin, 20% protein and glioma cyst fluid in the oedema
fluid. The number of smaller longer latency negative waves
was variable but was not confined to the waveform following
right hemicranial stimulation (cf A and C). L = MEP waveform
recorded following left hemicranial stimulation, R that
following right sided stimulation. Traces A, B cats infused
with JH-AA glioma cyst fluid, Traces C infused with
bradykinin 5 ug/ml.
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The number of waveform components following N^ was
variable and ranged from none to eight. The number of
these subcomponents varied between experiments using the
same infusate, however these differences were not confined
to the MEP generated by stimulation of the right (infused)
motor cortex or hemisphere (see Fig 16 and Table A.53).
3.2.x CEREBRAL BLOOD FLOW
Characteristic exponential washout patterns of Hj
clearance curves were obtained in all experiments. For
purposes of the study the flows in the right frontal
region (ie adjacent to the infusion locus) were compared
to those in the left frontal region. Electrodes recording
baseline CBF of less than 20 ml/100 gm brain/min were
considered to represent pure white matter blood flow.
Baseline frontal and parietal mean rCBF varied from 26 to
52 ml/100 gm brain / m i n in the various series of
experiments, with most values lying between 40 and 50
ml/100 g brain/min (Tables A.54 to A.62). The baseline R
and L frontal CBF values recorded in the sham cats (26 and
28 ml/100 g/min respectively) were significantly lower
than in any other series. However similar flow values were
recorded consistently throughout the experiment (Table
A .54 ) .
Mean CBF adjacent to the right frontal infusion site did
not change consistently or sign1f1cant1y from baseline
values throughout the saline, 20% protein, bradykinin,
arachidonic acid, JH-AA and TF-Oligo infusions. Mean CBF
also remained constant at the other three electrode
locations. The standard deviations for some of these flow
values was high (22 and 23 ml/100 g brain/min) due to the
spread of flow values eg the highest CBF value was 110
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ml/100 gm brain/ min.
Following infusion of the GD-GBM cyst fluid there was a
significant reduction in mean CBF adjacent to the right
frontal infusion site from 49 to 19 ml/100 g/min (Table
A.59). There was also a significant reduction in mean CBF
(from 41 to 30 ml/100 g/min) adjacent to the infusion site
with EB-GBM infusion. However a similar flow reduction was
also seen in the contralateral frontal region (Table
A . 6 1 ) .
CBF was recorded from electrodes in the white matter
during the arachidonic acid and 20% protein infusion
experiments. In neither of these experiments was there a
significant change in CBFW from baseline mean values of
17-21 ml/100 g/min, in either the infused or contralateral
hemisphere (Table A.63 and A.64).
At the completion of intracerebral infusion CBF CO2
reactivity was studied over the range of P CO„ values 25
a Z
to 56 mmHg. In 3 sham infusion experiments cerebrovascular
reactivity was present bifrontally in all five functioning
electrodes. rCBF increased by between 0.99 and 1.39 ml/100
g braln/min for each one torr increase in P C0o. TheCL Z
equations denoting the relationship between frontal CBF
and paC02, derived from linear regression analysis are
R Frontal CBF = 1.39 P C0o - 20
g a 2
n = 11 r = .83 p<0.01
L Frontal CBF = 0,99 P3CO, - 7.1
y a /L
n = 17 r = . 8 8 p<0.001
Following saline infusion CBF CO^ reactivity was preserved




























Figure 17: Patterns of CBF CO2 reactivity seen after the
various infusates. After saline, arachidonic acid and sham
(not shown) infusion CBF increased approximately 3% for each
mmHg rise in PgCO^- However after the malignant glioma cyst,
bradykinin and 20% protein (both not shown) infusates CBF
CC>2 reactivity is profoundly impaired.
and 0.88 (left) ml/100 g/min per torr increase in P COo.
a ^
CBF reactivity was also preserved at all electrode sites
following arachidonic acid infusion with CBF increasing by
between 0.77 and 1.36 ml/100 g/min per torr increase in
Pa<"°2 f°r the cortical electrodes (Fig 17) and 0.31 and
0.63 ml/100 g/min for the white matter electrodes (Tables
A.65 and A.66).
With protein or peptide infusates CBF CO2 reactivity was
variably impaired. Following 20% protein infusion CBF
reactivity was impaired with the correlation coefficients
being low (r = 0.30 to 0.35) with no significant
8Z
correlation between CBF and C 0 2 at any electrode location
(Table A.67). Following bradykinin infusion CBF C02
reactivity was also similarly impaired at all electrode
locations. The correlation coefficients ranged from 0.007
to 0.33, with none of these values being statistically
significant (Table A.68).
After infusion of the tumour cyst fluids JH-AA and GD-GBM
CBF CO 2 reactivity adjacent to the infusion site was
impaired with neither correlation coefficient being
statistically significant (Fig 17 and Table A.69). CBF CC>2
reactivity was present after infusion of EB-GBM cyst fluid
but the level of reactivity (0.42 ml/100 g/min per one
torr increase in pa^(-)2) was 60% lower than controls.
Paradoxically following the TF-Oligo cyst fluid infusate
reactivity was enhanced with CBF increasing by 2.2
ml/1OOg/min per torr increase in P C0o. Following the
a Z
tumour cyst fluid infusates reactivity was, with the
exception of EB-GBM cyst fluid (where a decrease in CBF
CC>2 reactivity was similar to the infused side) preserved
in the contralateral frontal and parietal regions (Table
A .69 ) .
3.2.xi BLOOD BRAIN BARRIER DISRUPTION
Coronal sections of the cat brains revealed no
intraparenchyma1 staining with Evans Blue following the
sham infusion, saline and saline/5% ether infusions (Fig
18a). Following the 20% protein infusion there was
extensive but light staining of the centrum ovale adjacent
to the infusion site that extended posteriorly into the
capsular fibres (Fig 18b). Following bradykinin 5000 ng/ml
infusion staining was either absent or light and limited
to the region directly adjacent to the infusion site. With
150 ug/ml bradykinin infusion there was light staining
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Figure18:Coronalsectionsfthcatbraif llowinginf s ofv ri uss lutio sntthe rightanteriorfo ebrainwh tematter.Aftes lineinfus n-. em orlocaltissu expansionbutnextravasationofintravenousEBluedy(A).Foll wing20%pr ein infusionthereextensivee travasationofEv sBlua dloc lexpansionfthwh te matter.ThereisalsofocalEvansBlus iningofthortexinrelationtbu rholesf r boththeintraventricularandinfusionneedles(B).Bradykinininfusio(15g/ml)ca sedlo tissueexpansionwithflatteningofadjace tgyridextravasationfEv sBlue(C).T intensitya dreaofEvansBlueextravastionaft rar chidonicc idinfw ssim larto thatshownwithbradykinin.
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over a region of 20 mm" that extended posteriorly from
the Infusion site into the capsular and longitudinal
association fibres (Fig 18c).
Intraparenchyma 1 staining following arachidonic acid
infusion was variable in area (range 15 - 50 mm ) but
generally light in intensity. Paradoxically this was
maximal (50 mm staining in the section 2 mm posterior to
infusion site) with the lowest dose of arachidonic acid
tested (2 mg/ml). With 10 mg /ml arachidonic acid infusion
Evans blue extravasation was limited to a 15 - 30 mm
region adjacent to the infusion needle with minimal
antero-posterior spread. In one cat there was also a small
(estimated 0.3 ml) hematoma adjacent to the ventricular
needle tract in the hemisphere contralateral to infusion.
There was minimal BBB disruption adjacent to this hematoma
cavity.
The most extensive extravasation of Evans Blue, and focal
brain swelling, was found in all seven cats following the
glioma cyst infusates. With GD-GBM cyst fluid the area of
intense blue staining 2 mm posterior to the plane of
2 9infusion was 40 mm (cat 1) and 64 mm (cat 2). In both
cats the disruption extended posteriorly in the
association fibres to the thalamic region (Fig 19a).
Following infusion of EB-GBM cyst fluid, similar patterns
and degrees of Evans blue extravasation were noted
although the hemispheric swelling was worse. Following
infusion of J H - A A cyst fluid there was intense staining of
the entire centrum ovale, arcuate fibres and outer
cortical laminae in both cats. The blue staining extended
both frontally and posteriorly to the retrotha1 amic region
(Fig 19b). Infusion of TF-Oligo fluid aslo caused




Figure19:Coronalsectionsfthecatbraishowingextr vasatioint avenousEBlue dyefollowinginfusiofvar usgliomacystfl dsintthenteriorforebrainwh tematte . Withallinfusatestherm kedexpansionofthwhitem t rflatt ningt overlyinggyrandobliterationfdjace tsu ci.Extravastionaft rGD-GBMcyfluiw s limitedbutrelativelyint nse(A).Th rsdiffusBstainingofwhitem tt rh hemisphericswellingaft rinfusioofJH-AAcystfl d(B).Extrava ationl oext nsive afterinfusionofTF-Oligocystfl id(C).W thbothel t rinfusatestfibr fth corpuscallosumshowminimallocalEvansB ueextravas tionalthought psularfibress ow extensivebluediscolouration.
Blue staining of variable intensity was also noted in the
cortex beneath some of the burrholes. In most cats two of
the 8 drilled areas exhibited some cortical staining. In
most animals this was superficial but in others very
light, and local, staining of the deeper cortical lamina
also occurred.
3.2.xiI BRAIN HISTOLOGY
Some histological features were common to all infusates.
In the regions adjacent to the infusion site there was
obvious pallor of the white matter using both H&E and
so 1ochrome-cyanin stains. This pallor radiated rostrally
into the gyral white matter, anteriorly and posteriorly
along the long association fibres of the centrum ovale and
caudally into the periventricular and capsular regions. In
these areas there was expansion of the extracellular space
of the white matter, which appeared vacuolated, and
dissolution of the eosinlophillc ground substance (Fig
20a-c). Between the deep cortical laminae and oedematous
brain there was a clear zone of approximately 300 u that
clearly demarcated the cortical from the subcortical
tissues (Fig 20b and c). In some sections there was a
transitional zone between oedematous and normal white
matter (Fig 21a). The subependymal white matter in the
region of the right frontal ventricular horn was also
oedematous but the ependymal epithelium was preserved.
Axons and myelinated fibres appeared separated
particularly in the oedematous corona radiata (Fig 21c).
In all studies the cortical laminae appeared normal. In
most animals there was some polymorphic infiltration of
the subarachnoid and Virchow-Robin spaces.
Following saline infusion there were no additional
features to those described above. After arachidonic acid
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Legends to Figure 20 overleaf.
r . I
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Figure 20a: Normal cortex and
so1ochrome-cyanin. The gyral
bluish green whilst the cortex
stains maroon (x 50)
white matter stained with
white matter is a uniform
(bottom right and top left)
Figure 20b: Cortex and oedematous white matter following
infusion of saline into the forebrain white matter. The
cortex (top right and bottom left) appears normal but the
white matter appears vacuolated and stains less intensely
than normal. In addition there is a clear zone demarcating
the deepest cortical laminae from the underlying white
matter. Beneath this clear zone the subcortical arcuate
fibres appear to stain more intensely than the underlying
gyral white matter (So1ochrome-cyanin, x 50).
Figure 20c: Oedematous gyral white matter following saline
infusion into the forebrain white matter. The white matter
is vacuolated with partial dissolution of the normal
eosinophilic ground substance. The deep cortical laminae
are clearly demarcated from the gyral white matter by a
vacuolated and relatively acellular zone (H & E x 100).
 




Figure 21 a: Spreading oedema "front" in the white matter
following 20% protein solution into the forebrain white
matter of the cat. The normal white matter (Left) is
composed of glial nuclei and relatively homogenous
staining ground substance. The oedematous white
matter (right) is vacuolated with dissolution of the
ground sustance. There is also some perivenous polymorphic
infiltration (top right). H & E x 200
Figure 21 b: Col lection-of polymorphic leucocytes in a
venule in oedematous brain following bradykinin (150ug/ml)
infusion into the forebrain white matter. The white matter
(in which three neurones can clearly be seen) is
oedematous with expansion of the extracellular space. The
central venule contains many polymorphs but few have
migrated into the surrounding tissue (H & E, x 200).
Figure 21 c: Separation of the fibres of the corona
radlata and intense venular po1ymorhonuc1ear leucocytic
stasis following infusion of arachidonic acid (10 mg/ml)
into the forebrain white matter of the cat. Vacuolation
and expansion of the oedematous white matter is clearly
seen together with separation of the myelinated fibres of
the corona radlata. There are large numbers of polmorphs
in the venules and some can be seen in the perivenular
white matter (H & E, x 200).
 
features to those described above. After arachidonic acid
and bradykinin infusions there was patchy perivenous
leucocytic infitrates, and engorgement of some white
matter venules with polymorphic collections (Fig 21b and
b). Polymorphic infiltration of the white matter was more
florid after the 20% protein and glioma cyst infusates
(Fig 21a). After some of the glioma cyst infusates there
were amorphous hyalinized areas around the infusion site
that were strongly PAS positive. In other regions the PAS
material could be seen spreading through the white matter.
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4 DISCUSSION
4.1 The quantitative, histological and b 1 omechanica 1
validity of a feline infusion model of brain oedema.
A model of brain oedema must Increase tissue water content
and tissue volume. Infusion of saline into the deep
forebrain white matter at a rate of 3.3 uL/min for three
hours increases local white matter water content by a mean
of 11.6 ml/100 g tissue but does not alter adjacent
cortical water content. These findings are similar to
those described in clinical cases of brain oedema,
experimental models of vasogenic brain oedema and a
previous study using intraparenchyma1 infusion (see Table
2; Yamada et a 1, 1979 ; Marmarou et a 1, 1980; Reulen et a 1,
1980 ; Hossmann et a 1 , 1980; HacDona Id et a 1 , 1986 ; Bell et
a 1 , 1 9 8 7).
Macroscopic examination of coronal sections of the brain
revealed local tissue swelling and light microscopical
studies confirmed that the oedema fluid was distributed
within the expanded and trabeculated white matter
extracellular space. Widening of the extracellular space,
separation of myelinated fibres and loosening of the
ground substance made the tissue appear pale with both H &
E and myelin stains and mimicked demye1ination
(Greenfield, 1939; Feigin & Popoff, 1963). These features
together with preservation of cortical architecture are
characteristic of the histological findings in human
peritumoural oedema (Caspar, 1933; Jaburek, 1 9 3 6 ;
Greenfield, 1939; Perret and Kernohan, 1943; Schelnker,
1947 ; Hossmann et a 1 , 1980). Glial swelling (Alzheimers
amoeboid glia), changes in glial nuclei, and irregularity
of the axis cylinders were not features presumably because
of the time course of the experiment and the crystalloid
nature of the infusate. The failure of Evans Blue
extravasation into the oedematous brain confirms previous
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u1trastructura1 studies that have shown the BBB, as well
as the endothelium and glial processes in the region of
the saline infusion remain normal (Lax et al, 1979;
Marmarou et al, 1980),
The saline infusion studies (at 3.3 ul/min) showed only a
moderate (10 mmHg over three hours) increase in ICP. This
increase was not statistically significant (p = 0.06) and
was also not significantly different from the mean ICP
recorded at the end of the sham infusion animals. The
increase in ICP in this study is almost identical to that
described using a 0.5 ml infusion over five hours
(Marmarou et al, 1 980). However a major increase in ICP
occurred with an infusion rate of 6.6 uL/min. The baseline
values for ICP recorded in this model are similar to the
3-10 mmHg range previously described as normal in the cat
(Marmarou et al, 1980; Iannotti et al, 1984; Takizawa et
al, 1986a; Gray and Rosner, 1987). Intracranial
hypertension is probably limited by the fall in brain
*D
tissue hydraulic resistance (from mean 9.8 to 4.3 x 10
mmHg/ml/mln) that enables the additional infusate to be
more readily dissipated into the white matter
extracellular space. Similar decreases in R^ have
previously been reported with the infusion oedema model
3(from maximum mean 6.4 to a minimum mean 0.8 x 10
mmHg/ml/min) using different infusion rates (Walstra et
al, 1980; Marmarou et al, 1980) and in oedematous brain
adjacent to ischemic lesions (Hatashita and Hoff, 1988).
The studies of PVI, C ^, and Rq during saline infusion
showed that the only significant change was in reduction
of C^. This suggests the pressure-volume buffering
capacity of the craniospinal axis is just beginning to be
compromised by this volume of infusate. This expected
decrease in compliance during saline infusion reflects the
impairment of vlscoelastic properties of the brain as it
becomes more water laden and less distensible.
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The mean baseline values recorded for PVI, and RQ are
similar to those described in cats studied under a
variety of physiological circumstances using various
anesthetic regimes. Mean normal PVI ranges from 0.43 to
0.90 ml (Karmarou et a 1 , 1 9 7 5 ; Gray and Rosner, 1 987;
Takizawa et al, 1986a; 1986b), mean normal CSF outflow
resistance values recorded at the lateral ventricle range
from 55 to 110 mmHg/ml/min (Marmarou et al, 1975; Sullivan
et al, 1979 ; Takizawa et al, 1985; 1986b) with mean
intracranial compliance values of .026 ml/mmHg (Marmarou
et al, 1975). The decrease in C ^ during the sham
experiments (p = 0.11) probably reflects a large normal
variance for this parameter since the range of compliance
values recorded during the sham experiments was within the
range of baseline compliance values recorded for different
series of cats in this study (Tables 3.36 and 3.37).
Similar variations in baseline compliance values have been
recorded in individual cats during other experiments in
our laboratory (I R Piper and I R Whittle, unpublished
observations). These findings may be partly explained by
the difficulties in recording compliance at low ICP where
small errors in absolute ICP values cause large errors in
compliance.
The infusion pressure data shows that was, with the
exception of a brief period following onset of the
infusion, only a few mmHg higher than IVP. Studies of
oedematous brain tissue pressure in subcortical tissue
underlying cortical freeze lesions and adjacent to
ischemic brain have also shown that tissue pressure rarely
rises more than 10 mmHg higher than intraventricular
pressure (Reulen et al, 1977; Iannotti et al, 1984;
Hatashita and Hoff, 1988). The existence of this tissue
pressure gradient together with the decrease in Rt is
thought to facilitate bulk flow of the oedema fluid and
its clearance by transependyma1 resorption (Reulen et al,
1977; 1980; Klatzo et al, 1980).
The experiments with saline infusion confirm that the
infusion model provides an area of focal brain oedema that
histologically, biomechanlcally, quantitatively, and
focal oedema does not cause BBB dysfunction, significant
changes in the vlscoelastic properties of the brain,
intracranial hypertension, compartmenta 1 shifts or
reduction of the CPP. These studies provide a baseline
against which other infusates may be compared.
4.2 The effects of focal brain oedema caused by saline
infusion on CBF, cortical SEP and HEP waveforms.
There were no significant changes in either the cortical
SEP or HEP waveforms despite focal increases of brain
water content by 10-12 % in the white matter of the
primary tha1amo-cortica1 somatosensory, primary cortico¬
spinal motor and fronto-parieta1 association fibres. The
Ng P1 o N17 P 2 7 cortical SEP waveform and standard
deviations of the latencies of the particular waveform
components, are similar to that previously described in
cats. The N
g (labelled P g by others) and the n-|q (P1 1 )
components represent thalamic and primary somatosensory
cortical activity, whilst the later components represent
association cortical activity (Towe et a 1 , 1964;
Poliakova, 1972; Sutton et al, 1980; 1982; Allison et al,
1982; see Dong et al, 1982).
If the focal oedema was to alter the SEP waveform the P-jq
and later components should theoretically be affected
since the oedema does not extend caudal to the thalamus.
That no changes in either waveform or amplitude were
induced by the saline infusion is similar to previous
experimental studies of the SEP in both cold induced
(Sutton et al, 1980) and infusion brain oedema (Tanaka et
al, 1983). These findings also complement clinical
studies that recorded normal or near normal cortical SEPs
mimicks human brain oedema. This model of
%
despite severe human peritumoural oedema (Penn, 1980;
Ebner et a 1, 1982 ; Whittle et a 1, 1987).
The waveform and latencies of the feline spinal MEPs
recorded following hemicranial stimulation are similar to
those previously described using various anesthetic
techniques and parameters of stimulation and recording
(Levy et a 1, 1984 ; Haghlgl and Oro, 1989)). In these
studies the latency of the initial major negative
component, which corresponds to the D wave, in the low to
mid thoracic region ranged from 2.2 to 6 ms. The
subsequent waveform components, which are related to the
I waves, are multiple with interpeak latencies of 0.8 to
1.0 ms. No previous studies have examined the stability of
these waveforms in oedematous brains although hypoxia,
structural damage to the spinal cord and brain do alter
the waveform (Levy et al, 1984; Haghigi and Oro, 1989).
The mean levels of rCBF, flow value standard deviations
and CBF CO2 reactivity recorded in this study are
comparable with values previously described in the cat
using similar anesthetic protocols and the clearance
technique (Marmarou et al, 1980; Tanaka et al, 1983;
Iannotti et al, 1984; Gray and Rosner, 1987; Hatashita and
Hoff, 1988). Neither sham nor saline infusion caused any
significant change in rCBF or CBF C02 reactivity. This
finding complements previous work in both cats and dogs
using the infusion model where both cortical and white
matter CBF remained stable over a five hour infusion
period (Marmarou et al, 1980; Tsubokawa et al, 1983;
Tanaka et al, 1983). These findings may be partly
explained by the maintenance of normal CPP since there is
no significant intracranial hypertension and the infusion
pressures, which are reflective of brain interstitial
pressure (lannotti et al, 1984), are with the exception of
a brief period following onset, similar to the
intraventricular pressure. The absence of either global or
C/7
focal decreases in CPP complements the stability of the
SEP and MEP waveforms since these are sensitive to ishemia
(Branston et a 1 , 1974 ; Levy et a 1 , 1984 ; Haghigi and Oro,
1 989 ) .
The saline model of infusion oedema does not alter rCBF,
impair cerebrovascular reactivity to changes in PaC02» or
alter SEP or MEP waveforms. These results show that focal
brain oedema with its attendant histological and
blomechanica1 changes, when not complicated by a primary
neural destructive lesion, does not alter these parameters
of brain physiology.
4.3 BBB opening following arachidonic acid, bradykinln,
20% protein and glioma cyst fluid infusates
Intracerebral extravasation of intra venous 1y administered
2% Evans blue was maximal following infusion of glioma
cyst fluid, intermediate after arachidonic acid and 20%
protein and lowest after bradykinin infusion. These
findings support a role for arachidonic acid, bradykinin
and components of the protein and glioma cyst solutions as
secondary mediators of vasogenic brain oedema. How do
these findings relate to previous studies and what
contribution do they make to the mechanisms and etiology
of vasogenic brain edema?
Focal opening of the BBB to Evans blue occurred with 3
ug of free interstitial bradykinin whilst 90 ug caused a
more extensive and intense extravasation of the vital dye.
These findings suggest that at 5ug/ml, which corresponds
to a concentration that would be obtained following
activation of all kininogen in plasma (Unterberg &
Baethmann, 1984), the infused bradykinin was either
rapidly enzymatica11y degraded, or that this concentration
was around the level required to increase brain capillary
permeability. The latter explanation is supported by
^8
ventricu1o-c1sterna 1 perfusion studies in which similar
levels of bradykinin in mock CSF (3-5ug/ml) failed to open
the subependymal BBB to Evans Blue (Unterberg & Baethmann,
1984). In brain oedema caused by a freeze lesion
concentrations of bradykinin of 600 ng/g fresh tissue have
been recovered (Maier-Hauff et al, 1984). This would
_ n
correspond to levels of 750 ng/ml (7 x 10 M) assuming the
tissue contained 80% water. There are also intrinsic
k i ninogen-kinin systems within the brain that can be
activated by plasma kail ikrein (MW 95 , 000 ) however at
present the potential of this system is not known
(Kamitani et al, 1985; Ellis et al, 1987) . In view of
these figures the concentrations of bradykinin infusion
used in this study range from maximal physiological to
pharmacological.
High local bradykinin levels may however occur in some
neuropatho1ogtea 1 environments since kinin activity may be
potentiated by a decrease in the normal o1igopeptidase or
endopeptidase levels, increased activation of local tissue
kinins as well as activation of plasma kininogen-kinins
from extravasated beta-2 macrog1obu1 ins. Conversely
several other enzymes derived from extravasated plasma
proteins would limit kallikreln and kinln activity (see
Section 2.5). The net effect of the kinin generating and
degrading enzyme systems would therefore be influenced by
the physiological microenvironment which in a malignant
glioma, would show considerable regional variation
(Russell & Rubinstein, 1989). The functional effects of
this bradykinin would in turn depend upon the presence of
Beta 1 and beta 2 bradykinin receptors in the tissue
(Regoli, 1 986).
Several studies in rodents and cats have examined the
potential of arachidonic acid, PGs and LTs to increase BBB
permeability. Intraparenchyma1 injection of from 10 to 160
ug arachidonic acid into the frontal lobe and caudate
99
nucleus of rats (Chan et a 1 , 1983 ; Aritake et a 1 , 1 9 8 3 ;
Black & Hoff, 1985) and cats (Unterberg et al, 1987a)
-IOC
caused focal BBB opening to Evans blue and I Bovine
Serum Albumin. These effects were dose dependent and not
blocked by the cyc1ooxygenase inhibitor indomethacin but
could be blocked by pretreatment with the lipoxygenase and
eye 1ooxygenase inhibitor BW 755 C, suggesting that LTs,
but not PGs, have an important role. Other cerebral
microinjection studies in the rat using between 20ng to
2 u g of either LTB4, LTC4 and LTE4 confirmed that LTs
caused BBB opening with LTB4 being the most potent BBB
opener (Black & Hoff, 1985). Conversely using the infusion
oedema model in cats, 15 umol of LTC^, LTD^ and LTE^, did
not cause BBB opening to sodium-fluorescein (Unterberg et
al, 1987a). These differences may reflect species effect
or differences in the susceptibility of the deep cortical
(rat studies) and white matter (cat studies) capillaries
to LTs. The effects of arachidonic acid on capillary
permeability and vasomotor tone are known to be species
specific and within one species brain parenchymal vessels
may react differently to pial arterioles or venules (see
Walker & Pickard, 1985; Wei et al, 1986; Watanabe &
Rosenblum, 1 987).
Cortical superfusion with various concentrations of sodium
arachidonate and 200 ug/ml arachidonic acid caused
opening of the feline pial capillaries to horse radish
peroxidase (HRP), sodium flourescein and flourescein
isothiocyanate (MW 62,000) an effect that was not blocked
by either indomethacin or BW 755 C nor reproduced using
LTC^, LTD^, LTE^, PGEj or PGH2 (Kontos et al, 1980; Wei
et al, 1986; Unterberg et al, 1987b). The studies with
indomethacin and BW 755 C support the hypothesis that
feline pial vascular permeability, like white matter
capillary permeability, is modulated by arachidonic acid
and not PGs or LTs. Interesting1y frog brain endothelial
capillary permeability is modulated in a similar fashion
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(Olesen & Crone, 1986).
The focal extravasation of intravenous administered Evans
Blue at the infusion site in this study confirms that
arachidonic acid has the capacity to increase permeability
of the normal BBB. The minimal concentration of
arachidonic acid infused was 100 times that used in
feline cortical perfusion experiments (Unterberg et a 1,
1987b), and either 10 times greater (Aritake et al, 1983)
or similar (Chan et al, 1983; Black & Hoff, 1985) to those
used in rodent intraparenchyma 1 injection studies. The
relationship of these coneentrations to those attained in
vivo is difficult to assess because of the problems with
accurate quantitation of arachidonic acid and its
metabolites. Eicosanoids have variable, but usually short
half lives, and artifactual post mortem production is
another problem (Walker & Plckard, 1985). However the
excess of those encountered pathologically. In normal CSF
arachidonic acid concentrations range between 10-200
ng/ml, and are 5 -10 fold higher after brain injury
(Westcott et al, 1987). Maximal concentrations of
arachidonic acid, PGs and or LTs measured in human brain
tumours range from 13 ug/ g (Black & Hoff, 1987) to 1 ug/g
(Castelli et al, 1987). Slightly higher levels (50 ug/g
protein) have been recorded following ischemia in the
gerbil (Dempsey et al, 1987).
The mechanisms of BBB opening by bradykinin and
arachidonic acid have not been elucidated by these
experiments. The limited BBB opening caused by bradykinin
may reflect its interstitial location since some of its
permeability altering properties are mediated through
endothelial relaxation (Rosenblum, 1988). Some BBB
opening may be secondary to polymorphic infiltration since
both agents have chemotaxic properties and perivascular
leucocytic infiltrates were present (Gamache et al, 1986).
used in this study would seem greatly in
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Other possible mechanisms involve synergistic effects
between bradykinin and prostaglandins (Walker & Pickard,
1985 ; Rao et a 1 , 1988 ; Regoli, 1986). The beta 2 , but not
beta 1, bradykinin receptor depends on the activation of
arachidonic acid (Regoli, 1986) and bradykinin stimulates
arachidonic acid release and metabolism as well as
indirectly generating superoxide radicals (Kontos et al,
1984). Free oxygen radicals are also released in
association with arachidonic acid metabolism, principly by
PG synthetase rather than lipoxygenase, and can cause
lipid peroxidation (Chan et al, 1984; Olesen & Crone,
1986; Wei et al, 1986). Peroxidation may mediate the
direct endothelial damage caused by arachidonic acid since
adverse effects on the endothelium can be prevented by
superoxide dismutase, catalase and mannitol, which are all
scavengers of free oxygen, and by cyclooxygenase
inhibitors which also block oxygen consumption (Del
Maestro et al, 1980; Kontos et al, 1980 ; Aritake et al,
1983; Wei et al, 1986).
The precise mechanisms of BBB opening following infusion
of 20% protein solution and glioma cyst fluid have also
not been elucidated by this study. The glutamate
concentration in the 20% protein infusate (2 uM) was 50
times less than that of normal plasma (Baethmann et al,
1989) and is unlikely to be a major factor. Glutamate
levels in the cyst fluids were not quantitated but were
probably either similar to or higher than plasma levels in
view of the the biochemical similarity to plasma and the
local ischemia seen in the malignant gliomas.
Although ventriculo-cisternal perfusion of mock CSF
containing plasma protein can cause subependymal opening
of the BBB (Oettlnger et al, 1976; Unterberg & Baethmann,
1984) a major problem in this study arises because the
proteins (bovine and human) infused are not allogeneic.
This may partly explain the infiltrates of
1 02
polymorphonuclear cells in the region of the infusion
since the time course of the leucocytic response is
similar to that described following intraventricular
injection of carrageenan, an inflammatory provoking
mucopo1ysaccaride, in mice (Gamache et al, 1986). Neuro-
pathologically the focal cerebritis also resembles early
bacterial abscess formation (Britt et al, 1981). However
major bacterial contamination of the 20% protein and
glioma cyst infusates is unlikely since all were
meticulously handled and stored prior to infusion.
Furthermore to experimentally generate such cerebritis
large numbers (more than 106 of virulent bacteria) must be
in the innoculum (Britt et al, 1981). The inflammatory
infiltrates probably are an ep i phenomenon of the
experimental model that has little clinical in vivo
relevance since polymorphic neutrophils, components of
which are responsible for "granulocytic brain oedema"
(Fishman et al, 1977), are uncommon in gliomas (Hanwehr et
al, 1984; Shinonaga et al, 1988) and were not observed in
histological examination of the tumour samples.
Lymphocytes and macrophage infiltrates are found in up to
60% of gliomas and the intensity of these infiltrates has
been correlated directly with the extent of peritumoural
oedema (Hanwehr et al, 1984; Shinonaga et al, 1988).
Since the absolute protein contents of the four glioma
cyst infusates were similar BBB opening mediated solely by
an immunological or inflammatory mechanism against the
foreign protein is not consistent with differences in
intensity and extent of extravasation of Evans blue.
Immunological mechanisms similar to those seen in acute
experimental encephalomyelitis cannot be involved since
this requires prior sensitization and it is unlikely that
either bovine or human serum contains anti-cat brain
antibodies (Unterberg & Baethmann, 1984). Acute
degranulation of mast cells could occur after exposure to
foreign protein or specific antigen, but these cells are
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uncommon in the white matter of the cat (Ibrahim, 1 9 74 ;
Edvinsson et al, 1976). If the various glioma cyst
infusates contained a specific BBB modulating compound
(Bruce et al, 1987; Criscuolo et al, 1988) its activity in
the experimental system does not directly relate to its in
vivo potency. The amount of oedema caused by each of the
four glioma cyst fluids in vivo was different but these
differences were not reproduced experimentally either by
the spatial distribution of Evans blue extravastion or
water contents of the oedematous brain. In particular BBB
opening was extensive following administration of cyst
fluid from an oligodendroglioma whereas in vivo, as shown
by CT scan, minimal oedema was associated with this
lesion. This inconsistency between in vivo and in vitro
brain oedema may be related to the preoperative
dexamethasone therapy that was administered to the
patients (see Appendix 2). Given that steroids are known
to influence production of a permeability modulating
protein as well as protein extravasation into the tumour
interstitium this preoperative therapy may have
significantly changed the BBB modulating potential of the
fluids (Hossmann et al, 1983; Bruce et al, 1987; Nakagawa
et al, 1987; Criscuolo et al, 1988).
When the infusion model is used to evaluate particular
agents as potential secondary mediators of vasogenic
brain oedema the capacity of that particular compound to
disrupt normal BBB is assessed. However in almost all
clinical and experimental studies of peritumoural brain
oedema the peritumoural BBB is preserved and the site of
vascular leakage is the tumour itself (see Section 1.
3 . i i i). The crucial factor in vivo however is the
potential for the putative agent to increase further the
ne oplastic capillary permeability. Damaged or neoplastic
capillaries may be more susceptible to the modulating
effects of arachidonic acid, bradykinin, tumour secretions
or plasma protein components than the normal BBB.
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Differential capillary sensitivity to various agents is
demonstrated in the hamster cheek pouch preparation where
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concentrations of arachidonic acid as low as 10 M (Del
Maestro et al, 1980) increase permeability, whilst a
vascular permeability (Unterberg et al, 1987b). The
hydraulic reflection coefficient of normal cerebral
capillaries is 10^ greater than that of intestinal
capillaries (Fenstermacher & Patlak, 1976) so differential
sensitivity of normal brain parenchymal and neoplastic
capillaries to particular agents would not be surprising .
Since bradykinin, arachidonic acid, 20% protein solution
and glioma cyst fluid can open the normal BBB it is
likely, that they will focally potentiate oedema
formation if the active components of these infusates are
generated in sufficient quantities in the tumour
interstitium.
Planimetric quantitation of dye extravasation alone proved
to be an unsatisfactory measure of BBB disruption since
the intensity, but not necessarily area, of dye staining
was variable with the selected infusates. Future studies
should optimally incorporate quantitation of vital dye
extravasation using spectrophotometric techniques (Durward
et al, 1983) so that relative potencies of different
agents and the effects of different concentrations of the
same agent can be assessed. The contribution of various
agents to BBB opening could also be more vigorously tested
using a battery of agents that detect differential BBB
opening eg HRP, Na-fluorescein, Evans Blue. Such studies
would enable BBB dysfunction to be quantitated, and
perhaps provide additional information about mechanisms of
BBB opening.
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4.4 Brain oedema and biomechanics following arachidonic
acid, bradykinin, 20% protein and glioma cyst fluid
infusion
The focal Increases in white matter water content
following infusion of bradykinin, arachidonic acid, 20%
protein solution and glioma cyst fluid were not
significant1y different (range 10.4 to 12.5 %) and were
similar to values obtained after saline infusion (11.6%).
This similarity is probably the result of limited
clearance of the infused fluid volume, the small
contribution from extravasated fluid with some infusates
during the time course of the experiment as well as
the limited spatial distribution of the white matter
samples that were analysed for water content.
Brain oedema caused by arachidonic acid is maximal at
between 6 (Aritake et a 1 , 1983) and 24 hours (Chan et a 1 ,
1983) after intracerebral injection. The dynamics of
bradykinin or other intracerebral protein induced oedema
is not known, however ischemic, cold induced and toxin
induced oedema are all maximal at 8-72 hours. The maximal
increase in brain water in experimental and clinical brain
oedema is usually less than 12 ml/100 g tissue and it
would seem that bulk flow of the oedema fluid is enhanced
by decreased brain tissue hydraulic resistance once such
levels are reached. Therefore although the volume of
oedematous white matter, which was not guantitated in
this study, may vary the absolute increase in tissue water
content at the oedema epicentre may be constant due to
tissue water saturation (Ito et al, 1986). This hypothesis
is supported by examination of coronal sections of the
brains which showed that volumetric swelling was variable
although tissue water contents close to the infusion sites
were similar (see Fig 18, 19). Analysis of further white
matter samples more distant from the infusion locus would
have enabled an estimate of relative brain swelling
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(Elliot & Jaspar, 1947)
The elevations in ICP following bradykinin. arachidonic
acid, 20% protein solution and glioma cyst fluid were not
statistically different from that recorded following
infusion of a similar volume of saline. Since PVI, RQ and
compliance are derived from ICP values the patterns of
change in these parameters were also generally similar to
those observed with saline infusates. The significant fall
in C ^ and rises in ICP were not associated with any
significant or consistent change in PVI. Normally the PVI
decreases with increased ICP due to intracranial mass
lesions (Marmarou et a 1 , 1975 ; Takizawa et a 1 , 1986a),
therefore measurement of the C ^ may be a more sensitive
indicator of early loss of craniospinal pressure-volume
reserve. However the fall in C^ in these experiments is
relatively small compared to that encountered following
intracranial hypertension caused by intracranial balloon
inflation or CSF infusion in cats (I R Piper & I R
Whittle, unpublished data). The increased protein content
of the glioma cyst fluids may account for part of the
highly significant rise in Rq with these infusates since,
after completion of the infusion R , remained elevated.
This may be caused by some of the infused protein entering
the CSF (Reulen et al, 1980). Further monitoring might
have shown further rises in R .
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4.5 CBF and cerebrovascular reactivity to C02
Overall the CBF and CBF C02 reactivity values were similar
to those previously reported using the H2 clearance
technique and barbiturate anesthesia (Marmarou et al,
1980; Tanaka et al, 1983; Ianotti et al, 1984; Grey &
Rosner, 1986). An isolated decrease in CBF adjacent to the
infusion locus was recorded in only one series of
experiments (GD-GBM). A bilateral decrease in frontal CBF
was recorded in one series of experiments (EB-GBM
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infusate) and a global transient increase in CBF was seen
in the solitary cat infused with oligodendroglioma cyst
fluid (TF-Oligo). Otherwise there was no consistent or
significant change from baseline rCBF at any electrode
location, during the course of the various infusions. In
the GD-GBM experiments it is possible that part of the
reduction in rCBF was due to tissue swelling so that flows
later in the experiment were weighed towards white matter
rather than cortical values.
The apparent stability of CBF during the Infusions may
reflect the shortcomings of the initial slope method of
determining CBF. If the clearance curves were
biexponentia1, with the fast component reflecting cortical
flow and the slow component white matter flow, a change in
one of these flows may be masked by determining only five
points over a two minute interval. To examine this
possibility, during the last four experiments, clearance
curves were recorded on a dedicated computer programme
designed to sample 120 points over a two minute interval
(Piper I R, unpublished work) and the curves analysed to
determine how many were biexponentia 1, and by how much CBF
values derived from the initial slope (IS) method over one
minute differed from those recorded by analysis of the IS
over 2 minutes. The results (see Appendix 5) showed that
20% of curves were biexponential, and the 2 minute IS
derived CBF gave a flow value that was a median of 3
m1/10Og/brain /min less than the computer derived 2 minute
IS flow. Stability of the rCBF during the various
infusions would therefore appear real.
After arachidonic acid infusion there was a focal, but not
significant, reduction in CBF CC>2 reactivity in the white
matter adjacent to the infusion site not associated with
any reduction in cortical CBF C02 reactivity. Following
the 20% protein, bradyklnln and all malignant glioma (but
not the oligodendroglioma) cyst fluid infusates there was
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focal loss of CBF CC>2 reactivity adjacent to the infusion
site. How do these findings compare to previous work and
what is their significance?
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PET and Xenon studies have shown that blood flow in
human peritumoural brain is either normal or low
(Palvolgyi, 1969; Kosmans, 1974; Lammertsma et a 1 , 1985)
and there may be reductions in distant ipsilateral and
contralateral hemispheric cortical CBF and CKR^ (De La
Paz et al, 1 983 ; Beaney et al, 1 985 ). Normal white matter
CBF has also been reported in experimental studies of
peritumoural oedema (Hossmann et al, 1980). In the PET
studies there was no evidence of peritumoural brain
hypoxia since if CBF was low there was a compensatory
increase in oxygen extraction ratio (Brooks et al, 1986).
A similar mechanism may account for the preservation of
phosphocreatine , ATP and ADP levels despite a 20-33 %
reduction in blood flow in oedematous brain following a
freeze lesion (Frei et al, 1973).
The effects of bradykinin and eicosanoids on cerebral
arteriolar and pial vasomotor tone have been extensively
studied (Regoli and Barabe, 1980; see Table 1, Walker &
Pickard, 1985; Regoli, 1986). These studies reveal
responses that differed between species, doses of drug
tested, vascular bed studied and experimental protocol
employed. In the cat arachidonic acid and most PGs except
P G12 are cerebral vasodilators, whilst in man they are
vasoconstricters. Bradykinin generally dilates arterioles
and constricts venules. Extrapolation of experimental data
concerning the vasomotor modulating actions of these
compounds to both clinical situations and other
experimental models is difficult. In peritumoural brain
oedema, the differential effects of eicosanoids, that are
released by active tumour secretion (Cooper et al, 1985;
Lauro et al, 1986; Black et al, 1986) and ischemic tumour
undergoing coagulative necrosis, on neoplastic vessels is
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unknown. It would seem from the PET studies (Lammertsma et
a 1 , 1985 ; Beaney et a 1 , 1985 ; Brooks et a 1 , 1986) that
tumour and perltumoural blood flow is certainly not
Increased in spite of extensive interactions between
elcosanoids and other vasomodulating peptides,
particularly bradykinin (Wah1 et a 1, 1 988 ; Unterberg et
a 1 , 1 9 84).
The most significant experimental finding with respect to
CBF is the loss of focal CBF COj reactivity in the regions
of brain made oedematous by the bradykinin, 20% protein
and the malignant glioma cyst infusates. Brain oedema per
se would not seem to be a cause of this loss of C 0
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reactivity since it was not seen after saline or
arachidonic acid infusions. Although it would appear that
kinins, activated plasma proteins or products of malignant
glioma secretion or necrosis mediate this impairment of
cerebrovascular C02 reactivity, the preservation of CBF
CC>2 reactivity after infusion with oligodendroglioma cyst
fluid compounds simple intepretation of this observation.
Biochemical and electrophoretic analysis of the various
cyst fluids shows only minor differences between the
malignant glioma and oligodendroglioma (Appendix 2), this
suggests that unless the oligodendroglioma secreted a
factor that enhanced CBF C02 reactivity (see Section 4.6)
extravasated proteins alone have little role. Previous
studies using topical application of bradykinin (10 ug/ml)
to pial vessels showed no impairment of C02 reactivity
(Kontos et al, 1984), suggesting that vasoparalysis is not
mediated by B2 receptors which have been found on both
cerebral endothelial and vascular smooth muscle cells
(Unterberg & Baethmann, 1984).
The mechanism(s) causing this impairment of CBF C02
reactivity following intracerebral infusion could be
mediated biochemically in two ways. Firstly bradykinin or
other peptide components of the infusates may effectively
1 i 0
paralyse the vascular smooth muscle. Alternatively they
may cause increased arteriolar resistance, so that at
normocapnia the more distal blood vessels are dilated to
maintain CBP, and the arteriole is incapable of further
dilatation in response to hypercapnia although the
reactivity mechanisms are intact. The vasoconstriction and
decrease in focal cerebral blood volume seen after
steroid therapy in some patients with brain tumours
suggest that in some cases the latter mechanism may be
important (Leenders et a 1 , 1985). Alternatively a
phenomenon similar to spreading cortical depression could
also mediate the impairment of CBF C02 reactivity, since
both CBF CC>2 reactivity and p 1 a 1 vascular responses to
bradyklnin are impaired after intracortical KC1
microinjection, which causes transient spreading
depression (Lauritzen, 1984 ; Leao, 1986; Wahl et a 1 ,
1987).
The mechanisms of global vasopara 1ysis after the 20%
protein and bradykinin infusions are unclear. Spreading
depression or vasoregulatory dysfunction of serotonergic
or adrenergic fibre projections from the raphe nuclei and
locus coeruleus could be involved. Serotonin levels in the
rodent brain increase after intracerebroventricu 1 a r
injection of bradykinin (Rao et al, 1988) and it is
possible that these infusates may have a similar effect
in cats. However similar global patterns of CBF
dysautoregulation were not seen after any of the glioma
cyst infusates and the precise roles of these ascending
fibres in CBF regulation is itself controversial (see
Mackenzie and Scatton, 1987).
Reduction of peritumoural brain CBF C02 reactivity has
been noted in brain tumour patients (Palvolgyi, 1969;
Mosmans, 1974), and in peritumoural brain in cats
following experimental tumour implantation (Hossmann et
al, 1980). CBF C02 reactivity is also reduced in brain
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made oedematous (with a plasma rich fluid) by freeze
lesions (Frei et al, 1973). This loss or impairment of CBF
reserve could possibly be clinically significant since an
"inverse" steal phenomenon could occur in response to
hypercapnia or increased local brain metabolism leading to
relative Ischemia in the oedematous brain (Palvolgyi,
1 969 ) .
4.6 Electrophysiological findings
Cortical SEP waveform component latencies recorded from
the infused and "control" hemispheres were reproducible
throughout the experiment with the standard deviations
for each component being similar to those previously
described (Poliakova, 1972; Iragui-Kadoz & Wiederholt,
1977 ; Sutton et al, 1980; 1982 ; Dong et al, 1982). Few
significant electrophysiological changes were recorded
despite the focal brain oedema and in some cats,
leucocytic infiltration of white matter. The lack of
change in the cortical SEP, particularly the components
with latencies of 10 ms or longer, may reflect the
relative insensitivity of this pathway to modulation in
the absence of frank cerebral ischemia or hypoxia
(Branston et al, 1974 ; Sutton et al, 1980; Dong et al,
1982; Levy et al, 1984; Kataoka et al, 1987). Preservation
of the cortical SEP waveform has also been reported
following cortical freeze lesions that produce profound
oedema (Sutton et al, 1980) and in many patient with brain
tumours (Penn, 1980; Ebner et al, 1983). It is unlikely
that the barbiturate anesthesia had a cerebral
"protective" effect since, for this, barbiturate levels
that cause EEG burst suppression are required. In cats
such EEG changes occur 15 minutes after intravenous doses
of pentobarbital of 27 mg/kg, such levels also cause
marked systemic hypotension (Sutton et al, 1982).
In the three experiments where attenuation of the P^ q_N-| 7
I I 2.
component occurred with development of a prominent Pjg-
N45-P65 comPOIient it is tempting to postulate that these
changes represent deafferentation of the somatosensory
cortex. Similar changes in the cortical SEP have been
described following ablation of all cortex except the
parietal association areas (Poliakova, 1972). In another
study however ablation of the primary and secondary
somatosensory cortex produced only attenuation of the Niy-
Pjg component (Dong et a 1 , 1982). Although these SEP
changes were not reproduced in a second experiment with
the GD-GBM cyst fluid, despite similar levels of focal
reduction in frontal CBF, the similarity of SEP waveform
changes seen with bradykinln 150 ug/ml and TF-Oligo
infusate, suggests they are in some way related to the
infusate and are not artlfactual. In patients with
peritumoural oedema however the changes in cortical SEPs
usually involve loss, rather than enhancement, of longer
latency components (Ebner et a 1 , 1983 ; Whittle et a 1 ,
1 987 )
The lack of distortion of the cortical SEP and cortically
derived spinal MEP waveforms by arachidonic acid infusions
into the primary somatosensory and corticospinal motor
fibre tracts was disappointing in view of previous
electrophysiological and biochemical findings. Incubation
of frog sciatic nerve with arachidonic acid (10 mg/ml)
diminished the height of the action potential and caused
myelin damage (Kasckow et al, 1986). Arachidonic acid and
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PGs in concentrations as low as 10 M can modulate
membrane potentials and neuronal function by altering
neurotransmitter uptake, synthesis and binding sites as
well as inhibiting brain mitochondrial function (Dorman et
al, 1986; Yu et al, 1986; Boksa et al, 1988 ; Schwarz et
al, 1988; Hillered & Chan, 1988). Exposure of rat cortical
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slices to arachidonic acid perfusates (3 x 10 M) causes
cytotoxic neuronal and glial swelling, uncoupling of
oxidative phosphorylation and inhibition of Na+/K+ ATPase
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(Chan & Fishman, 1978 ; Chan et a 1 , 1983). A 1 thought the
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lowest concentration of arachidontc acid (6.6 x 10 M)
infused Into the brain was much greater than the reported
concentrations of 1 0"^ and 1 0"^M in various types of brain
oedema (Wahl et al, 1988), much of its pathophysiological
effect will depend on its rate of uptake or metabolism.
Normal astrocytes metabolize arachidonic acid to both
prostanoids and LTs but metabolic rates are profoundly
influenced by the tissue microenvironment (Walker &
Pickard, 1985; Hartnung & Toyka, 1987)
The enzymatic degradation of Infused bradykinin by brain
oligopeptldases and endopeptidases may account for the
paucity of electrophysiological modulation with this
nonapeptide. These findings would suggest that bradykinin
probably does not influence axonal conduction or glial
function in the clinical setting even though there have
have been several in vitro studies showing that
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bradykinin, at concentrations of 10 to 10 M, can alter
cell membrane K+ conductance, synaptosomal uptake of
choline, intracellular Ca++ levels as well as the levels
of the important intracellular messengers cyclic guanosine
monophosphate (cGMP) and inositol phosphate (Reiser &
Hamprecht, 1982; 1985; Hamprecht, 1984; Reiser et al,
1984; Francel and Dawson, 1986; Pirola et al, 1986; Osugi
e t a 1, 1 986).
The paucity of electrophysiological changes following
infusion of the glioma cyst fluids may, as with the BBB
findings, be related to whether the patients had
preoperative steroid therapy. The TF-Oligo cyst fluid
induced some experimental SEP changes. Kr TF, who had no
preoperative steroid therapy, was having 5-7 complex
partial siezures a day at the time of surgery and it is
speculative to consider that the cyst fluid contained some
"excitotoxin" (Baethmann et al, 1989). This possibility is
supported by the transient global increase in CBF seen
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during infusion of this cyst fluid (Table A - 6 2).
Bradykinin at 150 ug/ml may have a similar excitotoxic
function, and hence the similar SEP changes, since
microinjection studies into the rat brain have shown
disruption of the EEG (Kariya et al, 1981). However why
GD-GBM cyst fluid should produce similar SEP changes is
difficult to explain since this patient had no seizures
and her clinical deficit has considerably improved during
the one week course of preoperative dexamethasone.
The symmetry of the MEP waveform in all experiments raises
the questions of either bilateral generation of the
descending spinal EP or activation of subcortical or
extrapyramidal descending pathways. This is a
controversial area since descending spinal feline EPs were
abolished following bilateral pyramidal section (Levy et
al, 1984) but recent work suggests that extrapyramidal
pathways may be involved in transmission of the rat MEP
(Fehlings et al, 1988). The contribution of nonpyramidal
pathways, such as corticobulbar, bu1 bore ticu1er, cortico-
cortical, corticopontine and corticoreticu 1 e r fibres to
the descending spinal EP following transcranial
stimulation is unclear (Patton & Amassian, 1954; York,
1987). If some of these nonpyramidal pathways were also
activated the spinal EP should be polyphasic with discrete
peaks corresponding to the different conduction velocities
of the different tracts. Most waveforms in this study had
three negative components, however the complexity and
amplitude of the waveform were directly related to the
stimulating current (see Appendix 4). Whether the
stimulating currents used in these experiments would cause
both local cortical and deep nuclear activation is
speculative (see Geddes, 1987; cf Amassian et al, 1987).
However the waveforms shown in Appendix 4 suggest
activation of a nuclear pool (? vestibular nucleus) with
fast conducting axons. Physiological factors that alter
MEP generation and conduction have not been as extensively
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studied as those that alter the cortical SEP (Branston et
al, 1974) but recent studies suggest that hypovolemia and
hypotension are critical (Haghlgi and Oro, 1989).
4.7 Comments on the rodent model of infusion oedema
Although the rodent model of infusion oedema is cheap,
readily available and has been shown to be technically
feasible its main disadvantage when studying vasogenic
brain oedema is the paucity of white matter. The
subcortical white matter is at most 1 mm thick (Paxinos &
Watson, 1982) and rapidly thins laterally. The thinness of
the white matter also makes accurate SG quantitation
difficult since white matter samples invariably include
portions of deep cortical laminae or the corpus striatum.
Nonetheless the fall in SG of oedematous brain is similar
to that recorded in other rodent models of oedema although
the SG values recorded for cortex were lower than previous
values (Aritaki et al, 1983; Nakagawa et al, 1987).
The paucity of hemispheric white matter also reguired that
infusates had to be delivered into the corpus striatum to
overcome the problem of leakage back along the needle
track (cf Black & Hoff, 1985). Changes in Rt and brain
tissue compliance therefore primarily reflect the response
of the corpus striatum rather than that of white matter.
This may account for the the mean initial rat (22 x 10
mmHg/ml/min) being double that of the cat (cf Tables A-6,
A-7 & A-38). The pattern of change in these parameters
from initial values is however similar to the feline
infusion model and in oedema surrounding an ischemic focus
in the cat (Hatashita & Hoff, 1988). Deposition of the
infusate into the more vascular caudate nucleus may lead
to a more rapid clearance of the infused fluid as well as
to a more rapid buffering, degradation or metabolism of
neuro or vasomodulating components within the infusate.
These factors may explain the small differences in total
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hemispheric water content and the stability of ICP, rCBF
and cortical SEPs daring both saline and 20% protein
infus ion.
The increase in ICP over the infusion period would seem
biologically insignif i cant. However, following acute
intracerebral injection of 50 ul of autologous blood (ie
equivalent to 5% of the rat hemishere volume), rat ICP
increases by a mean of only 4 mmHg (Kingman et al, 1 988 ).
Small rises in rat ICP may be associated with major
reduction in craniospinal pressure-vo1ume reserve however
the small size of the rat ventricle and CSF volume make it
very difficult to assess accurately the changes in the
viscoelastic properties of the brain caused by the
intracerebral infusions.
The CBF and CBF CC>2 reactivity data from the rodent
infusion model are comparable with some other studies
(Lauritzen, 1984; Bell et al, 1985). The relatively low
CBF, compared to those obtained using autoradiographic
techniques (Nakagawa et al, 1987), is probably related to
the effects of the anaesthetic and methodological
differences. The reduction of CBF CC^ reactivity at the
electrode adjacent to the 20% protein infusate could be
explained in terms similar to those mentioned for the cat
(see Section 4.4). However, the more focal impairment of
CBF CC>2 reactivity would favour some biochemical effect on
vasomotor tone. This effect could be mediated by
inhibition of the normal glial carbonic anhydrase-C0^
mediated response, inhibition of prostacyclin production
or local paralysis of vasomotor innervation (Walker &
Pickard, 1985; McKenzle & Scatton, 1987). If clearance or
buffering of the protein infusate was limited its
alkalinity would impair local CBF CO2 reactivity.
This study describes cortical SEP waveforms of longer
latency than previous studies which were primarily
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concerned with short latency ( < 6 ms) components and the
primary tha 1 amo-cortica 1 (the Pg ) response (Wiederholt
and Iragui-Madoz, 1977 ; Allison et a 1, 1982). The cortical
SEP waveforms recorded in the initial 30 ms following
forelimb stimulation are similar to those described
following hindlimb stimulation (Fehlings et a 1, 1 988).
The failure of saline or protein infusates to alter
waveform components, particularly those with a latency >6
ms, may be related to the preservation of CBF or to the
limited diffusion of the infusate since the forelimb
primary somatosensory cortex covers a large area (Hall &
Lindholm, 1 974).
The rodent infusion model does provide a ready and cheap
model of brain oedema. However, the small size of the
rodent brain and relative paucity of subcortical white
matter impose limitations on its use. Autoradiographic
methods are probably required to optimally exploit this
model (see p 123).
4.8 Final summary and future research
The major findings of this work are
1) Using normal saline infusate the feline model of
infusion oedema produces focal brain oedema that
quantitatively, histologically and biomechan ica 1 1y
resembles vasogenic brain oedema found in patients and
experimental models. The feature of this oedema is that it
is confined to the extracellular space of the white
matter, where it causes expansion and vacuolation of the
ground sustance and separation of myelinated fibres. The
cortical laminae are not involved. In the oedematous
region, brain tissue hydraulic resistance falls and
cerebral tissue compliance rises but PVI and CSF outflow
resistance remain constant. There is a small rise in ICP
associated with a fall in lumped craniospinal compliance.
Infusion pressure data suggests that brain tissue
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interstitial pressure in the oedematous area closely
parellels ICP. Ipsilateral hemispheric CBF, CBF COj
reactivity, cortical SEPs, cortically derived MEPs and BBB
function all remain normal.
2) The studies of BBB integrity, as assessed by
extravasation of intravenous 2% Evans Blue, revealed that
bradykinin (3 and 90 ug), arachidonic acid (1.2 - 9.0 mg),
20% protein solution and fluid aspirated from cystic human
gliomas could all disrupt BBB function in normal white
matter. In view of the biophysical properties of normal
white matter capillaries it is considered that either
these compounds or their metabolites, and specific
components of the 20% protein and glioma cyst fluids are
likely to be secondary mediators of vasogenic brain
oedema. The mechanisms of BBB modulation by each of these
compounds have not been identified, although it is
possible that leucocytes and inflammatory mechanisms may
contribute to the BBB opening by all these infusates.
3) Studies of rCBF during the three hour infusion period
with arachidonic acid, bradykinin and 20% protein
solution revealed stable flow values both adjacent to and
distant from the infusion site. This finding suggests that
at normal CPP and normocapnia neither brain oedema per se
nor the presence of these compounds in brain oedema fluid
causes cerebral hyperemia or ischemia. The effects of the
glioma cyst fluid infusates on rCBF during the period of
infusion were variable and may reflect the biological
heterogeneity of the tumours, methodological problems or
the effects of preoperative steroid therapy given to the
patients from whom the cyst fluids were obtained.
CBF CO2 reactivity was impaired either locally or globally
by bradykinin, 20% protein and the malignant glioma cyst
fluid infusates but not by intraparenchyma 1 arachidonic
acid, the oligodendroglioma cyst fluid or saline. The
mechanisms of this action were not elucidated but it does
support previous clinical and experimental studies showing
paralysis of CBF CO 2 regulation in oedematous brain and
patients with brain tumours.
4) Despite profound white matter oedema (mean 10 - 12
ml/100 g tissue increase in brain water content), and with
the oedema fluid containing compounds (arachidonlc acid
1.2 - 9.0 mg, bradykinin 3 ug) known to be capable of
endothelial, vasomotor, axonal and neuronal modulation or
cytotoxicity, the waveforms of cortical SEPs and
cortica1ly generated spinal MEPs remained constant.
Similar findings were noted after infusion of 20%
protein solution and in 5 of 7 cats infused with human
glioma cyst fluid. There was attenuation of the P1 g-N ^ ^
SEP component with development of a large P28_N45~P65
component after infusion of bradykinin 90 ug, TF-Oligo and
GD-GBM cyst fluid. In none of these experiments was there
a change in MEPs, and the findings in GD-GBM were not
reproducible in a second experiment. These findings
suggest that if compounds in the oedema fluid mediate
electrophysiological or o1igodendrog1ia1 dysfunction,
either more sensitive methods of assessment of local
neurophysiology are required to detect such dysfunction or
that in the case of the glioma cyst fluid infusates glial
or neuromodu1ative activity was modified by preoperative
steroid therapy given to 3 of the 4 patients.
5) A rodent model of infusion brain oedema was also
utilised but suffered from several shortcomings. These
were principally related to the small size of the rodent
brain and attendant paucity of white matter. Infusion
into the superficial aspect of the nucleus caudatoputamen
was required to avoid leakage around the infusion needle.
This grey matter infusion site probably modifies
clearance, uptake and metabolism of the infusate and
compounds quantification of the subcortical SG.
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Nonetheless changes in brain biomechanics were similar to
those encountered with the feline model and ICP, CBP and
cortical SEPs all remained stable despite focal brain
oedema caused by either saline or 20% protein infusates.
Interestingly the 20% protein infusate caused a reduction
in local CBF CO2 reactivity, a finding also noted in the
feline mode1.
What relevance does this thesis have with respect to
advancing knowledge on the etiology and pathophysiology of
human vasogenic brain oedema and in particular
peritumoural brain oedema? Firstly it provides an
experimental substrate for the common clinical observation
that in many patients brain function is preserved despite
profound brain oedema. Focal brain oedema per se does not
cause focal brain dysfunction, ischemia or significant
rises in brain tissue pressure. However if the brain
oedema fluid contains certain peptides or proteins this
model has confirmed previous experimental and clinical
observations that there is focal loss of CBF reserve. In
patients this loss of flow reserve may predispose patients
to flow-metabolism uncoupling should they experience
hypotension, hypoxia, raised ICP, hypercapnia or epilepsy.
If such a mechanism does underlie peritumoural brain
dysfunction steroids may cause clinical improvement by
reducing noxious protein or "exocitotoxin" extravasation
into the tumour interstitiurn, or by blocking synthesis or
release of vasomodu1 ating compounds by the tumour
Secondly it suggests that bradykinin, arachidonic acid,
plasma proteins and glioma products may secondarily
contribute to brain oedematogenesis (ie they are secondary
mediators of vasogenic brain oedema). However in view of
the levels of bradykinin and arachidonic acid Infused it
is unlikely that in patients either of these compounds
modulate axonal function in the oedema to us brain. If the
initial hypothesis is correct then what compounds do
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mediate peritumoural brain dysfunction and how can neural
dysfunction be optimally evaluated?
One approach to the identification of such mediators would
be the use of microdialysis in peritumoural brain
(Baethmann et a 1 , 1989: Persson et a 1 , 1989). A spectrum
of compounds in this region could be identified and
quantified, and compared to those found in normal white
matter. Such studies could be performed experimentally or
in humans studied during operations (Persson et a 1,
1989). Peptides such as glycine, gamma-ABA, aspartate and
glutamate would be of particular interest in view of their
roles in neuromodu1 ation. One of the criticisms of the
infusion model is that most neuromodulators alter function
via synaptic transmission and not at the axonal level
(Cooper et a 1, 1986). Exposure of cortical neurones to
concentrations of bradykinin and arachidonic acid such as
used in these experiments may have caused neuronal
modulation or cytotoxicity (Chan & Fishman, 1978; Wah1 et
al, 1 988). However, such an experimental design does not
complement the formation and distribution of peritumoural
brain oedema fluid in patients.
The problem of relating neuronal modulation, cerebral
dysrhythmia or alteration in evoked potentials to brain
dysfunction is profoundly difficult. Current investigative
techniques in neuropharmacology include the use of neural
tissue slice preparations and single cell explants to
study ion channels and other aspects of membrane
neurophysiology (Chan & Fishman, 1978; Cooper et al,
1986). The use of single cell recording techniques in the
oedematous region was considered but brain tissue swelling
would make data difficult to interpret (Lemon, 1 984 ; A G
Brown, personal communication, 1986). The problem also
arises of extrapolating events at the single neurone or
even molecular level in vitro to in vivo events and
overall neurological function. Autoradiographic studies
1Z z
using the Infusion model could be used to quantitatively
study CBF, CMRg^u, BBB function and protein synthesis in
precisely defined brain regions using deoxyglucose,
iodopyridine, gamma-lsobutyric acid and radiolabe1 led
leucine respectively (Nakagawa et a 1 , 1987; P A T Kelly,
personal communication 1988). The infusion model in the
rat would be particularly suitable for such multi-modality
analysis since the high resolution of quantitative
autoradiographic methods would enable precise analysis of
the effects of the infusate not only locally but also on
functionally related white and gray matter regions.
Although such studies would be expensive they have the
advantage of providing data about the modes of action of
infusates, their effects on flow-metabolism coupling and
the effects of hypercapnia.
This work has shown that under certain conditions CBF CC>2
reactivity is lost in focally oedematous brain. The
functional significance of this finding merits further
study in view of the previous correlative clinical and
experimental observations. Recording of CBF, cortical
SEPs, MEPs and EEG, at various P C0„ levels, following
a Z.
particular infusions into the cat forebrain would enable
this question to be addressed. Such studies would
demonstrate, if the loss of CBF CC>2 reactivity was
reproduced, whether an inverse steal phenomenon caused
focal ischemia severe enough to cause EEG dysrhythmia or
changes in the evoked potentials. Subfractionation of
plasma proteins, infusion of glioma conditioned media
(with and without added steroid) and varying
concentrations of bradykinln could also elucidate the
source of the dysautoregulatlon. The author hopes to
continue investigation into the enigma of peritumoural
brain dysfunction using the infusion model and refinements
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APPENDIX 1
CONSTITUENTS OF THE 20% PROTEIN INFUSATE
75 ml sterile water
10 ml bovine serum
9 ml Eagles Media (Contains the following essential amino
acids)
- Arginine 100 mg/1
- Histidine 42 mg/1
- L-Cystine 73 mg/1
- Phenyl alanine 33 mg/1
- Tyrosine 45 mg/1
- L-isoleucine 42 mg/ml
3.3 ml NaHC03
1 ml Nonessential aminoacids
1 ml streptomycin
- Cystine 28 mg /I
- L-Glutamine 290 mg/1
- L-Methionine 15 mg/1
- Tryptophan 10 mg/1
- Valine 47mg/l
- L-leucine 52 mg/ml
1 ml 1OOmM pyruvate
1 ml penicillin (100 U/ml)





EB-GBM TF-Oligo GD-EBM JH-AA
Na mmol/L 1 36 146 1 35 1 4 1
K mmol/L 3 .4 3 .7 3 .4 4 .6
CI mmo1/L 1 05 1 1 4 1 02 1 06
co2 mmol/L 1 8 21 1 8 1 5
Urea mmol/L 7 .4 6 . 7 5 . 1 8.4
Bill mmol/L 1 2 9 1 0 -
Alk P U/L 1 6 30 4 1 24
P 04 mmo1/L 1.19 o • 00 1 . 28 1.14
Ca mmol/L 1.76 1 .82 1.91 1.79
P r o t g/L 40 42 46 5 1
Alb g/L 28 30 29 35
C rea t mmo1/L 0 .06 0.09 0 .09 0.09
LD U/L 1289 1 275 5740 27 20
A s t U/L 40 70 1 35 60
IgA IU/ml 3 1 3 1 4 9 44
IgG IU/ml 56 50 66 53
IgH IU/ml 69 32 60 1 2 2
TFN * g/L 1.51 1 .26 1.52 2.43
Mg mmol/L 0.77 0.37 0.74 LD•O
Cho 1 mmo1/L 6 .4 5 . 2 5 . 5 3 . 1
Electrophoretic Profiles
% g/dl % g/dl % g/dl % g/dl
Albumin 67 2.67 64 2 .69 59 2 . 7 64 3.25
Alpha-1 4 . 1 6 3 . 1 1 3 . 1 3 1 .05
Alpha-2 7 .28 7 .28 1 2 .55 6 .29
Beta 1 1 .4 2 1 2 .5 1 1 4 .64 20 . 1 0
Gamma 1 2 .46 1 5 .62 1 3 .58 1 0 .52
















Variations of ICP with PaC02 in the normal rat
The following data was obtained from two rats that were
paralysed and ventilated. PaC02 adjustments were produced
by altering the tidal volume and respiratory rates of the
ventilater. In all cases the Pa02 was above 100 mmHg
ICP mean BP PaC02 pH
(mmHg) (mmHg) (mmHg)
6.5 1 00 4 2 7 . 30
4.0 1 35 32 7.43
4 .5 1 00 29 7.38
7 . 5 1 70 48 7 . 26
6 .0 1 50 39 7 . 35
4 . 5 1 20 32 7.43
5 .0 1 08 30 7 .39
a> • o 1 05 50 7 .25
Linear regression eguation for the relationship between
ICP and PaC02
ICP = 0.173 PaC02 - 0.81
r = 0.96 p < 0.001
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APPENDIX 4
The morphology and amplitude of the spinal MEP waveform is
directly related to stimulus intensity. At 10 mA stimulation
of the motor cortex through a platinum iridium electrode a
small negative (N) wave can be recorded from the low
thoracic cord. At 15 mA stimulation a larger waveform is
recorded and there is a negative subcomponent to the P wave.
At 25 mA stimulus the waveform is of larger amplitude with
two well defined negative peaks. R = waveform following
right cortical stimulation, L that following left cortical




12 0 poin t
(ml/1OOg/min) calculated using a 5 and
analysis of the initial slope
5 point CBF 120 point D1 f f e
43 47 -4
54 47 + 8
45 45 0
45 45 0
35 47* - 1 2
45 53* -8
4 2 47 -5
45 40 + 5
49 60* - 1 1









37 50* - 1 3
52 53 -1
58 59 - 1
35 5 1 * - 1 6
42 46 -4
46 4 7 -1
20 21 - 1
21 24 -3
23 25 -2
26 34 * -8
23 26 -3
35 4 1 -6
In these 30 comparative flow values the 5 point analysis
was below the computerized 120 point analysis in 21 cases,
the same in 3 and higher in 6 cases. Computerized analysis
using videographics also enabled bi-exponentia1 curves (*)
to be readily detected. Nontheless the median error,
assuming 120 point analysis is the most accurate method, was




Table A. 1: Rat Subcortical tissue specific gravity adjacent
and contralateral to the site of intracerebral infusion. All









1 .0384 + .0009





1 .0394 + .001 6
1 .0402 + .0011
p = 0.69 ** p < .001
Table A.2: Rat grey matter specific gravity adjacent and
contralateral to the site of intracerebral infusion. There
were no statistically significant differences between








1 . 041 7 + .0009
1 .0423 + .001 6
1 .0429 + .0022
CONTRALATERAL
HEMISPHERE
1 . 041 3 + .001 6
1.0418 + .0016
1.0418 + .0023
Table A.3: Brain water content determined using wet/dry
weights of the infused and contralateral "control"













77.5 + 0.66% 77.3 + 0.72% *
78.3 + 0.29% 77.8 + 0.65% **
**0.1 < p< 0.0 5
14^
Table A.4: ICP changes in the rat (n = 7) during
intracerebral infusion with saline at 0.1 ml/hr. All data
mean + SD.
Time ICP PaC°2 BP
(min) (mmHg) (mmHg) (mmHg)
0 4.4 + 1.6 * 34 +2.4 94 + 21
20 5.0 + 1.5 36 +2.9 95 + 20
40 5.5 + 1.6 36 +1.7 89 + 16
60 6.3 +1.6 * 38 +5.1 87 + 16
* p = 0.04
Table A.5: ICP changes during intracerebral infusion in the
rat (n = 7) with a 20% protein solution at 0.1 ml/hr. The
difference between 0 and 60 min ICP is not significant. All
data mean + SD.
Time ICP P C00 BP9. 2.
(min) (mmHg) (mmHg) (mmHg)
0 5.4 + 1.2 31.4 +3.2 92 +21
20 5.7 + 0.7 32.2 +2.1 96 +10
40 5.9 + 1.2 33.3 +2.7 88 +9
60 6.2 + 2.2 32.6 +1.7 93 +15
! £ 0
Table A.6: Infusion pressure, brain tissue hydraulic
resistance (R t) and brain tissue compliance (Ct) in the rat
during intracerebral saline infusion at 0.1 ml/hr. Data are
mean + SD, n = 15.
TIME INFUSION Rt(x 104) Ct (x 10~3)
(min) PRESSURE (mmHg) (mmHg/m1/min) (ml/mmHg)
Peak 38 + 20 * 2.275 + 1.10 * 0.22
20 24 + 15 * 1.437 + 0.89 * 1.38
40 23 + 13 1.425 + 0.81 2.81
60 21+12 1.233+0.77 4.85
* p <( .001
Table A.7: Infusion pressure, brain tissue hydraulic
resistance (R^) and brain tissue compliance (Ct) in the rat
during intracerebral 20% protein infusion at 0.1 ml/hr. Data
are mean _+ SD, n = 18.






* p < .001
(min) PRESSURE (mmHg) (mmHg/ml/min)
Peak 43 + 19 * 2.575 + 1.14 *





L5.9+0 612.384.120 537 .8944033 R6.1+0 312.874..920 217 51
20L
R






































5.6+0 5 6.1+0 9 5.4+0 6 6.1+1 0 5.3+0 5 6.2+0 9
12.3+0.9 12.5+0.6 12.0+0.6 12.5+0.4 12.0+0.5 12.4+0.
13.8+0. 14.0+0.6 14.0+0.5 13.6+0.4 13.5+0.2 13.8+0.3
19.9+.7 19.6+ 19.9+ 20.1+1 19.8+ 19.6+
26.5+1. 28.5+1.0 26.7+.2 28.5+1.3 27.5+.5 29.5+1.
81+9 83+9 79+4
34+.3 34+. 34+.5
TableA.9:Peaklat nci s(ms)ofthfivmajorcorticalSEPw ve rmc mponentsbtained fromtheinfus d(left)ancontralateral(right)hemisp e esduringintrac rebral0.120% proteininfusionthat(=5)overneh ur.Meanart ialp essure( AP)immHgd PgC02arelsolisted.Alldatame n+SD.
Table A.10: CBF (ml /1 00 g brain/ minute) during the course
of left frontal intracerebral saline infusion (0.1 ml/hr for
60 minutes) in the rat with corresponding mean arterial





n = 1 0
40 +14
37 +16
R Post Parietal 35 +17





























Table A.11: CBF (ml /1 00 g brain/ minute) during the course
of left frontal intracerebral 20% protein infusion (0.1
ml/hr for 60 minutes) in the rat with corresponding mean
arterial pressure (MAP) and P CO,. All data mean + SD.d Z. —
Baseline 20 min 45 min 70 min
Site n = 10 n=9 n=9 n=9
R Ant Parietal 45 +17 37 +12 42 +18 46 +16
L Ant Parietal 42 +15 36 +9 35 +11 40 +9
R Post Parietal 40 +16 32 +15 34 +15 37 +14
L Post Parietal 45 +16 41 +16 45 +16 42 +14
PaC02(mmHg) 32.8 +3.1 35 +4.0 33.9 +3.3 32.0 +2.7





RAntParietalCBF=1.613aC02-.9CBF1. 7PgC02+3.4 n=49r0.762=28.7 LAntParietalCBF=1.58PaC02-5.20 2g 2+2 . n=46r0.7530.482 RPostarietalCBF=1.433PaC02-2.90.85+2.9 n=37r0.762=0.53 LPostparietalCBF=1.51PaC02-2.8CBF=1.06a 02-.2 n=48r0.774290.605 TableA.12;hregressionquati ns,correlationco ffic e ts( )andl v lsfsig ifica ce (p)forCBF02reactivityrchofthef urcer b all c tionst stedf llowing0.1ml frontalintracerebra1salineand20%proteininfus o .<0.001f lloca io sexc ptL anteriorparietal,followingproteiinfusinly,wh re0.01">.00 .
Table A.13; Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled
following sham infusion into the right centrum ovale. All data
mean + S D.





















Table A.14: Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled at 5-7
mm depth following 0.6 ml saline infusion into the right
centrum ovale. All data mean + SD.















78.8 + 3.8 *






Table A.15: Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled at
depth of 5-7 mm, following infusion of 0.6 ml of 20% protein
solution into the right frontal centrum ovale. All data mean
+ SD.
Tis sue H20 content SG
Cortex R
Cortex L
3 82.3 + 0.3





White R 5-7 mm 4 80.9 + 0.4 *
White L 5-7 mm 4 69.9 + 0.3 *
1 .0265 + .0006
1 .0407 + .001 9
p .00 1
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Table A.16; Specific gravity and water content (ml/100 girt
tissue) of cat frontal cortex and white matter, sampled at
variable depth, following infusion of 0.6 ml of 5000 ng/ml
bradykinin solution (0.2 ml/hr for three hours) into the right
frontal centrum ovale. All data mean + SD.









1 .0430 + .0034











1 .0292 + .0029







1 .0407 + .0034
1 .0406 + .0038
P < ,00 1
Table A.17; Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled at
variable depth, following infusion of 0.6 ml of 150 ug/ml
bradykinin solution into the right frontal centrum ovale. All




White R 3-7 mm
White L 3-7 mm
* p < . 0 1
n H2° sg
2 79.7 + 0.4 1.0437 + .0009
2 80.1 + 0.3 1.0429 + .0004
4 76.8 + 2.7 * 1.0305 + .0036
3 68.9 + 1.2 * 1.0412 + .0014
Table A.18: Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled at
variable depth, following infusion of 0.6 ml of arachidonic
acid solution (2 - 15 mg/ml) into the right frontal centrum
ovale. All data mean + SD.













79.4 + 2.2 *




Table A.19: Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled at
variable depth, following infusion of 0.6 ml of human
glioblastoma cyst fluid (GD) into the right frontal centrum























Table A.20: Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled at
variable depth, following infusion of 0.6 ml of human
anaplastic astrocytoma cyst fluid (JH) into the right frontal






1 .0432 + .0009
1.0442 + .0008
Wh ite




68.8 + 1.2 *
1 .0335 + .0030
1 .041 7 + .001 4
p = .003
Table A.21: Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled at
variable depth, following infusion of 0.6 ml of human
glioblastoma cyst fluid (EB) into the right frontal centrum
ovale. All data mean + SD.


















70.0 + 2.0 *
1 .0320 + .0031
1 .0398 + .0027
.00 1
I 57
Table A.22: Specific gravity and water content (ml/100 gm
tissue) of cat frontal cortex and white matter, sampled at
variable depth, following infusion of 0.6 ml of human
oligodendroglioma cyst fluid (TF) into the right frontal
centrum ovale. All data mean + SD.













78.9 + 0.6 *
68.1 + 0.3 *
1 .0350 + .0004
1 .0424 + .0004
p = .002
Table A.23; Intraventricu1 ar pressure (ICP) recorded during
3 hour period of sham infusion in the cat with
corresponding mean arterial pressures and PaC02 levels (n =
3). All data mean + SD.
Time (min) ICP (mmHg) P C00(mmHg) BP (mmHg)
a. £
0 4.8 + 1.0 * 32.6 +3.0 110 + 7
60 5.0 + 2.6 35.6 +0.6 120 + 20
120 7.3+4.9 37.0+4.0 120
180 7.8 + 6.2 * 35.2 +1.0 123 + 6
360 10.5+ 3.5 46.5 +1.4 122 + 6
* p = 0.45
Table A.24; ICP changes in four cats having saline
saline/5% ether (*) infusion at either 0.2 or 0.3 ml/hr.
o r
Volume/hr Baseline 60 min 120 min 180 min
0 . 2 m 1 2 4 ,
o • to ml 1 2










Table A.25; Intraventricular pressure (ICP) recorded during
20% protein intracerebral infusion at 0.2 ml/hr for three
hours in the cat (n = 8), with corresponding mean arterial
pressures and paC02 levels. All data mean + SD.
Time (min) ICP (mmHg) PaC02(mmHg) BP (mmHg)
0 6.7 + 3.8 * 31.9 +2.28 135 + 19
60 11.4 + 7.6 32.8 +2.29 137 + 20
120 14.4 + 9.1 33.9 +2.97 132 + 19
180 16.9 + 9.4 * 34.8 +3.11 136 + 16
360 14.1 + 2.8 36.8 +6.0 110+ 10
* p = 0.02
Table A.26: Intraventricular
and after bradykinin infusion,
ug/ml (n = 1), in the cat. The
P
= CO~ levels are for the 5000
mean + SD.
pressure (ICP) recorded during
at 5000 ng/ml (n = 7) and 150
mean arterial pressures and
ng/ml infusion group. All data
Time ICP
(min) 5000 ng/ml










27 33 . 9 +2 .97
23 34.8+3.11
1 2 43.0 +5.7 1








Table A.27: Intraventricular pressure (ICP) recorded during
arachidonic acid infusion, at doses ranging from 2 - 15
mg/ml, in the cat (n = 6), with corresponding mean arterial
pressures and PaCC>2 levels. All data mean _+ SD.
Time ICP (mmHg) PaC02(mmHg) BP (mmHg)
0 5.1 + 2.4 * 34.4 +3.0 122 + 16
30 8.2 + 2.5 34.0 +3.7 128 + 12
60 8.0 + 3.6 34.2 +1.3 115 + 19
90 10.0 + 3.9 34.2 +2.4 114 + 20
120 11.8 + 3.2 34.8 +2.0 122 + 16
150 13.7+4.3 35.1+3.2 115+23
180 14.0+3.0* 34.8+1.3 115+25
360 8.2+1.1 37.6+4.4 121+13
* p <C .001
Table A.28 Intraventr1cu1 ar pressure (ICP) recorded during
3 hour period of intracerebral infusion of 0,6 ml of human
glioblastoma cyst fluid (GD) in the cat (n = 2), with
corresponding mean arterial pressures and PgC02 levels. All
da ta mean + SD.
Time ICP (mmHg) PaC02(mmHg) BP (mmHg)
0 6.0 + 3.5 34.0 + 1.8 138 + 3
60 11.0 + 0.8 33.5 + 2.8 130
120 15.8+10 32.0+1.7 120
180 21.3 + 5.3 34.2 + 1.7 110
360 12.8+1 42.5+4 115
IfeO
Table A.29; Intraventricular pressure (ICP) recorded during
3 hour period of intracerebral infusion of 0,6 ml of human
anaplastic astrocytoma cyst fluid (JH) in the cat (n = 2),
with corresponding mean arterial pressures and PaC02 levels,
All data mean _+ SD.
Time ICP (mmHg) PaC02(mmHg) BP (mmHg)
0 8.3 + 1.7 34.3 + 2.2 140 + 6
60 13.8 + 1.8 33.5 + 0.8 125 + 14
120 17.5 + 3.5 33.0 + 1.4 118 + 11
180 22.0 + 5.6 32.0 + 1.4 118 + 11
360 16.2 + 3.2 34.0 + 1.4 115
Table A.30; Intraventricular pressure (ICP) recorded during
3 hour period of intracerebral infusion of 0,6 ml of human
glioblastoma cyst fluid (EB) in the cat (n = 2), with
corresponding mean arterial pressures and PaCC>2 levels. All
da ta mean + SD.
Time ICP (mmHg) PaC02(mmHg) BP (mmHg)
0 9.8 + 3.2 34.3 + 5.0 130 + 11
60 12.3 + 5.3 34.5 + 2.1 132 + 17
120 14.5 + 7.2 33.8 + 0.5 127 + 11
180 19.0 + 9.0 32.5 + 3.5 135 + 7
360 9.8+3.3 37.0 135+7
Table A.31; Intraventricular pressure (ICP) recorded during
and after a 3 hour period of intracerebral infusion of 0,6
ml of human oligodendroglioma cyst fluid (TF) in one cat
with corresponding mean arterial pressures and PaC02 levels.
All data mean + SD.
Time ICP (mmHg) P CO,(mmHg) BP (mmHg)
a £
0 3.0 33 120
60 9.5 35 130
120 14 30 130
180 13 32 125
300 35 1 00
TIMESHAMALINE20%PROT INB ADYKINIA CHIDONICID (min)n=3)3(=8)65 0 60 120 180 3600.411+.048 0.367+.110 0 .342+128 0 .335+13 0.4080.379+.114 0 .460+.160 0 .499+.048 0.436+.040 NA0.529+.1 3 0.517+.173 0.545+.170 0.515+.078 0 .445+190 .444+169 0.437+.150 0 .483+18 0 .456+18 0.398+.122






TableA.32:hIntr cranialpressurevolumindex(PVI)malculat dfollowing intraventricular0.1mlsalinebolusdu ingintracerebralf sionfhh rstratof 0.2ml/hrwitsaline,20%proteinandbradyki in5 00ng/mlsolut o s.Alld aime+SD.P valuesref rtodifferencesbetwe nas line(0)d180miPVIva u .
TIMEEB-GBM
(min)=2 0.538+.069 600.4 0+.051 1200.398+095 1800.462+3 3600.462
JH-AA
(n=2) 0.417+.034 0.418+.016 0 .428+.044 0 .464+058 0.490+.035
GD-GBM (n=2) 0.361+.107 0.352+.043 0.315+.143 0.316+.053 0.332
TF-OLigo (n=1) 0.371 0 .504 0.509 0.386 0.480
TableA.33:heintracranialpressurevolumindex(PVI)mlcalc latedfoll wing anintraventricu1r0.1mlsalinebolusdu ngintrace ebralf sionfhr hoursatratef0.2ml/hrwiv riousu angliomacystfl id .Alld tis mean+SD.
TIME (min) 0 60 120 180 360
SHAM
(a=3) 70+31 84+47 173+85 149+04 130
SALINE
(n=3) 120+95 137+99 125+87 205+96 NA
2.0%PROTEIN (a=8) 88+57 139+91 138+13 128+06 152+73
BRADYKININ (n=6) 70+31 103+93 133+1 189+96 136+8






TableA.34;CSFoutf owresistancemmHg/ml/minb forandt60i ut intervalsduringin racerebralinfus onalulatedonmi utefter intraventricularinjectionof0.1mlb lussaline.Aldati e n+,SD.Pv l s refertodifferencesbetwe nas line(0)a d180miva u .
TIME
(min) 0 60 120 180 360
EB-GBM (n=2) 170+53 137+89 260+48 252+8 224
JH-AA (n=2) 78+22
140+6 240+74 269+74 325+
GD-GBM
(n=2) 89+24 241+97 195+67 457+1 4 430+205
TF-OLIGO (n=1) 50 140 184 183 88
TableA.35:CSFoutf owresistance(mmHg/m1/min)measuredbefor andt60mi uteintervalsduringi tr ce ebralinf sionw h varioushumangliomacystflu donei tefter intraventricularject onof0.1mlb lussaline.Ald tean +SD.
TIMESHAMALIN20%PROTEINBR DYKINA CHIDONICD (n=3)3)h865
0 .042+08 60.036+1 120. 24+.013 180.024+13 360.012
,039+.018 ,026+.020 ,019+.018 ,012+.005 NA
,039+.011 ,023+.013 ,015+. 08 ,014+.009 ,015+. 03
.040+.019 .028+.019 .023+.019 .014+07 .012+09






TableA.36:Lumpedcraniospinalom liance(ml/ mHg)measurebefora dt60mi tint va s duringintrace ebrali f siofollowint v ntricu1je tof0.1mlsaline.All datame n+SD.pvaluesref rtoiffer nceincompliancbetw eas li(0)and180mi te values.
TIKEEB-GBM (min)n=2) 0.029+.013 600.016+.004 1200.015+. 02 1800.008 3600.022
JH-AA
(a=2) 0.022+.013 0.013+.001 0.011+.001 0.009+.001 0.011+.4
GD-GBM (n=2) 0.031+.0 1 0.014+.001 0.010+.0 2 0.008+.001 0.011
TF-OLIGO (a=1) 0 .047 0.023 0.016 0.012
TableA.37:Lampedcraniospinalom liance(ml/ mHg)record dfo l w gintrv ntricular bolusinjectionf0.1mlsal nefor ,duri gandfterintrace ebralf siwith gliomacystfluid.Alldatamean+SD
Table A.38: Infusion pressure ) and ICP (both in mmHg)
at specific times (min) during intracerebral infusion in 8
cats. Brain tissue hydraulic resistance ( R ._ ) is in
mmHg/ml/min x 10. Cat 1 protein infusion, cat 2 saline
infusion, cats 3-8 bradykinin infusion. No ICP data
available for cats 1 and 5. Mean + SD for each parameter at
each time point is listed in the last three rows.
Cat 2-3
Time (min)
1 0 60 1 20 1 80
r inf
ICP

































































































TIMELOCUSSEPLAT NCIES (mln) N6P107284 BaseR5.69 2+1 16.2 _+.329.5+0 749 L5.9+0 29 416.07283 60R5.3+0 28 916.562914 L5.9+0.29 1 615.4+2.2936 120R5.5+0 28 8.5.7 _+.829444, L6.1+092753.2.0339 180R5.68 7+6.292 5140 L6.0+0.49 2 816.2+2.739_ 360R5.5+0 28.8_125 4.629. +0.747 L5.9+0 29 716.5338 TableA.39;Shortndlo gatencycompo nts(ms)ft aorticalEP followingrepawstimulatiodurinandfterh mr ghtintr ce ebralI f sio forthreeh urs(n=3).Intert ialamplitudefP1Q-N 7componentvar between4and10uV.Alld tam+SD



















R L R L R L R L
N6
5.2







16.0 14.8 14.6 14.4 14.4 14.8 14.4 14.6 12.8
"28 29.0 29.0 28.5 27.7 26.8 25.7 25.5 25.8 24.0 25.0
N47 42 45 43 44 38 46
39 45 36
60 60 64 54 59 51 57







BaseR5.69+016 829.57 L5.69 4+0.316.829 70 60R.1+0.410.016,6+ .329.5 2.1 L5.8+0 3917.2_.6303745 120R5.4+0 79 616.2.331 02 1 L5.4+0.39.4+0.16.0306 180R5.69 8+0.317 +0.830 74 L5.4+0.39.4+0.16.6+0.331.0+0.78 360R6.10.88 6+0.331 52 152 L5.5+0 19 9416.0.31 52 2 TableA.45:Shortndlo gatencycomponents(ms)ft articalSEP followingf repawstimulationdurirightint acerebralf siow h anaplasticastrocytomacy tfluid(JH)orth eeh u s0.2ml/hrndix hoursaftercommencementfthinfusio(=2).Data+SD.
TIMELOCUSSEPLAT NCIES (min) N6P107284 BaseR5.8+0 310.77.427 673 L6.4+0 610.27 6.28 5845 60R5.610.2+0 36 427439 L6.2+0 310.066 6341+4 120R5.4+0 30.0.652 5.14 +2 L5.69+015.828 540+3 180R5.60.0+05 826.7+3 L5.6+0.69.4+0.315.227.0+1.38" 360R6.2+0 310.064_.72 5.4 _+ L5.8+0 310.27 063 542 TableA.46:Shortndlo glatencycompo nts(ms)ft aorticalEP followingrepawstimulationdurinrightintrace ebralf siowith glioblastomacy tfluid(GD)rthreehoursa0.2ml/hrns xfter commencementfthinfusio(n=2).Data+SD.
TIMELOCUSSEPAT NCIES (min) N6P10n 7p284 BaseR5.2+0 69 0,814.7327.048 L5.4+0 39 015.2729 048+7 60R5.2+0 69 815.228 047 L6.2+0.89.8+1.715.7+0.130.47 6 120R5.69 5+04.5429.849 L5.69 5+_0.114.9■+29.048 180R5.294+0367.5 _+2486 L5.4+0 39 7114..628528" 360R5.+0 89 _2.014594 L6.1+0 79 215.227 5051+4 TableA.47:Shortndlo gatencycompon nts(ms)ft aorticalEP followingrepawstimulatiodurinr ghtintrace ebralf siow th glioblastomacy tfluid(EB)rthreehou sa0.2m /hrns xrfte commencementfthinfusion(n=2).Data+SD.
Table A.48: Latencies (ms) and amplitudes (uV) of the major
components of the MEP recorded in the low thoracic region
following unilateral transcranial stimulation three hours
after completion of sham infusion into the right frontal
centrum ovale. The amplitude is derived from the N1-P1
component.
Cat Side N2 N3 Amplitude
1 R 2.80 3.28 3.76 120
L 2.80 3.32 3.84 120
2 R 2.76 3.56 5.76 35
L 2.86 3.60 5.24 12
Table A.49; Latencies (ms) and amplitudes (uV) of the major
components of the MEP recorded in the low thoracic region
following unilateral transcranial stimulation three hours
after completion of saline infusion into the right frontal
centrum ovale. The amplitude is derived from the N1 -P1
component.
Cat Side N1 N2 P2 N3 Amplitude
1 R 3.16 3.36 3.64 4.68 20
L 3.16 3.32 3.56 4.64 6
2 R 2.60 3.28 4.32 12
L 2.56 3.40 4.24 10
Table A.50: Latencies (ms) and amplitudes (uV) of the major
components of the MEP recorded in the low thoracic region
following unilateral transcranial stimulation three hours
after completion of 20% protein infusion into the right
frontal centrum ovale. The N1 amplitude is derived from
the N .J -Pi component.
Cat Side N., P1 N2 N3 N4 Amp
1 R 2.48 2.76 3.20 4.32 6.44 75
L 2.52 2.76 3.16 4.36 6.60 75
2 R 2.60 2.92 3.28 - - 15
L 2.56 2.84 3.40 - - 15
ne
Table A.51: Latencies (ms) and amplitudes (uV) of the major
components of the MEP recorded in the low thoracic region
following unilateral transcranial stimulation three hours
after completion of bradykinin infusion into the right
frontal centrum ovale. The N1 amplitude is derived from the
N^-p^ component. Cats 1 - 4 bradykinin 5000 ng /ml infusion,
cat 5 bradykinin 150 ug/ml infusion.
Cat Side N1 PN2 N3 N4 Amp
1 R 2.95 3.23 3.60 4.05 4.65 8
L 2.95 3.20 3.60 - 4.70 8
2 R 2 .88 3 .08 4 .00 - - 7
L 2.88 3.12 4.30 - - 7
3 R 2.40 2.60 2.80 3.20 3.64 30
L 2.40 2.68 2.80 3.40 3.80 30
4 R 2.60 2.92 3.28 4.68 6.36 25
L 2.56 2.84 3.40 4.92 6.88 25
5 R 2.52 2.72 3.28 4.36 6.56 100
L 2.52 2.76 3.28 4.24 6.60 90
Table A.52: Latencies (ms) and amplitudes (uV) of the major
components of the MEP recorded in the low thoracic region
following unilateral transcranial stimulation three hours
after completion of arachidonic acid infusion into the
right frontal centrum ovale. The N1 amplitude is derived
from the P^-N1 component. Cats 1 - 3 arachidonic acid 10
mg/ml infusion, cat 4 arachidonic acid 15 mg/ml infusion.
Cat Side N1 P1 N2 N3 N4 Amp
1 R 2.40 2.80 3.16 3.64 4.68 60
L 2.36 2.72 3.16 3.68 5.04 60
2 R 2.16 2.32 2.60 2.80 - 40
L 2.16 2.32 2.56 2.76 - 40
3 R 2.36 2.76 3.12 3.64 - 8
L 2.32 2.72 3.12 3.52 - 8
4 R 2.24 2.52 2.70 3.08 3.56 50
L 2.24 2.52 2.76 3.08 3.56 50
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Table A.53: Latencies (ms) and amplitudes (uV) of the major
component.s of the MEP recorded in the low thoracic region
following unilateral transcranial stimulation three hours
after completion of human glioma cyst fluid infusion into
the right frontal centrum ovale. The amplitude is
derived from the P ^-N j component. Cat prefix refers to
tumour type and patient from which extracted. Cat JH-AA *
MEP recorded from Tg region.
Cat Side N^ P| N2 N3 N^ Amp
GBM-GD R 2.64 3.16 - 8
L 2.44 2.76 - - - 8
GBM-GD R 2.92 3.40 3.72 4.04 4.92 50
L 2.80 3.08 3.40 4.28 4.76 50
JH-AA R 2.52 - 3.08 3.36 3.92 100
L 2.52 - 3.12 3.40 4.00 100
JH-AA* R 2.12 2.84 3.56 6.08 - 40
L 2.12 2.84 3.56 6.08 - 40
GBM-EB R 2.80 - - - 6.16 300
L 2.80 - - - 6.16 300
GBM-EB R 2.88 - 3.20 - 5.64 200
L 2.84 - 3.24 - 5.72 200
TF-OLI R 2.28 2.64 3.04 3.44 3.68 60
L 2.28 2.60 3.04 3.44 3.68 200
Table 3.54: rCBF (ml/100 g brain/min) before and during the
course of sham infusion with corresponding PaC02 values (n









0 Frontal 26 + 6 28 + 5 32 . 6 + 3 . 0
Parietal 36 + 5 38 + 1 8
60 Front al 32 + 6 31 + 1 1 35 . 6 + 0 . 6
Parietal 50 + 8 42 + 1 7
1 20 Front a1 28 + 6 32 + 6 37.0 + 4.0
Parietal 46 T 6 44 + 6
180 Front al 29 + 10 29 + 7 35.2 + 1 .0
Parietal 43 + 3 40 + 1 2
teo
Table A.55: rCBF (ml/100 g brain/min) before and during R
frontal 0.2 ml/hr saline infusion, with corresponding paC02
(n = 3). All data mean + SD.
TIME































4 2 + 6
35 + 12
4 1 +9
31.6 + 1 .5
Table A.56: rCBF (ml/100 gm brain/min) during three hours of
intracerebral infusion with 20% protein infusion at 0.2
ml/hr in the cat (n = 7). All data mean _+ SD.
TIME INFUSED (R) CONTROL (L) PaC°2
(min) HEMISPHERE HEMISPHERE (mmHg)
0 Frontal 42 + 1 6 38 +_ 5 31 _+ 3.6
Parietal 47 _+ 1 6 36 + 1 0
60 Frontal 49 +16 44+14 32+1.9
Parietal 48 +11 45 + 18
120 Frontal 49 +12 48 + 18 32 + 3.2
Parietal 53 +13 48 + 19
180 Frontal 46 +13 49 + 18 34 + 3.7
Parietal 48 +12 48 + 18
Table A.57; rCBF (ml/100 g brain/min) during three hours of
R frontal infusion with 5000 ng/ml bradyklnin solution at an
infusion rate of 0.2 ml/hr in the cat (n = 6). All data mean
± SD •
TIME INFUSED (R) CONTROL (L) PaC02
(min) HEMISPHERE HEMISPHERE (mmHg)
0 Frontal 43 +23 42 + 22 34 + 2.6
Parietal 39 +15 52 + 14
60 Frontal 41+16 39+18 34 + 1.9
Parietal 36 +15 50 + 15
120 Frontal 44 +16 37 + 16 35 + 1.7
Parietal 37 +10 53 + 14
180 Frontal 41 +13 40 + 12 34 + 1.4
Parietal 35+9 52+18
Table A.58: rCBF (ml/100 g brain/min) during three hours of
intracerebral infusion with arachidonic acid solution (2-15
mg/ml) at an infusion rate of 0.2 ml/hr in the cat (n = 6).
Mean BP ranged from 114 to 122 mmHg during the period of
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Table A.59: rCBF (ml/100 g brain/min) during three hours of
intracerebral infusion with glioblastoma cyst fluid (GD) at
an infusion rate of 0.2 ml/hr in the cat (n = 2). Mean BP
ranged from 110 to 138 mmHg during the period of infusion.











49 + 7 *
50 + 17














3 1 + 15





39 + 15 34 + 1 .7
p <. .001
Table A.60: rCBF (ml/100 g braln/mln) during three hours of
intracerebral infusion with anaplastic astrocytoma cyst
fluid (JH) at an infusion rate of 0.2 ml/hr in the cat (n =
2). Mean BP ranged from 110 to 150 mmHg during the period of
infusion. All data mean + SD
TIME



































Table A.61: rCBF (ml/100 g brain/min) during three hours of
intracerebral infusion with anaplastic astrocytoma cyst
fluid (EB) at an infusion rate of 0.2 ml/hr in the cat (n =
2). Mean BP ranged from 110 to 138 mmHg during the period of
































30 + 3 *
40 + 4
30 + 11 * *
57 + 18
34 + 1.7
* p = 0.003 * * p = 0.018
Table A.62: rCBF (ml/100 g brain/mtn) during three hours of
intracerebral infusion with oligodendroglioma cyst fluid
(TF) at an infusion rate of 0.2 ml/hr in the cat (n =1).
Mean BP ranged from 110 to 138 mmHg during the period of





































Table A.63; Frontal white matter CBF (ml/1OOg brain/min)
during right intracerebral infusion with 20% protein






















3 1 + 3.6
32 + 1 .9
32 + 3.2
34 + 3.7
Table A.64; Frontal and parietal white matter CBFw (ml/100 g
brain/min) during intracerebral infusion with arachidonic
acid solution (10 mg/ml) at a
(n = 5). All data mean + SD
rate of 0.2 ml/hr in the cat
TIME




































Table A.65: CBF C02 reactivity following right frontal
infusion with 0.6 ml of arachidonlc acid solution (2.5 - 15
mg/ml) was expressed by the following eguations (derived
from linear regression analysis of CBF and C02 data).
Correlation coefficients and levels of significance are also
listed.
1 R Frontal CBF = 0.85 PaC02 + 9.2
n = 2 2 r = 0.58 0.01 > p>0.001
2 L Frontal CBF = 1.36 PgC02 - 1.9
n = 30 r = 0.60 p < 0.001
3 R Parietal CBF = 1.01 PgC02 + 17.9
n = 18 r = 0.70 p 0 . 0 0 1
CBF = 0.77 PgC02 + 26.1
n = 14 r = 0.75 p < 0.001
4 L Parietal
Table A.66: CBFW reactivity to changes in PgC02 following
right frontal intracerebral arachidonic acid infusion was
expressed by the following eguations and correlation
coefficients (derived from linear regression analysis of CBF
and C02 data).
1 R Frontal CBPW = °-31 paC02 + 7,5
n = 22 r = 0.60 p^0.001
2 L Frontal CBF = 0.63 P=C0o + 1w a 2
n =12 r = 0.77 0.01)p > 0.001
3 R Parietal CBFw = °»58 paC02 + 5,2
n = 8 r = 0.87 0.01 ")>p '^0.001
CBF = 0.51 P=C0o - 0.2w a 2 .
n = 12 r = 0.79 0 . 01 y p 0 . 0 0 1
4 L Parietal F„ = .
Table A.67: CBF CC>2 reactivity at four different loci,
following right intracerebral 20% protein infusion was
expressed by the following eguations and correlation
coefficients (derived from linear regression analysis).
1 R Frontal CBF = 0.571 P CO, + 33.99 z
2 L Frontal CBF = 0.431 P=C0o + 32.8
a Z
3 R Parietal CBF = 0.42 P=CO, + 39.7
a Z
4 L Parietal CEF = 0.636 POO, + 29
a Z
n = 30 r = 0.35 p = NS
P
g C O 2 + 32.8
n = 20 r = 0.32 p = NS
PgC02 + 39.7
n = 1 7 r = 0.30 p = NS
PgC02 + 29
n = 1 1 r = 0.34 p = N S
165
Table A.68: CBF C02 reactivity at four different loci,
following right frontal infusion with 0.6 ml of 5000 ng/ml
bradykinin solution was expressed by the following
equations and correlation coefficients (derived from linear
regression analysis).
R Frontal CBF = 0.57 P,C0o + 13
y a ^
R Parietal CBF„ = 0.005 P C0o + 27
y a.
L Parietal CBF„ = 0.71 P,C0o + 23
y a Z.
n = 27 r = 0.33 0.1 ) p > 0.05
L Frontal CBFq = °»32 PaC02 + 29
n = 2 5 r = 0.14 p 0 . 1
F = . 02 + 27
n = 24 r = 0.007 p > 0 . 1
BF = . P 02 + 23
n = 28 r = 0.32 P } 0 . 1
to the right frontal infusion site, following
infusion of glioma cyst fluid was expressed by the following















0.29 PaC02 + 1 8
=13, r = 0.24,
0.4 2 PgC02 + 1 1
=16, r = 0.81,
0.13 PgC02 + 20
r = 0.14,1 6,
2.25 P _C0
= 9,
a 2 - 32
r = 0.96,
p = NS























0.36 PgC02 + 12
r = 0.56.




p < 0 . 00 1
p < 0.05
p < 0.001
p < 0.001
